Abstract Issue: American Society of Hypertension Nineteenth Annual Scientific Meeting
TABLE OF CONTENTS
Volume 17, Issue 5S (May 2004)
Abstracts
OR-1: Impact of hypertension on sympathetic nerve hyperactivity in the dysmetabolic syndrome
Robert J. Huggett, Jeff Bannister, Alan F. Mackintosh and David A.S.G. Mary
Am J Hypertens 17: 1A-1A; doi:10.1016/j.amjhyper.2004.03.001
OR-2: Risk and impact of incident glucose disorders in hypertensive older adults treated with an ace inhibitor, a diuretic, or a calcium channel blocker: a report from the allhat trial
Joshua I. Barzilay, Sara Pressel, Barry R. Davis, Karen L. Margolis, Jeffey Cutler, Stephen T. Ong, Jan Basile, Laurie S. Sadler, John Summerson and Paul K. Whelton for the ALLHAT Collaborative Research Group
Am J Hypertens 17: 1A-1A; doi:10.1016/j.amjhyper.2004.03.002
OR-3: The metabolic syndrome influences left ventricular mass and function in non-diabetic patients
Anna M. Grandi, Mariaelena Giudici, Paolo Saggiorato, Emanuela Laurita, Francesco Solbiati, Francesca Piperno, Andrea M. Maresca and Achille Venco
Am J Hypertens 17: 1A-2A; doi:10.1016/j.amjhyper.2004.03.074
OR-4: Albuminuria predicts cardiovascular outcome with losartan versus atenolol in patients with diabetes, hypertension and left ventricular hypertrophy. A life diabetes substudy
Hans Ibsen, Michael Hecht Olsen, Kristian Wachtell, Knut Borch-Johnsen, Lars Lindholm, Bjoern Dahloef and Steve Snapinn
Am J Hypertens 17: 2A-2A; doi:10.1016/j.amjhyper.2004.03.003
OR-5: Hunting for hypertension genes: The national millennium genome project in japan, the first report
Tetsuro Miki, Yasuharu Tabara, Katsuhiko Kohara and Jun Nakura the Study Group of Millennium Genome Project for Hypertension
Am J Hypertens 17: 3A-3A; doi:10.1016/j.amjhyper.2004.03.004
OR-6: Modifications in the proteome of hearts from spontaneously hypertensive rats (SHR) treated with antihypertensive drugs
Julio Gallego-Delgado, Alberto Lazaro, Julio Osende, Fernando Vivanco and Jesus Egido
Am J Hypertens 17: 3A-3A; doi:10.1016/j.amjhyper.2004.03.005
OR-7: Arterial elasticity and structural changes of the cardiovascular system in asymptomatic young adults: The bogalusa heart study
G.S. Berenson, W. Chen, S.R. Srinivasan, E.R. Urbina and S. Li
Am J Hypertens 17: 3A-4A; doi:10.1016/j.amjhyper.2004.03.006
OR-8: Ovarian hormones modulate neointima formation in an animal vascular injury model through effects on neutrophil chemokine production
Nathaniel M. Weathington, Andrew P. Miller, Ji An Feng, Dongqi Xing, J.Edwin Blalock, Yiu Fai Chen and Suzanne Oparil
Am J Hypertens 17: 5A-5A; doi:10.1016/j.amjhyper.2004.03.007
OR-9: History of hypertension and 5-year global mortality and causes of death after acute myocardial infarction
Giuseppe Berton, Rocco Cordiano, Rosa Palmieri, Stefania Petucco, Valeria Pagliara, Paolo Mormino and Paolo Palatini
Am J Hypertens 17: 5A-5A; doi:10.1016/j.amjhyper.2004.03.008
OR-10: Exercise and cardiovascular mortality among hypertension subjects
Fang Jing and Michael H. Alderman
Am J Hypertens 17: 5A-6A; doi:10.1016/j.amjhyper.2004.03.009
OR-11: RGS2 expression and intracellular ca2+ mobilization in fibroblasts from hypertensive patients
Michelangelo Sartori, Giulio Ceolotto, Livia Lenzini, Italia Papparella, Lorenzo A. Calò, Elisa Pagnin and Andrea Semplicini
Am J Hypertens 17: 7A-7A; doi:10.1016/j.amjhyper.2004.03.010
OR-12: Atrial natriuretic peptide inhibits collagen production in cardiac fibroblast
Dajun Wang, Suzanne Oparil and Yiu-Fai Chen
Am J Hypertens 17: 7A-7A; doi:10.1016/j.amjhyper.2004.03.011
OR 13: Aspirin reduces platelet vascular endothelial growth factor and angiopoietin-1
Sunil K. Nadar, Andrew D. Blann and Gregory Y.H. Lip
Am J Hypertens 17: 7A-8A; doi:10.1016/j.amjhyper.2004.03.012
OR 14: Platelet type 12S-lipoxygenase antisense knockout or biochemical inhibition induce programmed cell death in human vascular smooth muscle cells
Gary Weisinger, Merav Hirsh, Esther Knoll and Naftali Stern
Am J Hypertens 17: 8A-8A; doi:10.1016/j.amjhyper.2004.03.013
OR 15: Angiotensin-converting enzyme regulates bradykinin receptor gene exression
Ivana Ignjacev, Ekaterina Kintsurashvili, Conrado Johns, Olga Vitseva, Sherene Shenouda, Irene Gavras and Haralambos Gavras
Am J Hypertens 17: 8A-8A; doi:10.1016/j.amjhyper.2004.03.014
OR 16: Dependence of renal excretory response to ETA receptor blockade on renal endothelin (ET) synthesis
Radoslav Girchev, Angela Baecker, Petya Markova and Herbert J. Kramer
Am J Hypertens 17: 8A-8A; doi:10.1016/j.amjhyper.2004.03.015
OR 17: Effect of perindopril/indapamide versus atenolol on angiogenesis and endothelial function in essential hypertension
Natali A.Y. Chung and Gregory Y.H. Lip
Am J Hypertens 17: 9A-9A; doi:10.1016/j.amjhyper.2004.03.016
OR 18: The red blood cell (RBC) argenine-nitric oxide pathway may be related to the phenoptypic expression of low RBC potassium in hypertensives
Maria C. Delgado and Alan B. Weder
Am J Hypertens 17: 9A-9A; doi:10.1016/j.amjhyper.2004.03.017
OR 19: Ambulatory blood pressure monitoring predicts increased left ventricular mass in children with primary hypertension
Deborah P. Jones, Phyllis A. Richey, Kim A. Fisher and Thomas G. DiSessa
Am J Hypertens 17: 10A-10A; doi:10.1016/j.amjhyper.2004.03.018
OR 20: Diastolic dysfunction in normotensive offspring of essential hypertensive parents
Alfredo Garzon, Federico Soria, Arcadi Garcia, Gines Ortega, Nicolas Ortega, Francisca Teruel, Ramon Rubio and Mariano Valdes
Am J Hypertens 17: 10A-10A; doi:10.1016/j.amjhyper.2004.03.019
OR 21: Intracerebral adenoviral gene transfer of superoxide dismutase (SOD) blocks the effects of angiotensin II (ang II) in rabbits with chronic heart failure (CHF)
Irving H. Zucker, Lie Gao and Kurtis G. Cornish
Am J Hypertens 17: 11A-11A; doi:10.1016/j.amjhyper.2004.03.020
OR 22: The relationship of matrix metalloproteinase and tissue inhibitor of MMP and diastolic function in left ventricular hypertrophy
Leslie L. Clark, Weems R. Pennington, Amy Hardin, Catherine McClure, Rupak Mukherjee, Michael R. Zile, Daniel T. Lackland and Francis G. Spinale
Am J Hypertens 17: 11A-11A; doi:10.1016/j.amjhyper.2004.03.021
OR 23: Cardiac repolarization and its relation to left ventricular geometry and rate in reverse remodeling
Karin Malmqvist, Thomas Kahan, Magnus Edner and Lennart Bergfeldt
Am J Hypertens 17: 11A-11A; doi:10.1016/j.amjhyper.2004.03.022
OR 24: Vascular heme oxygenase-1 ameliorates aldosterone-elicited arterial injury in mice
Toshisuke Morita, Takao Sugiyama and Gen Yoshino
Am J Hypertens 17: 12A-12A; doi:10.1016/j.amjhyper.2004.03.023
OR 25: Hypokalemia in the absence of elevated aldosterone ameliorates renal dmamge in stroke prone spontaneously hypertensive rats (shrsp)
Gagan D. Singh, Praveen N. Chander, Iram H. Huda, Jeffrey M. Ranaudo and Charles T. Stier Jr..
Am J Hypertens 17: 12A-12A; doi:10.1016/j.amjhyper.2004.03.024
OR 26: Activation of the intrarenal renin-angiotensin system in diabetic women ingesting the oral contraceptive
Sofia B. Ahmed, Deborah A. Price, Lori M. Laffel, M.Cecilia Lansang, Radomir Stevanovic, Naomi D.L. Fisher and Norman K. Hollenberg
Am J Hypertens 17: 12A-12A; doi:10.1016/j.amjhyper.2004.03.025
OR 27: Central I1- imidazoline receptors and blood pressure: a crosstalk with 
2-adrenergic receptors
P. Bousquet, V. Bruban, S. Schann, J.D. Ehrardt, L. Monassier and J. Feldman
Am J Hypertens 17: 13A-13A; doi:10.1016/j.amjhyper.2004.03.026
OR 28: High cholesterol diet induces baroreceptor dysfunction in guinea pigs
Joy Owen, Stephen J. Lewis and Graves E. Jonathan
Am J Hypertens 17: 13A-13A; doi:10.1016/j.amjhyper.2004.03.027
OR 29: New quantitative assessment of orthostatic hypotension: A white-noise approach with random head-up tilting
Fumiyasu Yamasaki, Kyoko Sato, Motonori Ando, Yoshinori Doi, Tetsuro Sugiura and Takayuki Sato
Am J Hypertens 17: 13A-14A; doi:10.1016/j.amjhyper.2004.03.028
OR 30: Different roles of vagal and sympathetic systems in heart rate control for stabilizing arterial pressure against orthostatic stress in humans
Fumiyasu Yamasaki, Kyoko Sato, Motonori Ando, Yoshinori Doi, Tetsuro Sugiura and Takayuki Sato
Am J Hypertens 17: 14A-14A; doi:10.1016/j.amjhyper.2004.03.029
OR 31: Central versus peripheral sympathetic inhibition on arterial blood pressure and heart rate variability in essential hypertension
Christos Nicopoulos, Aikaterini Fountoulaki, John Giannakoulis, Vasilis Demopoulos, John Skoularigis and Fillipos Triposkiadis
Am J Hypertens 17: 14A-14A; doi:10.1016/j.amjhyper.2004.03.030
OR 32: Whole-blood viscosity, autonomic nervous system, and effects of mental stress in borderline hypertensive and normotensive subjects
Henrik M. Reims, Knut Sevre, Aud Høieggen, Eigil Fossum, Ivar Eide and Sverre E. Kjeldsen
Am J Hypertens 17: 14A-15A; doi:10.1016/j.amjhyper.2004.03.031
OR 33: Hemodynamic, autonomic and neurohormonal behaviour in a ten-minute head-up tilt evaluation in different orthostatic intolerance syndromes
Joao P Freitas, Rosa M Santos, Elsa Azevedo, Mario J Carvalho, Anthony Meiracker, Francisco R Goncalves, Cassiano Abreu-Lima and Frans Boomsma
Am J Hypertens 17: 15A-15A; doi:10.1016/j.amjhyper.2004.03.032
OR 34: Hypertensives elicit higher pulse wave velocity at rest and during an isometric exercise grip test
Ciaran F. Reid and Michael A. Conway
Am J Hypertens 17: 15A-15A; doi:10.1016/j.amjhyper.2004.03.033
OR 35: Coadministered vardenafil (for erectile dysfunction) and tamsulosin do not induce hypotension in patients with benign prostatic hypertrophy
Stephen Auerback, Marc Gittelman, Arthur Mazzu, P.R. Sundaresan and William B. White
Am J Hypertens 17: 16A-16A; doi:10.1016/j.amjhyper.2004.03.034
OR 36: Phosphodiesterase type 5 inhibition with sildenafil preserves endothelial function during smoking
Konstantinos Aznaouridis, Charalambos Vlachopoulos, Nikolaos Alexopoulos, Demosthenes Panagiotakos, Nikolaos Ioakeimidis, Dorothea Tsekoura, Dimitris Tousoulis, Christos Pitsavos and Christodoulos Stefanadis
Am J Hypertens 17: 16A-16A; doi:10.1016/j.amjhyper.2004.03.035
OR 37: Relationship of arterial elasticity and erectile dysfunction in hypertensive men
Don Loebl Jr., Helen Fain and L.Michael Prisant
Am J Hypertens 17: 16A-16A; doi:10.1016/j.amjhyper.2004.03.036
OR 38: Sildenafil citrate has mild nitrate-like hemodynamic effects in patients with coronary artery disease and erectile dysfunction
Arthur Crowley and Hunter Gillies
Am J Hypertens 17: 16A-17A; doi:10.1016/j.amjhyper.2004.03.037
OR 39: Ouabain-like factor and acute salt loading in low-renin hypertension
Silvana Balzan, Enza Fommei, Giuseppina Niccolini, Annalisa Iervasi, Tina Prontera, Pietro Di Cecco, Paolo Gazzetti and Silvano Masini
Am J Hypertens 17: 18A-18A; doi:10.1016/j.amjhyper.2004.03.038
OR 40: In salt-sensitive hypertension statins protect end-organ injury via increased no production and decreased reactive oxygen species
Ming-Sheng Zhou, Edgar A. Jaimes and Leopoldo Raij
Am J Hypertens 17: 18A-18A; doi:10.1016/j.amjhyper.2004.03.039
OR 41: Race differences in stress-induced pressure natriuresis and left ventricular geometry
Gregory A. Harshfield and Gaston K. Kapuku
Am J Hypertens 17: 18A-18A; doi:10.1016/j.amjhyper.2004.03.040
OR 42: Novel role for podocin as a genetic cause of hypertension
Keith Di Petrillo, Susan Sheehan, Efthymia Melista, Jing Cui, Anita De Stefano, Clint Baldwin, Haralambos Gavras, Gary Churchill and Beverly Paigen
Am J Hypertens 17: 19A-19A; doi:10.1016/j.amjhyper.2004.03.041
OR 43: Matrix metallopeptidase gene polymorphisms and pulse pressure in a large japanese general population
Katsuhiko Kohara, Michiko Fujisawa, Fujiko Ando, Yasuharu Tabara, Naoakira Niino, Yoshiji Yamada, Tetsuro Miki and Hiroshi Shimokata
Am J Hypertens 17: 19A-19A; doi:10.1016/j.amjhyper.2004.03.042
OR 44: Genetic influences of 
adrenergic receptors polymorphisms on aortic stiffness and left ventricular hypertrophy in patients with essential hypertension
Ming Yuan, Mitsuru Ohishi, Norihisa Ito, Ken Sugimoto, Masaharu Kaibe, Takashi Takagi, Tomohiro Katsuya, Hiromi Rakugi and Toshio Ogihara
Am J Hypertens 17: 19A-19A; doi:10.1016/j.amjhyper.2004.03.043
OR 45: D5 dopamine receptor regulation of reactive oxygen species production and blood pressure in mice
Zhiwei Yang, Peiying Yu, Laureano D. Asicol, Zheng Wang, John E. Jones, David R. Sibley and Pedro A. Jose
Am J Hypertens 17: 20A-20A; doi:10.1016/j.amjhyper.2004.03.044
OR 46: The role of renal superoxide dismutase (SOD) on the slow pressor effects of angiotensin II
W.J. Welch, G. Solis, T. Chabrashvili and C.S. Wilcox
Am J Hypertens 17: 20A-20A; doi:10.1016/j.amjhyper.2004.03.045
OR 47: Renal endothelin receptor type B upregulation in rats with low or high renin hypertension
Noureddine Brakch, Saad Abdel-Sayed, Flore Allemandou, Hans R. Brunner and Juerg Nussberger
Am J Hypertens 17: 20A-21A; doi:10.1016/j.amjhyper.2004.03.046
OR 48: Left ventricular hypertrophy in chronic kidney disease
Ernesto Paoletti, Paolo Cassottana, Diego Bellino, Beatrice Damasio and Giuseppe Cannella
Am J Hypertens 17: 21A-21A; doi:10.1016/j.amjhyper.2004.03.047
OR 49: Uric acid, nephron number and the pathogenesis of essential hypertension
Daniel I. Feig, Takahiko Nakagawa, S.Ananth Karumanchi, Duk-Hee Kang and Richard J. Johnson
Am J Hypertens 17: 21A-21A; doi:10.1016/j.amjhyper.2004.03.048
OR 50: Intensive blood pressure control with valsartan decreases progression of urinary albumin excretion in normotensive type 2 diabetic patients
Raymond O. Estacio, Anne L. Esler, Rita A. Lundgren and Robert W. Schrier
Am J Hypertens 17: 21A-22A; doi:10.1016/j.amjhyper.2004.03.049
OR 51: Risk factors associated to nephroangiosclerosis
Corina Stanescu, Rheuni Boulahrouz, Christophe Charasse, Marie-Paule Ramée and Pierre Simon
Am J Hypertens 17: 22A-22A; doi:10.1016/j.amjhyper.2004.03.050
OR 52: Analysis of antihypertensive drug use and ESRD incidence in Canada and US
Ralph G. Hawkins and Mark C. Houston
Am J Hypertens 17: 22A-22A; doi:10.1016/j.amjhyper.2004.03.051
OR 53: Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in hypertension: relationship to cardiovascular risk and treatment
Muzahir H. Tayebjee, Sunil K. Nadar, Andrew D. Blann, D.Gareth Beevers, Robert J. MacFadyen and Gregory Y. Lip
Am J Hypertens 17: 23A-23A; doi:10.1016/j.amjhyper.2004.03.052
OR 54: Total body potassium and systemic and local arterial stiffness: The gennet study
Antonio J. Delgado, Maria C. Delgado and Alan B. Weder
Am J Hypertens 17: 23A-23A; doi:10.1016/j.amjhyper.2004.03.053
OR 55: Efficacy of angiotensin receptor blockade to improve vascular compliance in people with kidney disease: A pilot study
Renee Ellis, Jay Garg, Dave Chua, Vishweshwar Shetty and George L. Bakris
Am J Hypertens 17: 23A-24A; doi:10.1016/j.amjhyper.2004.03.054
OR 56: Exposure to passive smoking. A test to predict endothelial dysfunction and atherosclerotic lesions
Chiara Bellotto and Aurelio Leone
Am J Hypertens 17: 24A-24A; doi:10.1016/j.amjhyper.2004.03.055
OR 57: Obesity raises blood pressure in normal subjects via high cardiac output and impaired vasodilation
Sandra J. Taler, Nancy Driscoll, Mary Tibor, Genie Sprau, Jo Ellen Augustine, Timothy S. Larson, Mark D. Stegall and Stephen C. Textor
Am J Hypertens 17: 25A-25A; doi:10.1016/j.amjhyper.2004.03.056
OR 58: Morbid obesity without CV risk factors is associated with normal arterial compliance with no improvement after weight loss. Morbidly obese patients with multiple risk factors have decreased arterial elasticity and improve after significant weight loss: evaluation of arterial elasticity, inflammatory markers and humoral factors before and after surgical intervention for morbid obesity (lap band)
Marina Shargorodsky, Alexander Flied, Dov Gavish, Eyal Leibovitz, Mona Boaz and Reuven Zimlichman
Am J Hypertens 17: 25A-25A; doi:10.1016/j.amjhyper.2004.03.057
OR 59: Distribution of the metabolic syndrome risk factors in obese African american women
Lien Diep, John Kwagyan, Abid Maqbool, Shichen Xu, Christiana Bettencourt, Muluemebet Ketete, Debra Ordor, Carl Tilghman, Gina Victor and Otelio Randall
Am J Hypertens 17: 25A-26A; doi:10.1016/j.amjhyper.2004.03.058
OR 60: What are the determinants for silent cerebral infarct in japanese diabetic patients – ambulatory blood pressure or glycemic control?
Kazuo Eguchi, Kazuomi Kario, Satoshi Hoshide, Joji Ishikawa, Masato Morinari and Kazuyuki Shimada
Am J Hypertens 17: 26A-26A; doi:10.1016/j.amjhyper.2004.03.059
OR 61: Asymptomatic left ventricular dysfunction: A potent predictor of cardiac complications in hypertension
Paolo Verdecchia, Fabio Angeli, Gian Paolo Reboldi, Roberto Gattobigio, Erberto Carluccio, Fabrizio Poeta and Carlo Porcellati
Am J Hypertens 17: 27A-27A; doi:10.1016/j.amjhyper.2004.03.060
OR 62: Left ventricular hypertrophy in hypertensive African-americans with coronary artery disease increases the 10 year mortality risk
Andreas E. Pittaras, Peter F. Kokkinos, Athanasios J. Manolis, Puneet Narayan, Steve Singh and Vasilios Papademetriou
Am J Hypertens 17: 27A-27A; doi:10.1016/j.amjhyper.2004.03.061
OR 63: Baseline echocardiographic characteristics and the predictors of LV mass in the african american study of kidney disease (AASK)
Vladimir Ilic, Gail Peterson, Tudor Vagaonescu, Avril Gabriel, Cynthia Kendrick and Robert A. Phillips AASK Investigators
Am J Hypertens 17: 27A-28A; doi:10.1016/j.amjhyper.2004.03.062
OR 64: Relationship between sympathetic activation in hypertension and left ventricular hypertrophy quantified by magnetic resonance imaging
Joanna Burns, Mohan U. Sivananthan, David A.S.G. Mary, Alan F. Mackintosh, Stephen G. Ball and John P. Greenwood
Am J Hypertens 17: 28A-28A; doi:10.1016/j.amjhyper.2004.03.063
OR 65: Hypertensive response to exercise: Impact on spect radionuclide imaging and angiographic correlation
Michael G. Reinig, Mitchell Somma, Rido Cha, Joseph Parrillo and Elias Iliadis
Am J Hypertens 17: 28A-28A; doi:10.1016/j.amjhyper.2004.03.064
OR 66: Poor blood pressure control after coronary revascularisation is a disregard problem
Natasha G. Roseva-Nielsen, Kjeld S. Kristensen, Tage L. Svendsen and Ulrik Talleruphuus
Am J Hypertens 17: 28A-29A; doi:10.1016/j.amjhyper.2004.03.065
OR 67: Hypertensive chronic heart failure – value of plasma semicarbazide-sensitive amine oxidase as an useful tool for the diagnosis and follow-up of patients with left ventricular systolic dysfunction
Luiz F.Menezes Falcao, Fausto Pinto, Fatima Veiga, Luciano P. Ravara and Peter A.van Zwieten
Am J Hypertens 17: 29A-29A; doi:10.1016/j.amjhyper.2004.03.066
OR 68: Left ventricular structure and function predict clinical cardiovascular risk in prehypertension: The strong heart study
Marilyn B. Lawrence Wright, Richard B. Devereux, Mary J. Roman, Marcello Chinali, Lyle G. Best, James M. Galloway, Richard R. Fabsitz, Zhang Ying, Elisa T. Lee and Barbara V. Howard
Am J Hypertens 17: 29A-29A; doi:10.1016/j.amjhyper.2004.03.067
OR 69: The effect of low blood pressure goals on achieved blood pressure in high risk hypertensives
Robert A. Phillips, Tom A. Karson, Grethe S. Birketvidt, Warren Ho, Donald A. Smith, Stanley Tuhrim, Benjamin Stein, Mohammed Rafey and Sylvan Wallenstein
Am J Hypertens 17: 30A-30A; doi:10.1016/j.amjhyper.2004.03.068
OR 70: Blood pressure control by randomized drug group in allhat
William C. Cushman, Charles E. Ford, Paula Einhorn, Jackson T. Wright Jr., Richard A. Preston, Barry R. Davis and Jan N. Basile
Am J Hypertens 17: 30A-30A; doi:10.1016/j.amjhyper.2004.03.069
OR 71: Results of monotherapy in allhat: On-treatment analyses
Jeffrey A. Cutler, Linda B. Piller, Sara Pressel, James F. Graumlich, Bruce P. Hamilton, David C. Parish, Nauman Qureshi, Otelio S. Randall and Barry R. Davis ALLHAT Collaborative Research Group
Am J Hypertens 17: 30A-31A; doi:10.1016/j.amjhyper.2004.03.070
OR 72: Amino acid conjugated small molecule BLX-1002 lowers blood glucose in insulin resistant db/db and ob/ob mice and inhibits TNF- , IL-6 cytokines
Deben Dey, Bindu Pandey, Abhijeet Nag, Ivan Peng, Mansi Chovatia, Partha Neogi and Bishwajit Nag
Am J Hypertens 17: 32A-32A; doi:10.1016/j.amjhyper.2004.03.071
OR 73: Corrrelations between cardiovascular risk factors and insulin resistance in hypertensive and normotensive obese patients
Olga González-Albarrán, Carlos Roa, Juana Fraile, Pedro Pines, José Mar
éa Sancho and Rafael Garcéa-Robles
Am J Hypertens 17: 32A-32A; doi:10.1016/j.amjhyper.2004.03.072
OR 74: Insulin resistance, not diabetes status, determines blood pressure in obese and type 2 diabetic patients
Richard Z. Lewanczuk, Breay W. Paty and Ellen L. Toth
Am J Hypertens 17: 32A-32A; doi:10.1016/j.amjhyper.2004.03.073
P-1: Lack of effect of repetitive acupuncture on clinic and ambulatory blood pressure
Richard C. Robinson, Zhongyun Wang, Ronald G. Victor, Wanpen Vongpatanasin, Weiguo Zhang, Aamer Abbas, Robert J. Gatchel and Norman M. Kaplan
Am J Hypertens 17: 33A-33A; doi:10.1016/j.amjhyper.2004.03.075
P-2: Korean red ginseng lowers blood pressure in individuals with hypertension
P. Mark Stavro, Minna Woo and Vladimir Vuksan
Am J Hypertens 17: 33A-33A; doi:10.1016/j.amjhyper.2004.03.076
P-3: Application of measured hypercapnic-hypoxic breathing protocols in rehabilitation of hypertensive-asthmatic female patients
Ruslan I. Sydorchuk, Larysa P. Sydorchuk and Igor I. Sydorchuk
Am J Hypertens 17: 33A-33A; doi:10.1016/j.amjhyper.2004.03.077
P-4: American ginseng has a neutral effect on blood pressure in individuals with hypertension
Vladimir Vuksan, Minna Woo and P.Mark Stavro
Am J Hypertens 17: 34A-34A; doi:10.1016/j.amjhyper.2004.03.078
P-5: Abnormal nocturnal blood pressure patterns and prevelance of stroke
Paula Alcantara, Carlos S. Moreira, Cristina Alcantara and José Braz-Nogueira
Am J Hypertens 17: 35A-35A; doi:10.1016/j.amjhyper.2004.03.079
P-6: Nocturnal blood pressure pattern and target organ damage
Paula Alcantara, Carlos S. Moreira, Cristina Alcantara and José Braz-Nogueira
Am J Hypertens 17: 35A-35A; doi:10.1016/j.amjhyper.2004.03.080
P-7: High prevalence of masked hypertension in treated hypertensive patients with type 2 diabetes mellitus
Kerrayem Alsuwaida, Robert Parkes, Jeffrey So, Denice Feig and Alexander Logan
Am J Hypertens 17: 35A-35A; doi:10.1016/j.amjhyper.2004.03.081
P-8: How much white coat effect is superimposed on ambulatory blood pressure monitoring (ABPM) results?
Serkan Kahraman, Ali E. Duman, Rahmi Yilmaz, Gultekin Genctoy, Mustafa Arici, Bulent Altun, Yunus Erdem and Cetin Turgan
Am J Hypertens 17: 36A-36A; doi:10.1016/j.amjhyper.2004.03.082
P-9: Impact of clinical inertia on the estimation of blood pressure control in treated patients with essential hypertension
Carlos Calvo, Jose E. Lopez, Maria J. Dominguez, Ramon C. Hermida, Diana E. Ayala, Manuel Covelo, Maria L. Romero and Vicente Lorenzo
Am J Hypertens 17: 36A-36A; doi:10.1016/j.amjhyper.2004.03.083
P-10: Time-weighted vs conventional quantification of 24 H average systolic and diastolic ambulatory blood pressures
José A. Octavio, Jesús Contreras, Bernardo Octavio, Federico Moleiro, Gianfranco Parati, Stefano Omboni and Giuseppe Mancia
Am J Hypertens 17: 36A-36A; doi:10.1016/j.amjhyper.2004.03.084
P-11: Usefulness of repeated office blood pressure measurements to disclose white coat hypertension
Giuseppe Crippa, Claudio Venturi, Matteo Giorgi-Pierfranceschi and Enrico Sverzellati
Am J Hypertens 17: 37A-37A; doi:10.1016/j.amjhyper.2004.03.085
P-12: Interaction between glyceryl trinitrate and sildenafil citrate (viagra®) may last less than 4 hours
Arthur R. Crowley, Gary J. Muirhead, Hunter Gillies and Ian Osterloh
Am J Hypertens 17: 37A-37A; doi:10.1016/j.amjhyper.2004.03.086
P-13: Absence of relationship between non-dipping status and plasma levels of inflammatory markers in patients with untreated essential hypertension
K. Dimitriadis, C. Tsioufis, C. Vasiliadi, C. Stefanadis and I. Kallikazaros
Am J Hypertens 17: 37A-38A; doi:10.1016/j.amjhyper.2004.03.087
P-14: Peculiarities of blood pressure measurement in adult patients on regular antihypertensive treatment
Paulo O. Duarte, Mariana G. Freiria, Maria Cândida N. Santilli, Micheli Rigon, Cinthia S. Arantes, Jaqueline M.S. Sampaio, Jaciara M. Viana and Nereida K.C. Lima
Am J Hypertens 17: 38A-38A; doi:10.1016/j.amjhyper.2004.03.088
P-15: Treatment and conrol of hypertension & associated risk factors at va & non-va in the southeast
Brent M. Egan, Jan N. Basile, Daniel T. Lackland and Florence N. Hutchinson
Am J Hypertens 17: 38A-38A; doi:10.1016/j.amjhyper.2004.03.089
P-16: Validation of the omron® HEM-637 it device for blood pressure measurement according to the international validation protocol?
Mohamed A. El Assaad, Jirar A. Topouchian and Roland G. Asmar
Am J Hypertens 17: 38A-39A; doi:10.1016/j.amjhyper.2004.03.090
P-17: Pre-hypertension is common and predicts the development of hypertension in young active males
Alon Grossman, Chagai Grossman, Erez Barenboim, Bella Azaria, Yaniv Sherer, Liav Goldstein and Ehud Grossman
Am J Hypertens 17: 39A-39A; doi:10.1016/j.amjhyper.2004.03.091
P-18: The day-night variability of blood pressure is associated with the autonomic and baroreflex-mediated modulation of the sinoatrial node
Luigina Guasti, Cinzia Simoni, Luca T. Mainardi, Chiara Crespi, Maria G. Cimpanelli, Giovanni Gaudio, Elena Consolaro, Sergio Cerutti and Achille Venco
Am J Hypertens 17: 39A-39A; doi:10.1016/j.amjhyper.2004.03.092
P-19: Sampling requirements for the tolerance-hyperbaric test in the diagnosis of essential hypertension
Ramon C. Hermida, Diana E. Ayala, Carlos Calvo, Artemio Mojon, Jose R. Fernandez, Ignacio Alonso, Maria J. Dominguez, Manuel Covelo and Jose E. Lopez
Am J Hypertens 17: 39A-40A; doi:10.1016/j.amjhyper.2004.03.093
P-20: Effects of hygienic-dietary recommendations on ambulatory blood pressure in untreated patients with grade 1 hypertension
Ramon C. Hermida, Diana E. Ayala, Carlos Calvo, Maria J. Dominguez, Manuel Covelo, Artemio Mojon, Jose R. Fernandez, Maria J. Fontao, Rita Soler and Jose E. Lopez
Am J Hypertens 17: 40A-40A; doi:10.1016/j.amjhyper.2004.03.094
P-21: Differences in the seasonal variation of plasma glucose between dipper and nondipper hypertensive patients
Ramon C. Hermida, Diana E. Ayala, Carlos Calvo, Maria J. Dominguez, Manuel Covelo, Artemio Mojon, Jose R. Fernandez, Maria J. Fontao, Rita Soler and Jose E. Lopez
Am J Hypertens 17: 40A-40A; doi:10.1016/j.amjhyper.2004.03.095
P-22: Administration time-dependent effects of low-dose aspirin on ambulatory blood pressure in grade 1 hypertensive patients
Ramon C. Hermida, Diana E. Ayala, Carlos Calvo, Maria J. Dominguez, Manuel Covelo, Artemio Mojon, Jose R. Fernandez, Maria J. Fontao, Rita Soler and Jose E. Lopez
Am J Hypertens 17: 40A-41A; doi:10.1016/j.amjhyper.2004.03.096
P-23: The pressor effect due to ambulatory blood pressure monitoring persists in hypertensive patients repeatedly evaluated three or more times
Carlos Calvo, Ramon C. Hermida, Diana E. Ayala, Jose E. Lopez, Maria J. Dominguez, Manuel Covelo, Maria J. Fontao, Rita Soler, Artemio Mojon and Jose R. Fernandez
Am J Hypertens 17: 41A-41A; doi:10.1016/j.amjhyper.2004.03.097
P-24: Ambulatory blood pressure pattern in patients with resistant hypertension as a function of the circadian time of antihypertensive therapy
Ramon C. Hermida, Diana E. Ayala, Carlos Calvo, Maria J. Dominguez, Manuel Covelo, Artemio Mojon, Jose R. Fernandez and Jose E. Lopez
Am J Hypertens 17: 41A-41A; doi:10.1016/j.amjhyper.2004.03.098
P-25: Significant increase of ambulatory pulse pressure in subjects with white coat hypertension
Ramon C. Hermida, Carlos Calvo, Diana E. Ayala, Manuel Covelo, Maria J. Dominguez, Artemio Mojon, Jose R. Fernandez and Jose E. Lopez
Am J Hypertens 17: 41A-42A; doi:10.1016/j.amjhyper.2004.03.099
P-26: Factors infuencing the difference between clinic and ambulatory blood pressure measurements in untreated patients with essential hypertension
Ramon C. Hermida, Diana E. Ayala, Carlos Calvo, Maria J. Dominguez, Manuel Covelo, Maria J. Fontao, Rita Soler and Jose E. Lopez
Am J Hypertens 17: 42A-42A; doi:10.1016/j.amjhyper.2004.03.100
P-27: Diagnosis of hypertension based on ambulatory blood pressure monitoring: Are 24 hours of sampling enough?
Ramon C. Hermida, Diana E. Ayala, Carlos Calvo, Maria J. Dominguez, Manuel Covelo, Artemio Mojon, Jose R. Fernandez and Jose E. Lopez
Am J Hypertens 17: 42A-42A; doi:10.1016/j.amjhyper.2004.03.101
P-28: Biological markers of the day/night blood pressure ratio in patients with essential hypertension
Ramon C. Hermida, Diana E. Ayala, Carlos Calvo, Maria J. Dominguez, Manuel Covelo, Artemio Mojon, Jose R. Fernandez, Maria J. Fontao, Rita Soler and Jose E. Lopez
Am J Hypertens 17: 43A-43A; doi:10.1016/j.amjhyper.2004.03.102
P-29: Differences between clinic and ambulatory blood pressure measurements in untreated patients with grade 1–2 hypertension
Ramon C. Hermida, Diana E. Ayala, Carlos Calvo, Maria J. Dominguez, Manuel Covelo, Maria J. Fontao, Rita Soler and Jose E. Lopez
Am J Hypertens 17: 43A-43A; doi:10.1016/j.amjhyper.2004.03.103
P-30: Prevalence of non-dipper blood pressure pattern in elderly patients with essential hypertension as a function of circadian time of antihypertensive treatment
Carlos Calvo, Ramon C. Hermida, Diana E. Ayala, Jose E. Lopez, Maria J. Dominguez and Manuel Covelo
Am J Hypertens 17: 43A-44A; doi:10.1016/j.amjhyper.2004.03.104
P-31: Prevalence of nondipper blood pressure profile in patients with and without obstructive sleep apnea
Ramon C. Hermida, Carlos Zamarron, Diana E. Ayala, Maria J. Fontao and Carlos Calvo
Am J Hypertens 17: 44A-44A; doi:10.1016/j.amjhyper.2004.03.105
P-32: Analysis of the circadian rhythm of blood pressure in 514 patients with primary hypertension
Ji Xu, Qi Hua and Rongkun Liu
Am J Hypertens 17: 44A-44A; doi:10.1016/j.amjhyper.2004.03.106
P-33: Study of systolic time interval in patients with essential hypertension by echocardiography
Jing Gao, Qi Hua and Lisong Liu
Am J Hypertens 17: 44A-44A; doi:10.1016/j.amjhyper.2004.03.107
P-34: Blood pressure, cognitive function, and activity of daily living in elderly
Jette K. Ingerslev, Stig Munkgaard, Anders B. Bille, Kirsten Schulz-Larsen and Karen M. Leimand
Am J Hypertens 17: 44A-45A; doi:10.1016/j.amjhyper.2004.03.108
P-35: Morning hypertension is masked in well-controlled hypertensives: the Jichi morning hypertension research (J-MORE) study
Joji Ishikawa, Kazuomi Kario, Masato Morinari, Satoshi Hoshide, Kazuo Eguchi, Shizukiyo Ishikawa and Kazuyuki Shimada
Am J Hypertens 17: 45A-45A; doi:10.1016/j.amjhyper.2004.03.109
P-36: Regular alcohol drinking masks morning hypertension in well-controlled hypertensives: The Jichi morning hypertension research (J-MORE) study
Joji Ishikawa, Kazuomi Kario, Masato Morinari, Satoshi Hoshide, Kazuo Eguchi, Shizukiyo Ishikawa and Kazuyuki Shimada
Am J Hypertens 17: 45A-45A; doi:10.1016/j.amjhyper.2004.03.110
P-37: Pressor response in the first measurement of self-measured blood pressure monitoring in stable hypertensives: The Jichi morning hypertension research (J-MORE) study
Joji Ishikawa, Kazuomi Kario, Masato Morinari, Satoshi Hoshide, Kazuo Eguchi, Shizukiyo Ishikawa and Kazuyuki Shimada
Am J Hypertens 17: 45A-46A; doi:10.1016/j.amjhyper.2004.03.111
P-38: Determinants of exaggerated morning-evening surge by self-measured blood pressure monitoring in medicated hypertensives: The jichi morning hypertension research (J-MORE) study
Joji Ishikawa, Kazuomi Kario, Masato Morinari, Satoshi Hoshide, Kazuo Eguchi, Shizukiyo Ishikawa and Kazuyuki Shimada
Am J Hypertens 17: 46A-46A; doi:10.1016/j.amjhyper.2004.03.112
P-39: Denial of stress persistently elevates ambulatory blood pressure at work and at home over the menstrual cycle
Gary D. James
Am J Hypertens 17: 46A-46A; doi:10.1016/j.amjhyper.2004.03.113
P-40: A cross sectional and longitudinal analysis of systolic and diastolic blood pressure control in diabetic patients
Linda A. Joseph, Jonathan Castro, Shahram Khorrami, Geethanjali Sennimalai, Pramodini Gosukonda, Mrunalini Deshmukh, Surender Arora, John Makaryus, Carla Casulo, Diwakar Lingam, Sandra D'Angelo, Mai Mahmoud, John J. Shin, Gul Bahtiyar, Amal Farag, James R. Sowers and Samy I. McFarlane
Am J Hypertens 17: 47A-47A; doi:10.1016/j.amjhyper.2004.03.114
P-41: White coat effect and blood pressure variation in centenarian
Medet Jumabay, Yukio Ozawa, Satoshi Saito, Yoichi Izumi, Yuji Kasamaki, Hiroshi Kawamura and Yitong Ma
Am J Hypertens 17: 47A-47A; doi:10.1016/j.amjhyper.2004.03.115
P-42: Augmented morning sympathetic activation in hypertensive smokers: The Japanese halt study
Kazuomi Kario, Thomas G. Pickering, Masato Morinari, Joji Ishikawa, Shizukiyo Ishikawa, Kazuo Eguchi, Satoshi Hoshide and Kazuyuki Shimada
Am J Hypertens 17: 47A-47A; doi:10.1016/j.amjhyper.2004.03.116
P-43: Definition of salt sensitivity using a statistically significant change in blood pressure on exposure to dietary salt
Jyothsna Kodali, Mahboob Rahman, Jackson T. Wright Jr., Janice G. Douglas, Kaine Onwuzulike and Valerie Griffin
Am J Hypertens 17: 48A-48A; doi:10.1016/j.amjhyper.2004.03.117
P-44: Radial augmentation index: a simple and easy-obtainable parameter for vascular aging
Katsuhiko Kohara, Yasuharu Tabara, Akira Oshiumi, Yoshinori Miyawaki, Tatsuya Kobayashi and Tetsuro Miki
Am J Hypertens 17: 48A-48A; doi:10.1016/j.amjhyper.2004.03.118
P-45: Validation of UA-767 plus device for self-measurement of blood pressure
Zhanna D. Kobalava, Ioulia V. Kotovskaia, Olga S. Rusakova and Lala A. Babaeva
Am J Hypertens 17: 48A-48A; doi:10.1016/j.amjhyper.2004.03.119
P-46: The importance of the clinical observer in the development of a white-coat effect in African-American patients with hypertension
P.T. Labinson, W.B. White, H. Gift, S. Giacco and G.A. Mansoor
Am J Hypertens 17: 48A-49A; doi:10.1016/j.amjhyper.2004.03.120
P-47: Nondipping pattern of nocturnal blood pressure in patients with coronary heart disease is associated with abnormal diastolic left ventricular filling and higher ambulatory pulse pressure
Kaeng W. Lee and Gregory Y.H. Lip
Am J Hypertens 17: 49A-49A; doi:10.1016/j.amjhyper.2004.03.121
P-48: The influence of adding AT1 antagonist treatment to hypertensive and type 2 diabetes mellitus patients with nondipping pattern in 24hABPM
Dalya Navot-Mintzer, Hava Tabenkin and Shuki Leshem
Am J Hypertens 17: 49A-50A; doi:10.1016/j.amjhyper.2004.03.122
P-49: Impacts of ambulatory pulse pressure and office pulse pressure on left ventricular hypertrophy in patients with essential hypertension
Lisong Liu, Qi Hua and Jian Zhang
Am J Hypertens 17: 50A-50A; doi:10.1016/j.amjhyper.2004.03.123
P-50: Relationship of age, left ventricular hypertrophy and 24-hour mean pulse pressure in patients with essential hypertension
Lisong Liu, Qi Hua, Jian Zhang and Beilei Pang
Am J Hypertens 17: 50A-50A; doi:10.1016/j.amjhyper.2004.03.124
P-51: The lisinopril effects upon blood pressure diurnal rhythm and left ventricular myocardial mass in essential hypertension
Elena G. Kupchinskaya, Elena V. Bobrova, Larissa V. Bezrodna and Irina V. Lizogub
Am J Hypertens 17: 50A-50A; doi:10.1016/j.amjhyper.2004.03.125
P-52: Blood pressure morning surge and daytime BP variability and target organ damage in normotensives, hypertensives and diabetics
Cristina Amaral, Loide Barbosa, Susana Bertoquini, Joao Maldonado, Jose A. Silva and Jorge Polónia
Am J Hypertens 17: 50A-51A; doi:10.1016/j.amjhyper.2004.03.126
P-53: Receiver operating characteristics of home blood pressure measurements thatbest detect ambulatory hypertension
George A. Mansoor and William B. White
Am J Hypertens 17: 51A-51A; doi:10.1016/j.amjhyper.2004.03.127
P-54: In-hospital night shift minimally affects 24-hour blood pressure, even if a nocturnal BP increase is seen
Natale R. Musso, Fiorella Altomonte, Claudia Brusasco, Giovanni Baldi, Vincenza De Iorgi and Claudio Vergassola
Am J Hypertens 17: 51A-51A; doi:10.1016/j.amjhyper.2004.03.128
P-55: Self-blood pressure monitoring: Validation of the braun vitalscan plus 1650 bp monitor
Hector L. Nolly, Marcelo A. Romero, Omar R. Reinoso and Alejandro H. Nolly
Am J Hypertens 17: 52A-52A; doi:10.1016/j.amjhyper.2004.03.129
P-56: Indications for ambulatory blood pressure monitoring in a national health service setting
Giuseppe Pannarale, Luigi Gianturco, Francesca Mirabelli, Silvia Franchitto, Sara Di Michele, Carlo Gaudio and Francesco Fedele
Am J Hypertens 17: 52A-52A; doi:10.1016/j.amjhyper.2004.03.130
P-57: The dinamap dilemma: Inaccuracy of the commonly used dinamap 8100 compared to simultaenous mercury manometer measurement in hospitalized patients at different levels of blood pressure
Seth B. Parker and Susan P. Steigerwalt
Am J Hypertens 17: 52A-52A; doi:10.1016/j.amjhyper.2004.03.131
P-58: Office blood pressure measurement with the BpTRU automated device is a valid alternative to ambulatory blood pressure montoring
Mark J. Penny, Kim Do, Lai Hong Siew, Belinda Williams and Karen A. Duggan
Am J Hypertens 17: 53A-53A; doi:10.1016/j.amjhyper.2004.03.132
P-59: Stratification of cardiovascular risk by ambulatory blood pressure stage in uncomplicated mild clinic hypertension
Sante D. Pierdomenico, Anna Bucci, Domenico Lapenna, Franco Cuccurullo and Andrea Mezzetti
Am J Hypertens 17: 53A-53A; doi:10.1016/j.amjhyper.2004.03.133
P-60: Follow-up clinic and ambulatory blood pressure in normotensives and treated and untreated white coat hypertensives (evaluation after 4–9 years)
Jorge J. Polonia, Guilherme Gama, Susana Bertoquini and Cristina Amaral
Am J Hypertens 17: 53A-54A; doi:10.1016/j.amjhyper.2004.03.134
P-61: The relationship between systolic and diastolic BP: effect of season, salt and paced breathing
Talma Rosenthal, Yael Barkai, Carmit Rachima-Maoz, Edna Peleg, Ariela Alter and Benjamin Gavish
Am J Hypertens 17: 54A-54A; doi:10.1016/j.amjhyper.2004.03.135
P-62: Blood pressure in treated hypertensives in poland
Adam Grzybowski, Jerzy Bellwon, Marcin Gruchala, Wojciech Sobiczewski and Andrzej Rynkiewicz
Am J Hypertens 17: 54A-54A; doi:10.1016/j.amjhyper.2004.03.136
P-63: The early morning diastolic blood pressure decrease as a cardiovascular protection factor. An inverse effect to J-shaped curve
Enrique Bernal, Maria Calbacho, Arturo Ugalde, Olivia Sanchez, David Coca, Elena Sanchez-Largo, Rosa Fabregate, Ana Bajo and Jose Saban-Ruiz
Am J Hypertens 17: 54A-55A; doi:10.1016/j.amjhyper.2004.03.137
P-64: Short-term and circadian blood pressure variability in diabetic hypertensives
Aparna Sahoo and Michael C. Ruddy
Am J Hypertens 17: 55A-55A; doi:10.1016/j.amjhyper.2004.03.138
P-65: Similar effect of losartan/hydrochlorothiazide therapy for black and non-black patients with severe hypertension
Christina Salerno, Peter Di Battiste, Robin Mukherjee, Gilbert Gleim, Steve Snapinn and Laura Demopoulos
Am J Hypertens 17: 55A-55A; doi:10.1016/j.amjhyper.2004.03.139
P-66: Normotensives and white coat hypertensives matched for daytime ambulatory blood pressure levels show similar damage of cardiovascular target organs
Jorge J. Polonia, Guilherme Gama, Susana Bertoquini, Jose A. Silva, Loide Barbosa and Joao Maldonado
Am J Hypertens 17: 55A-56A; doi:10.1016/j.amjhyper.2004.03.140
P-67: A novel blood pressure waveform analysis
Ralph Barnes, Ronald Smith, Pavel Levy and Carlos Ferrario
Am J Hypertens 17: 56A-56A; doi:10.1016/j.amjhyper.2004.03.141
P-68: Non-invasive characterization of arterial system function
Ralph W. Barnes, Ronald D. Smith, Pavel J. Levy and Carlos M. Ferraro
Am J Hypertens 17: 56A-56A; doi:10.1016/j.amjhyper.2004.03.142
P-69: How long should patients sit before an accurate office blood pressure reading is obtained?
P.Mark Stavro, Lawrence Leiter and Vladimir Vuksan
Am J Hypertens 17: 56A-57A; doi:10.1016/j.amjhyper.2004.03.143
P-70: Reproducibility of home and ambulatory blood pressure in children and adolescents
George S. Stergiou, Christina V. Alamara, Eleanna V. Salgami, Iraklis N. Vaindirlis, Catherine Dacou-Voutetakis and Theodore D. Mountokalakis
Am J Hypertens 17: 57A-57A; doi:10.1016/j.amjhyper.2004.03.144
P-71: The effects of extended duty hours on ambulatory blood pressures in internal medicine, pediatric, and med-peds residents
Jimmy L. Stewart, Kimberly Harkins, Deborah King and Marion Wofford
Am J Hypertens 17: 57A-57A; doi:10.1016/j.amjhyper.2004.03.145
P-72: Blood pressure and pulse dynamics quantify everyday life's emotions — if excessive by circadian overswinging, chat
Balasasikumar Sundaram, R. Hanumansetty, G. Cornelissen, Kuniaki Otsuka, George S. Katinas, Jarmila Seigelova, Pavel Homolka, Salvador Sanchez De La Pena, Katarina Borer, Erwin Schaffer, Daniel C. Holley and Franz Halberg
Am J Hypertens 17: 57A-58A; doi:10.1016/j.amjhyper.2004.03.146
P-73: Is ambulatory pulse pressure elevated in hypertensive patients with transient myocardial ischemia by 24-h cardiotens monitoring?
Sakir Uen, Johannes Baulmann, Burkhard Weisser, Hans Vetter, Rainer Düsing and Thomas Mengden
Am J Hypertens 17: 58A-58A; doi:10.1016/j.amjhyper.2004.03.147
P-74: Different prognostic impact of blood pressure variability on cardiac and cerebrovascular events in hypertension
Paolo Verdecchia, Fabio Angeli, Gian Paolo Reboldi, Roberto Gattobogio, Cristian Rapicetta, Claudia Borgioni, Maurizio Bentivoglio, Guglielmo Benemio and Carlo Porcellati
Am J Hypertens 17: 58A-58A; doi:10.1016/j.amjhyper.2004.03.148
P-75: Bell, diaphragm or electronic amplification in the measurement of blood pressure?
Risto Vesalainen, Kari Kangassalo, Antti Kariluoto and Ilkka Kantola
Am J Hypertens 17: 58A-59A; doi:10.1016/j.amjhyper.2004.03.149
P-76: A large-scale ambulatory blood pressure monitoring (ABPM) trial in the practice setting: efficacy of the angiotensin receptor blocker, telmisartan
W.B. White, G.L. Bakris, T.D. Giles, G. Davidai and M.A. Weber
Am J Hypertens 17: 59A-59A; doi:10.1016/j.amjhyper.2004.03.150
P-77: Comparison of the omron HEM-637 wrist monitor to the auscultation method with the wrist position sensor on or disabled
Steven A. Yarows
Am J Hypertens 17: 59A-59A; doi:10.1016/j.amjhyper.2004.03.151
P-78: Blood pressure measurements in a community pharmacy compared to home blood pressures
Alan J. Zillich, Barry L. Carter and Patty Kumbera
Am J Hypertens 17: 59A-60A; doi:10.1016/j.amjhyper.2004.03.152
P-79: Advanced cerebrovascular damage in diabetic white-coat hypertension
Kazuo Eguchi, Kazuomi Kario, Satoshi Hoshide, Masato Morinari, Joji Ishikawa and Kazuyuki Shimada
Am J Hypertens 17: 61A-61A; doi:10.1016/j.amjhyper.2004.03.153
P-80: Diabetic masked hypertension: risk for stroke in japanese
Kazuo Eguchi, Kazuomi Kario, Masato Morinari and Kazuyuki Shimada
Am J Hypertens 17: 61A-61A; doi:10.1016/j.amjhyper.2004.03.154
P-81: Different impact on the association between hypertension and stroke among obese and non-obese japanese
Shizukiyo Ishikawa, Kazuomi Kario, Kazunori Kayaba, Kazuyuki Shimada and Eiji Kajii
Am J Hypertens 17: 61A-61A; doi:10.1016/j.amjhyper.2004.03.155
P-82: The effect of valsartan on the endothelial function of the retinal capillary bed in elderly hypertensive subjects
Sebastian Oehmer, Joanna Harazny, Christian Delles, Thomas Schwarz, Renate Handrock, Georg Michelson and Roland E. Schmieder
Am J Hypertens 17: 62A-62A; doi:10.1016/j.amjhyper.2004.03.156
P-83: The significance of hypertension and lipids on latter thromboembolic stroke in greek population
Spyridon Paximadas, Stamata Pagoni, Marios Kosmidis, Athanasios Papadimitriou and Nausika Sakarellou
Am J Hypertens 17: 62A-62A; doi:10.1016/j.amjhyper.2004.03.157
P-84: A molecular variant of the AT1R gene is a risk factor for ischemic stroke in hypertensive subjects
Speranza Rubattu, Emanuele Di Angelantonio, Rosita Stanzione, Bastianina Zanda, Anna Evangelista, Paola De Paolis, Angelo Pirisi and Massimo Volpe
Am J Hypertens 17: 62A-62A; doi:10.1016/j.amjhyper.2004.03.158
P-85: Increased postprandial blood pressure and pulse pressure cause target organ damages in metabolic syndrome
Yinxing Ni, Zhiming Zhu, Jun Yu, Zhigang Zhao and Gang Zhang
Am J Hypertens 17: 63A-63A; doi:10.1016/j.amjhyper.2004.03.159
P-86: Fibrinolytic system in normotensive subjects and hypertensive patients
Maria J. Armas-Hernandez, Rafael Hernandez-Hernandez, Beatriz Pacheco, Beatriz Sosa-Canache, Rosalba Cammarata, Atiff R. Carvajal, Maria C. Armas-Padilla and Jaime Guerrero
Am J Hypertens 17: 64A-64A; doi:10.1016/j.amjhyper.2004.03.160
P-87: At1 receptor blockers improve endothelial function (EF) and fibrinolytic activity (FA) in hypertensive patients with initial target organ damage
Mario Campanella, Roberto Summa, Stefano Stuard, Maria Rita Nanni and Virgilio Di Luzio
Am J Hypertens 17: 64A-64A; doi:10.1016/j.amjhyper.2004.03.161
P-88: Effect of perindopril and atenolol on fibrinolysis in hypertensive patients with acute ischemic stroke
Roberto Fogari, Carlo Pasotti, Annalisa Zoppi, Luca Corradi, Amedeo Mugellini, Paola Preti, Ettore Malacco and Andrea Rinaldi
Am J Hypertens 17: 64A-64A; doi:10.1016/j.amjhyper.2004.03.162
P-89: Atorvastatin-amlodipine combination and fibrinolytic balance in hypertensive hypercholesterolemic insulin-resistent patients
Roberto Fogari, Giuseppe Derosa, Ettore Malacco, Leonardina Ciccarelli, Andrea Rinaldi, Paola Preti and Amedeo Mugellini
Am J Hypertens 17: 65A-65A; doi:10.1016/j.amjhyper.2004.03.163
P-90: Effect of manidipine and atenolol on platelet aggregability in isolated systolic hypertension with and without type 2 diabetes mellitus
Roberto Fogari, Giuseppe Derosa, Paola Preti, Carlo Pasotti, Luca Corradi, Ettore Malacco, Andrea Rinaldi and Amedeo Mugellini
Am J Hypertens 17: 65A-65A; doi:10.1016/j.amjhyper.2004.03.164
P-91: Losartan on fibrinolytic system in hypertension
Rafael Hernandez-Hernandez, Beatriz Sosa-Canache, Maria C. Armas-Padilla, Rosalba Cammarata, Beatriz Pacheco, Atiff R. Carvajal, Maria J. Armas-Hernandez and Jaime Guerrero
Am J Hypertens 17: 65A-65A; doi:10.1016/j.amjhyper.2004.03.165
P-92: High pulse pressure but not mean arterial blood pressure is associated with abnormal thrombogenesis and endothelial damage/dysfunction in patients with coronary heart disease with and without hypertension
Kaeng W. Lee and Gregory Y.H. Lip
Am J Hypertens 17: 66A-66A; doi:10.1016/j.amjhyper.2004.03.166
P-93: Positive effect of a low dose combination of perindopril/ indapamide on the D-dimers and the endothelial factors in hypertensive patients
Gregory Y.H. Lip, Andrew Blann and Gareth Beevers
Am J Hypertens 17: 66A-66A; doi:10.1016/j.amjhyper.2004.03.167
P-94: Differential regulation of renal endothelin ETA and ETB receptors in rats withexperimental heart failure
Zaid Abassi, Bahaa' N. Francis, Samuel N. Heyman, Tony Karram, Joseph Winaver and Aaron Hoffman
Am J Hypertens 17: 67A-67A; doi:10.1016/j.amjhyper.2004.03.168
P-95: Losartan on nitric oxide in patients with hypertension
Maria C. Armas-Padilla, Rafael Hernandez-Hernandez, Maria J. Armas-Hernandez, Beatriz Sosa-Canache, Beatriz Pacheco, Jaime Guerrero, Atiff R. Carvajal and Rosalba Cammarata
Am J Hypertens 17: 67A-67A; doi:10.1016/j.amjhyper.2004.03.169
P-96: Association of homocysteine levels with salt sensitivity in non-diabetic hypertensives
K.A. Aznaouridis, G.P. Vyssoulis, E.A. Karpanou, A.N. Arapogianni, C.A. Chrysohoou, A.I. Zervoudaki, D.V. Cokkinos and C.I. Stefanadis
Am J Hypertens 17: 67A-67A; doi:10.1016/j.amjhyper.2004.03.170
P-97: Gene transfer of human GTP cyclohydrolase i restores superoxide-induced arterial tetrahydrobiopterin deficiency and endothelial dysfunction in DOCA-salt hypertensive rats
Jie-Sheng Zheng, Gregory D. Fink and Alex F. Chen
Am J Hypertens 17: 67A-68A; doi:10.1016/j.amjhyper.2004.03.171
P-98: Microalbuminuria and endothelial activation in treated and untreated diabetic and non-diabetic hypertensives
Santina Cottone, Giuseppe Mulè, Emilio Nardi, Rosalia Arsena, Chiara Briolotta, Maria Carmela Lorito, Anna Vadalà and Giovanni Cerasola
Am J Hypertens 17: 68A-68A; doi:10.1016/j.amjhyper.2004.03.172
P-99: Endothelial dysfucntion and vascular inflammation in essential hypertension
Maria Larroussse, Ernesto Bragulat, Marta Segarra, Cristina Sierra, Antonio Coca and Alejandro De la Sierra
Am J Hypertens 17: 68A-68A; doi:10.1016/j.amjhyper.2004.03.173
P-100: Regulation of systolic blood pressure by serotonin, through 5-HT2B receptor, and ovarian hormones in nos inhibition-induced hypertensive mice
Nelly Etienne, Lahcen Elfertak, Alain Guimont, Laurent Monassier and Luc Maroteaux
Am J Hypertens 17: 68A-69A; doi:10.1016/j.amjhyper.2004.03.174
P-101: Cocoa rich in flavanols reverses endothelial dysfunction of human aging via NO
Naomi D.L. Fisher, Meghan Hughes and Norman K. Hollenberg
Am J Hypertens 17: 69A-69A; doi:10.1016/j.amjhyper.2004.03.175
P-102: Soy protein diet improves endothelial function in the brachial artery of renal transplant patients
Isabella Kardasz, Lorenzo Ghiadoni, Adamasco Cupisti, Claudia D'Alessandro, Ester Morelli, Giuliano Barsotti, Stefano Taddei and Antonio Salvetti
Am J Hypertens 17: 69A-69A; doi:10.1016/j.amjhyper.2004.03.176
P-103: Relationship between cardiovascular risk profile and endothelial dysfunction in the forearm microcirculation
Lorenzo Ghiadoni, Daniele Versari, Agostino Virdis, Alessandro Cipriano, Yvonne Plantinga, Stefano Taddei and Antonio Salvetti
Am J Hypertens 17: 70A-70A; doi:10.1016/j.amjhyper.2004.03.177
P-104: The effect of rosuvastatin on endothelial function in patients with moderate hypercholesterolaemia
Lynn D. Greig, Debbie Kerr, Michael K. Palmer, Helena Melezinkova and David J. Webb
Am J Hypertens 17: 70A-70A; doi:10.1016/j.amjhyper.2004.03.178
P-105: Comparison of lower and upper arm occlusion for induction of flow-mediated dilation in cigarette smokers
Sashi Guthikonda, Christine A. Sinkey, Kenneth Woods and William G. Haynes
Am J Hypertens 17: 70A-70A; doi:10.1016/j.amjhyper.2004.03.179
P-106: Nitric oxide and malondialdehyde levels in healhty normotensive subjects and hypertensive patients
Rafael Hernandez-Hernandez, Maria C. Armas-Padilla, Rosalba Cammarata, Beatriz Sosa-Canache, Betriz Pacheco, Jaime Guerrero, Atiff R. Carvajal and Maria J. Armas-Hernandez
Am J Hypertens 17: 71A-71A; doi:10.1016/j.amjhyper.2004.03.180
P-107: Effects of oral magnesium (MG++) and potassium (K+) therapy on thallium perfusion scan defects, quality of life and pulse wave analysis in hypertensive patients with syndrome X
Sabine Hoerzer, Thomas C. Wascher, Rainer W. Lipp, Josef Haas, Werner W. Klein and Robert Zweiker
Am J Hypertens 17: 71A-71A; doi:10.1016/j.amjhyper.2004.03.181
P-108: Endothelial function in patients with sleep apnea but without hypertension
Huseyin Oflaz, Caglar Cuhadaroglu, Burak Pamukcu, Ahmet K. Bilge, Turhan Ece and Nevres Koylan
Am J Hypertens 17: 71A-71A; doi:10.1016/j.amjhyper.2004.03.182
P-109: Impaired response of the denervated kidney to endothelin receptor blockade in normotensive wistar-kyoto (WKY) and spontaneously hypertensive rats (SHR)
Radoslav Girchev, Angela Baecker, Petya Markova and Herbert J. Kramer
Am J Hypertens 17: 72A-72A; doi:10.1016/j.amjhyper.2004.03.183
P-110: Effects of erythropoietin on blood pressure and hematocrit
Mary S. Lee, John S. Lee, Jong Y. Lee and Franz Halberg
Am J Hypertens 17: 72A-72A; doi:10.1016/j.amjhyper.2004.03.184
P-111: Effects of pure human erythropoietin-binding protein and its antibody
Jong Y. Lee
Am J Hypertens 17: 72A-72A; doi:10.1016/j.amjhyper.2004.03.185
P-112: Aminoguanidine restores reactivity of pulmonary and systemic vessels in rats with monocrotaline-induced pulmonary hypertension
Natalia A. Medvedeva, Anton P. Bonartsev, Anna V. Slavutskaya, Konstantin B. Diakonov and Aleksandr B. Postnikov
Am J Hypertens 17: 72A-73A; doi:10.1016/j.amjhyper.2004.03.186
P-113: The pathogenesis of pulmonary hypertension in hemodialysis patients via arterial-venous access
Farid Nakhoul, Mordechai Yigla, Rima Gilman, Shimon A. Reisner, Rawi Ramadan and Zaid Abassi
Am J Hypertens 17: 73A-73A; doi:10.1016/j.amjhyper.2004.03.187
P-114: Impaired stimulated no-activity by erythropoetin in hypertensive subjects
Sebastian Oehmer, Bernhard M.W. Schmidt, Karl Hilgers, Markus P. Schneider and Roland E. Schmieder
Am J Hypertens 17: 73A-73A; doi:10.1016/j.amjhyper.2004.03.188
P-115: Use of ace inhibitors or angiotensin receptor blockers did not improve endothelial function in white coat hypertension
Rene A. Oliveros, Tressey Hamilton, Laura M. Busch and Edwin "Eli" J. Whitney
Am J Hypertens 17: 73A-73A; doi:10.1016/j.amjhyper.2004.03.189
P-116: Coffee exerts an acute unfavorable effect on endothelial function of healthy subjects
Chris Papamichael, Konstantinos Aznaouridis, Emmanouel Karatzis, Kalliopi Karatzi, Kimon Stamatelopoulos, John Lekakis and Myron Mavrikakis
Am J Hypertens 17: 74A-74A; doi:10.1016/j.amjhyper.2004.03.190
P-117: The B-type natriuretic peptide as a defensive mechanism against endothelin, in high cardiovascular risk patients without target-organ damage
Jose Saban-Ruiz, Enrique Bernal, Arturo Ugalde, Maria Calbacho, Olivia Sanchez, David Coca, Elena Sanchez-Largo, Ana Bajo and Rosa Fabregate
Am J Hypertens 17: 74A-74A; doi:10.1016/j.amjhyper.2004.03.191
P-118: A higher C-reactive protein in presence of an elevated pulse pressure could challenge the old theory that conceives arteriosclerosis as a degenerative process
Enrique Bernal, Elena Sanchez-Largo, Arturo Ugalde, Maria Calbacho, David Coca, Ana Bajo, Luisa-Maria Villar, Olivia Sanchez, Rosa Fabregate and Jose Saban-Ruiz
Am J Hypertens 17: 74A-74A; doi:10.1016/j.amjhyper.2004.03.192
P-119: Why is flow mediated dilation dependent on arterial size? assessment of the shear stimulus using phase contrast magnetic resonance imaging
Harry A. Silber, Pamela Ouyang, David A. Bluemke, Sandeep N. Gupta, Thomas K. Foo and Joao A.C. Lima
Am J Hypertens 17: 75A-75A; doi:10.1016/j.amjhyper.2004.03.193
P-120: Left ventricle dysfunction in patients survived after myocardial infarction and arterial hypertension by treating with taurin-containing drugs
Igor Petrovich Vakalyuk and Yaroslava Leonidivna Kurtach
Am J Hypertens 17: 75A-75A; doi:10.1016/j.amjhyper.2004.03.194
P-121: The origin of reactive oxygen species in adrenocorticotropic hormone-induced hypertension in the rat
Yi Zhang, T. Pang, M.M. Chan, M.C. Andrews, C.G. Schyvens, K.U. McKenzie and J.A. Whitworth
Am J Hypertens 17: 75A-75A; doi:10.1016/j.amjhyper.2004.03.195
P-122: Total body potassium (TBK) on systemic and local arterial stiffness (AS): Its role on gender-related differences in arterial stiffness
Antonio J. Delgado, Maria C. Delgado and Alan B. Weder
Am J Hypertens 17: 76A-76A; doi:10.1016/j.amjhyper.2004.03.196
P-123: Gender differences in proteinuria in aged stroke-prone spontaneously hypertensive rats are independent of blood pressure
Gagan Singh, Shreeharsha N. Masineni, Praveen N. Chander, Jeffrey M. Ranaudo, Iram R. Hassan and Charles T. Stier Jr.
Am J Hypertens 17: 76A-76A; doi:10.1016/j.amjhyper.2004.03.197
P-124: Study with carboxylesterase 1 gene variants in hypertensive patients - in relation to the responsiveness to angiotensin converting enzyme inhibitor
Eiichi Geshi, Tsukasa Saito, Tetsuo Sakai, Hiroshi Suzuki, Shinji Koba and Takashi Katagiri
Am J Hypertens 17: 78A-78A; doi:10.1016/j.amjhyper.2004.03.198
P-125: Large conductance K+ channel B1 subunit polymorphisms affect human stress blood pressure responses
Danuta King, Fangwen Rao, Jennifer Wessel, Guangfa Zhang, Brinda K. Rana, Bruce A. Hamilton, Douglas W. Smith, Robert J. Parmer, Nicholas J. Schork and Daniel T. O'Connor
Am J Hypertens 17: 78A-78A; doi:10.1016/j.amjhyper.2004.03.199
P-126: Genetic risk factor for the susceptibility for chronic chlamydia pneumoniae infection: J-shipp study
Katsuhiko Kohara, Yasuharu Tabara, Michiko Abe, Rieko Tachibana, Jun Nakura and Tetsuro Miki
Am J Hypertens 17: 78A-79A; doi:10.1016/j.amjhyper.2004.03.200
P-127: eNOS-knock-out mice display a disturbed 24-h rhythm in heart rate but not in blood pressure
Bjoern Lemmer, Marhan Arraj, Martin Thomas and Patrick Zuther
Am J Hypertens 17: 79A-79A; doi:10.1016/j.amjhyper.2004.03.201
P-128: A novel mutation in thecyp11b1 gene in a patient with 11-hydroxylase deficiency
Roja Motaghedi, Bozena Slowinska, Barbara Cerami, Monina Cabrera, Maria I. New and Robert C. Wilson
Am J Hypertens 17: 79A-79A; doi:10.1016/j.amjhyper.2004.03.202
P-129: Beta-adrenergic control of human heart rate variability (HRV): Prediction by multiple single nucleotide polymorphisms (SNSP) at the beta-2 (ADRB2) though not the beta-1 (ADRB1) adrenergic receptor genetic loci
Fangwen Rao, Danuta King, Jennifer Wessel, Nifholas J. Schork and Daniel T. O'Connor
Am J Hypertens 17: 79A-80A; doi:10.1016/j.amjhyper.2004.03.203
P-130: Paraoxonase gene polymorphisms and oxidative stress
Rieko Tachibana, Katsuhiko Kohara, Yasuharu Tabara, Jun Nakura and Tetsuro Miki
Am J Hypertens 17: 80A-80A; doi:10.1016/j.amjhyper.2004.03.204
P-131: Autonomic nervous system activity (baroreflex sensitivity): Prediction by polymorphism at the tyrosine hydroxylase (TH) locus, the rate-limiting enzyme in catecholamine biosynthesis
Lian Zhang, Fangwen Rao, Danuta King, Rubin Chandran, Jennifer Wessel, Brinda K. Rana, Brian P. Kennedy, Guangfa Zhang, Michael G. Ziegler, Nicholas J. Schork and Daniel T. O'Connor
Am J Hypertens 17: 80A-80A; doi:10.1016/j.amjhyper.2004.03.205
P-132: Chronic cocaine abuse as a cause of left ventricular hypertrophy?
Aamer Abbas, Paul J. Fadel, Sharonda Clark, Ronald G. Victor and Wanpen Vongpatanasin
Am J Hypertens 17: 81A-81A; doi:10.1016/j.amjhyper.2004.03.206
P-133: QRS area-based electrocardiographic criteria detect left ventricular hypertrophy more frequently than other conventional methods in hypertensive patients included in the sara study
Vivencio Barrios, Alberto Calderon, Onofre Vegazo, Raul Fernandez, Juan P. Tomas and Luis M. Molinero
Am J Hypertens 17: 81A-81A; doi:10.1016/j.amjhyper.2004.03.207
P-134: Assessment of B-type natriuretic peptide (BNP) and n-terminal (NT)-probnp in hypertensive patients with heart failure
Daniela Degli Esposti, Maddelena Veronesi, Eugenio Cosentino, Ada Dormi, Stefano Bacchelli, Domenico Maione, Maria Grazia Prandin, Claudio Borghi and Ettore Ambrosioni
Am J Hypertens 17: 81A-82A; doi:10.1016/j.amjhyper.2004.03.208
P-135: Assessment of B-type natriuretic peptide (BNP) and N-terminal (NT)-probnp in patients with heart failure of hypertensive or not hypertensive origin
Daniela Degli Esposti, Eugenio Cosentino, Maddalena Veronesi, Ada Dormi, Stefano Bacchelli, Domenico Maione, Vincenzo Immordino, Claudio Borghi and Ettore Ambrosioni
Am J Hypertens 17: 82A-82A; doi:10.1016/j.amjhyper.2004.03.209
P-136: Cardiomyocyte apoptosis and survival in hypertensive patients with chronic heart failure
Arantxa González, Begoña López, Ramón Querejeta, Mariano Larman, Maréa A. Fortuño and Javier Déez
Am J Hypertens 17: 82A-82A; doi:10.1016/j.amjhyper.2004.03.210
P-137: Hypertensive heart failure patients: Pharmacologic treatment patterns by primary care physicians in va and non-va settings
Brent M. Egan, Michael R. Zile, Jan N. Basile and Florence N. Hutchison
Am J Hypertens 17: 82A-83A; doi:10.1016/j.amjhyper.2004.03.211
P-138: Effect of benazepril amlodipine combination on left ventricular hypertrophy in hypertensive type 2 diabetic patients
Roberto Fogari, Ettore Malacco, Carlo Pasotti, Luca Corradi, Amedeo Mugellini, Andrea Rinaldi, Paola Preti and Pierangelo Lazzari
Am J Hypertens 17: 83A-83A; doi:10.1016/j.amjhyper.2004.03.212
P-139: Dietary fat type modulates angiotensin II-induced early left ventricular hypertrophic responses in rats
Gabor Foldes, Szilvia Vajda, Zoltan Lako-Futo, Balazs Sarman, Reka Skoumal, Mika Ilves, Rudolf de Chatel, Istvan Lepran, Heikki Ruskoaho and Miklos Toth
Am J Hypertens 17: 83A-83A; doi:10.1016/j.amjhyper.2004.03.213
P-140: Early administration of either spironolactone or eprosartan reduces cardiac hypertrophy and fibrosis in rats with heart failure: possible involvement of ACE and ACE-2
Tony Karram, Anan Abbasi, Joseph Winaver, Aaron Hoffman and Zaid Abassi
Am J Hypertens 17: 84A-84A; doi:10.1016/j.amjhyper.2004.03.214
P-141: Organ-protection by an A 1-blocker plus an angiotensin converting enzyme inhibitor in hypertensive rats
Alberto Lazaro, Julio Gallego-Delgado, Dulcenombre Gómez-Garre, Julio Osende and Jesús Egido
Am J Hypertens 17: 84A-84A; doi:10.1016/j.amjhyper.2004.03.215
P-142: The clinical practice of measurement of wall thickness does not accurately predict the presence or absence of left ventricular hypertrophy: a prospective echocardiographic study
David W. Leibowitz, Michael Bursztyn, Fanny Ben-Ibgi and Abraham T. Weiss
Am J Hypertens 17: 84A-85A; doi:10.1016/j.amjhyper.2004.03.216
P-143: Brain natriuretic peptide and atrial natriuretic peptide in hypertensive chronic heart failure
Luiz F. Menezes Falcao, Fausto Pinto, Fatima Veiga, Luciano P. Ravara and Peter A.van Zwieten
Am J Hypertens 17: 85A-85A; doi:10.1016/j.amjhyper.2004.03.217
P-144: Comparison between clinical and echocardiographic patterns of dilated cardiomiophaty secondary to hypertension and primary dilated cardiomiophaty
Albertino Damasceno, Cherizade Aly, Gulnaze Arif, Domingos Diogo, Jose Silva Cardoso and Jorge Polonia
Am J Hypertens 17: 85A-85A; doi:10.1016/j.amjhyper.2004.03.218
P-145: Effect of smoking on left ventricular hypertrophy, in untreated patients with essential hypertension
John A. Popadakis, George E. Vrentzos, Irene Kazakou, Antonia Kalikaki and Emmanouel S. Ganotakis
Am J Hypertens 17: 85A-86A; doi:10.1016/j.amjhyper.2004.03.219
P-146: Left ventricular remodeling, carotid intima-media thickness and endothelial fuction in untreated hypertensive patients
Eugene V. Shlyakhto, Alexandra O. Conrady, Oleg G. Rudomanov, Dmitry V. Zaharov and Natalya V. Vahrameeva
Am J Hypertens 17: 86A-86A; doi:10.1016/j.amjhyper.2004.03.220
P-147: The effect of mildronate on autonomic nervous system function in patients with heart failure
Daina Voita, Daina Bojare, Ilze Skarda and Indulis Kukulis
Am J Hypertens 17: 86A-86A; doi:10.1016/j.amjhyper.2004.03.221
P-147A: Atrial natriuretic peptide dose dependently inhibits cardiac remodeling after exposure to pressure overload
Veronica Franco, Yiu Fai Chen, Ji An Feng, Fadi Hage, Suzanne Oparil and Gilbert Perry
Am J Hypertens 17: 86A-87A; doi:10.1016/j.amjhyper.2004.03.222
P-148: Long-term renoprotective effects of usual versus high dose of telmisartan in non-diabetic nephropathies
Pedro Aranda, Francisco J. Aranda, Miguel A. Frutos, Eduardo Lopez de Novales, Pedro J. Aranda and Luis M. Ruilope
Am J Hypertens 17: 88A-88A; doi:10.1016/j.amjhyper.2004.03.223
P-149: Mild renal impairment is associated with increased cardiovascular risk in hypertensive patients
G.P. Vyssoulis, E.A. Karpanou, K.A. Aznaouridis, C.A. Chrysohoou, G.H. Antonakoudis, D.V. Cokkinos and C.I. Stefanadis
Am J Hypertens 17: 88A-88A; doi:10.1016/j.amjhyper.2004.03.224
P-150: Effects of olmesartan medoxomil (OLM) and losartan potassium (LOS) in patients with hypertension (HTN), type 2 diabetes mellitus (T2DM), and microalbuminuria
George Bakris, Nathaniel Winer and Michael Jones
Am J Hypertens 17: 88A-89A; doi:10.1016/j.amjhyper.2004.03.225
P-151: Correlation between estimated glomerular filtration rate and microalbuminuria in treated essential hypertensive patients
Carlos Campo, Julian Segura, Cecilia Roldan, Luisa Fernandez, Lucia Guerrero and Luis M. Ruilope
Am J Hypertens 17: 89A-89A; doi:10.1016/j.amjhyper.2004.03.226
P-152: Prevalence and incidence of urinary sediment alterations in hypertensive patients
Elena Ratto, Carlos Campo, Julian Segura, Cecilia Roldan, Luis Vigil, Jose L. Rodicio and Luis M. Ruilope
Am J Hypertens 17: 89A-89A; doi:10.1016/j.amjhyper.2004.03.227
P-153: Reduced survival in atherosclerotic renovascular hypertensives compared to age, gender, and race-matched essential hypertensives
Kenneth L. Choi and William J. Elliott
Am J Hypertens 17: 89A-90A; doi:10.1016/j.amjhyper.2004.03.228
P-154: Evidence that phosphodiesterase 4b plays a mechanistic role in salt-adaptation and is a therapeutic target for hypertension in the dahl rat
Alan Jung, Marie K. Baraoidan, Kumar Kotlo and Robert S. Danziger
Am J Hypertens 17: 90A-90A; doi:10.1016/j.amjhyper.2004.03.229
P-155: Relationships between circulating plasma levels of inflammatory markers and urinary albumin excretion rate in untreated subjects with essential hypertension
K. Dimitriadis, C. Tsioufis, M. Toutouza, C. Stefanadis and I. Kallikazaros
Am J Hypertens 17: 90A-90A; doi:10.1016/j.amjhyper.2004.03.230
P-156: Nitric oxide synthase inhibition mediated afferent and efferent arteriolar vasoconstriction involves L-type calcium channel activation
Ming-Guo Feng and L.Gabriel Navar
Am J Hypertens 17: 90A-91A; doi:10.1016/j.amjhyper.2004.03.231
P-157: Effects of perindopril, irbesartan, and perindopril plus irbesartan on blood pressure, renal hemodynamics, proteinuria, renin angiotesin-aldosterone system, and TGF-B1, in type 2 diabetes with nephropathy
Jorge Paulo Matos, Maria Lourdes Rodrigues, Debora Torres Valença, Vagner Lobão Ismerin, Claudio Sergio Lau, Sergio Girao Barroso, Edson Boasquevisque, Virginia Genelhu Abreu and Emilio Antonio Francischetti
Am J Hypertens 17: 91A-91A; doi:10.1016/j.amjhyper.2004.03.232
P-158: HDL mediates reverse cholesterol transport from mesangial cells via map kinase
Siddhartha S. Ghosh, Shobha Ghosh, Todd W.B. Gehr and Domenic A. Sica
Am J Hypertens 17: 91A-91A; doi:10.1016/j.amjhyper.2004.03.233
P-159: Prognosis in hemodialysis patients without cardiac dysfunction: high levels versus low levels of brain natriuretic peptide
Yuji Hara, Akiyoshi Ogimoto, Tomoaki Ohtsuka, Yuji Shigematsu and Jitsuo Higaki
Am J Hypertens 17: 91A-92A; doi:10.1016/j.amjhyper.2004.03.234
P-160: Conversion from cyclosporine a to tacrolimus has beneficial effects on blood pressure in longterm renal transplant recipients
Uta Hillebrand, Ulf Gerhardt and Barbara Suwelack
Am J Hypertens 17: 92A-92A; doi:10.1016/j.amjhyper.2004.03.235
P-161: Renal resistive index in hypertensive and normotensive subjects
Roberto A. Ingaramo
Am J Hypertens 17: 92A-92A; doi:10.1016/j.amjhyper.2004.03.236
P-162: Outcomes after renal angioplasty and stent placement in hypertensive african americans with critical renal artery stenosis
Deepak Koul, Amanda I. Dudley, Tariq Shafi, Samar Nasser, Errol Crook, Richard Spears and John M. Flack
Am J Hypertens 17: 92A-93A; doi:10.1016/j.amjhyper.2004.03.237
P-163: Intense ultrafiltration for normalization of blood pressure during hospitalization in patients with dialysis refractory hypertension
Chamberlain I. Obialo, Shalini Sharda and Waindel Belizaire
Am J Hypertens 17: 93A-93A; doi:10.1016/j.amjhyper.2004.03.238
P-164: Primary aldosteronism may be associated with albuminuria and hyperfiltration
Jean Ribstein, Pierre Fesler, Guilhem Du Cailar and Albert Mimran
Am J Hypertens 17: 93A-93A; doi:10.1016/j.amjhyper.2004.03.239
P-165: Cardiovascular structure and renal function in a general population in northern italy: The vobarno study
Massimo Salvetti, Maria Lorenza Muiesan, Cristina Monteduro, Anna Paini, Bianca Bonzi, Paolo Poisa, Sara Viola and Enrico Agabiti Rosei
Am J Hypertens 17: 93A-93A; doi:10.1016/j.amjhyper.2004.03.240
P-166: Selective sodium-loading induces renal vasoconstriction in salt-sensitive african-americans
Olga Schmidlin, Alex Forman and R.Curtis Morris Jr
Am J Hypertens 17: 94A-94A; doi:10.1016/j.amjhyper.2004.03.241
P-167: Renal status of malignant-accelerated hypertension in he developing countries
Yackoob Kassim Seedat
Am J Hypertens 17: 94A-94A; doi:10.1016/j.amjhyper.2004.03.242
P-168: Development of chronic kidney disease and cardiovascular prognosis in long-term treated hypertensive patients
Julian Segura, Carlos Campo, Cecilia Roldan, Luis Vigil, Lucia Guerrero, Luisa Fernandez, Jose L. Rodicio and Luis M. Ruilope
Am J Hypertens 17: 94A-94A; doi:10.1016/j.amjhyper.2004.03.243
P-169: Orlistat attenuates urinary albumin excretion rate in obese essential hypertensive patients
C. Tsioufis, V. Katsi, K. Dimitriadis, I. Kallikazaros and C. Stefanadis
Am J Hypertens 17: 95A-95A; doi:10.1016/j.amjhyper.2004.03.244
P-170: Different expression of aquapolin-2 mrna in kidney tissue between spontaneously hypertensive and normotensive wistar kyoto rats
Jihua Huang, Liangdi Xie, Huajun Wang and Changsheng Xu
Am J Hypertens 17: 95A-95A; doi:10.1016/j.amjhyper.2004.03.245
P-171: Effects of perindopril on 24-h blood pressure in hypertensive patients with diabetic nephropathy
Gen Yasuda, Nariaki Ogawa, Gaku Shimura, Daisaku Ando, Kazuhiko Shibata, Satoshi Umemura and Osamu Tochikubo
Am J Hypertens 17: 95A-95A; doi:10.1016/j.amjhyper.2004.03.246
P-172: Differential regulation of blood pressure and renal function by renal at1 receptors in normotensive and spontaneously hypertensive rats
Minoru Yoneda, Hironobu Sanada, Junichi Yatabe, Sanae Midorikawa, Shigeatsu Hashimoto, Tsuyoshi Watanabe, Midori Sasaki, Pedro A. Jose and Robin A. Felder
Am J Hypertens 17: 95A-96A; doi:10.1016/j.amjhyper.2004.03.247
P-173: Role of Ga12- and Ga13-protein subunit linkage of D3 dopamine receptors in the impaired natriuretic effect of d3 dopamine receptors in SHRS
Chunyu Zeng, Laureano D. Asico, Shaopeng Zheng, Ulrich Hopfer, Gilbert M. Eisner, Robin A. Felder and Pedro A. Jose
Am J Hypertens 17: 96A-96A; doi:10.1016/j.amjhyper.2004.03.248
P-174: Potassium depletion inhibits translation of extracellular-superoxide dismutase in vascular smooth muscle cells
Masako Honsei, Jing Liu, Toshiro Fujita and Katsutoshi Takahashi
Am J Hypertens 17: 97A-97A; doi:10.1016/j.amjhyper.2004.03.249
P-175: Increased calcium and decreased magnesium concentrations and an increased calcium/magnesium ratio in shr versus wky: Relation to arteriosclerosis
Klaus Kisters, Franz Wessels, Faruk Tokmak, Bernhard Gremmler, Markus Kosch and Martin Hausberg
Am J Hypertens 17: 97A-97A; doi:10.1016/j.amjhyper.2004.03.250
P-176: Ambulatory blood pressure (ABP) abnormalities correlate with the presence of microalbuminuria (MA) in minority adolescents with type 2 diabetes mellitus (T2DM)
Leigh M. Ettinger, Mehul B. Patel, Katherine Freeman, Joan R.Di Martino-Nardi and Joseph T. Flynn
Am J Hypertens 17: 98A-98A; doi:10.1016/j.amjhyper.2004.03.251
P-177: Alterations in circadian and ultradian cardiovascular rhythms in children with chronic renal failure
Charlotte Hadtstein, Elke Wühl, Otto Mehls and Franz Schaefer the ESCAPE Trial Group
Am J Hypertens 17: 98A-98A; doi:10.1016/j.amjhyper.2004.03.252
P-178: Steep blood pressure increase in low birth weight newborns
Isabel Torró, Consuelo Garcia-Vicent, José Fayos, Vicente Alvarez, Francisco Aguilar, Javier Martin de Llano and Empar Lurbe
Am J Hypertens 17: 98A-98A; doi:10.1016/j.amjhyper.2004.03.253
P-179: Sodium-lithium countertransport and the risk of children hypertension: A 10-year prospective studay in china
Jianjun Mu, Zhiquan Liu, Dingyi Yang, Yimu Liang and Zhexun Wang
Am J Hypertens 17: 99A-99A; doi:10.1016/j.amjhyper.2004.03.254
P-180: The favourable anti-infllamatory effect of pritor in essential hypertension
Ilgar G. Alizade and Nigar T. Aliyeva-Karayeva
Am J Hypertens 17: 100A-100A; doi:10.1016/j.amjhyper.2004.03.255
P-181: Lercanidipine improves its antihypertensive effectiveness with no impairment on its good tolerability profile in higher-risk hypertensives. The laura study
Vivencio Barrios, Alberto Calderon, Angel Navarro, Carlos Noya, Juan P. Tomas, Alejandro Amador, Inmaculada Herranz, Luis Prieto, Carlos Escobar and Blanca Blanco
Am J Hypertens 17: 100A-100A; doi:10.1016/j.amjhyper.2004.03.256
P-182: The effectiveness and tolerability of lercanidipine is independent of body mass or body fat indexes. The lerzamig study
Vivencio Barrios, Alberto Calderon, Angel Navarro, Carlos Noya, Inmaculada Herranz, Luis Prieto, Juan P. Tomas, Carlos Escobar, Blanca Blanco and Alejandro Amador
Am J Hypertens 17: 100A-100A; doi:10.1016/j.amjhyper.2004.03.257
P-183: Effectiveness of dihydropyridine calcium channel blockers, angiotensin receptor blockers, and ace inhibitors in combination with diuretics or beta blockers in blood pressure change and control among hypertensive adults in clinical practice
John D. Bisognano, Trent McLaughlin, Dahlia Garza, Brian Schwartz and Simon Tang
Am J Hypertens 17: 100A-101A; doi:10.1016/j.amjhyper.2004.03.258
P-184: Dihydropyridine calcium channel blockers, angiotensin receptor blockers, and ace inhibitors in combination with diuretics or beta blockers: Real world effectiveness in blood pressure change and control among patients with diabetes and hypertension
John D. Bisognano, Trent McLaughlin, Dahlia Garza, Brian Schwartz and Simon Tang
Am J Hypertens 17: 101A-101A; doi:10.1016/j.amjhyper.2004.03.259
P-185: Temporal trend of antihypertensive drugs therapy and blood pressure control in the brisighella heart study
Claudio Borghi, Ada Dormi, Antonio Gaddi, Eugenio Cosentino, Vincenzo Immordino and Ettore Ambrosioni
Am J Hypertens 17: 101A-101A; doi:10.1016/j.amjhyper.2004.03.260
P-186: Adverse effects and reasons for switch reported by patients on antihypertensive medications
Kristina Chen, Daniel Glass, Chiun-Fang Chiou, Craig Plauschinat, Feride Frech, Ann Harper and Robert Dubois
Am J Hypertens 17: 102A-102A; doi:10.1016/j.amjhyper.2004.03.261
P-187: Combination therapy with an ace-inhibitor (ACEI)/calcium channel blocker (CCB) for hypertensive patients non-responsive to ace-inhibitor monotherapy: An efficacy and safety trial
Steven G. Chrysant and George L. Bakris
Am J Hypertens 17: 102A-102A; doi:10.1016/j.amjhyper.2004.03.262
P-188: Olmesartan medoxomil lowers blood pressure as rapidly as amlodipine besylate in patients with mild to moderate hypertension: results of a randomized, double-blind, placebo-controlled study
Steven Chrysant and Antonia Wang
Am J Hypertens 17: 102A-102A; doi:10.1016/j.amjhyper.2004.03.263
P-189: Prevalence of antihypertensive drug monotherapy at a specialty hypertension clinic
Dave Y. Chua, Raju Behara, Peter Meyer, Kelly Karavolas, Henry R. Black and William J. Elliott
Am J Hypertens 17: 103A-103A; doi:10.1016/j.amjhyper.2004.03.264
P-190: The effect of accupril on circadian blood pressure patterns in hypertensive subjects with left ventricle hypertrophy
Lilian Soares da Costa, Hugo Sabino, Ricardo Zajdenverg, Soriano de Carvalho Furtado Neto, Cantidio Drumond Neto and Antonio Jazbik
Am J Hypertens 17: 103A-103A; doi:10.1016/j.amjhyper.2004.03.265
P-191: Effect of antihypertensive treatment with telmisartan or lercanidipine on blood pressure variability
Giuseppe Crippa, Matteo Giorgi-Pierfranceschi, Claudio Venturi and Enrico Sverzellati
Am J Hypertens 17: 103A-103A; doi:10.1016/j.amjhyper.2004.03.266
P-192: Effect of eprosartan on pulse pressure and other blood pressure components in patients with isolated systolic hypertension
Alejandro De la Sierra, Anna Muñoz, Emma Arcos, Juan-Salvador López and Jordi Relats
Am J Hypertens 17: 104A-104A; doi:10.1016/j.amjhyper.2004.03.267
P-193: Acute effect of AT1 receptor blocker telmisartan on arterial stiffness and left ventricular function in hypertension
Antonio J. Delgado and Carlos L. Delgado-Leon
Am J Hypertens 17: 104A-104A; doi:10.1016/j.amjhyper.2004.03.268
P-194: Morning BP reduction: which drug can lower most?
Kazuo Eguchi, Kazuomi Kario, Joji Ishikawa and Kazuyuki Shimada
Am J Hypertens 17: 104A-104A; doi:10.1016/j.amjhyper.2004.03.269
P-195: Fixed-dose combination antihypertensive therapy with trandolapril/verapamil: A meta-analytic comparison against monotherapy
Michelle A. Faulkner and Daniel E. Hilleman
Am J Hypertens 17: 105A-105A; doi:10.1016/j.amjhyper.2004.03.270
P-196: Cost-effectiveness of a fixed-dose combination agent in high-risk hypertensive patients
Michelle A. Faulkner, Daniel E. Hilleman and Antonio P. Reyes
Am J Hypertens 17: 105A-105A; doi:10.1016/j.amjhyper.2004.03.271
P-197: Effects of telmisartan hydrochlorothiazide combination versus nifedipine gits on blood pressure and sympathetic activity in hypertension
Roberto Fogari, Amedeo Mugellini, Andrea Rinaldi, Carlo Pasotti, Elena Fogari, Luca Corradi and Paola Preti
Am J Hypertens 17: 105A-106A; doi:10.1016/j.amjhyper.2004.03.272
P-198: The effect of baseline physical activity on cardiovascular outcomes in patients treated for hypertension with LVH.
Eigil Fossum, Gilbert Gleim, Sverre E. Kjeldsen, Stevo Julius, Richard B. Devereux, William E. Brady and Björn Dahlöf
Am J Hypertens 17: 106A-106A; doi:10.1016/j.amjhyper.2004.03.273
P-199: Long-term plasma catecholamine levels in patients with hypertension and left ventricular hypertrophy treated with losartan or atenolol. Icarus, a life substudy
Eigil Fossum, Michael Hecht Olsen, Aud Hoieggen, Kristian Wachtell, Henrik Mikael Reims, Hans Ibsen, Stevo Julius and Sverre E. Kjeldsen
Am J Hypertens 17: 106A-106A; doi:10.1016/j.amjhyper.2004.03.274
P-200: Treatment of hypertension in patients with diabetes mellitus: initial losartan/hydrochlorothiazide combination versus ramipril monotherapy
Jonathan Fox, Kellie Leight, Santosh Sutradhar, Gilbert Gleim, Laura Demopoulos, Andrew Lewin and George Bakris
Am J Hypertens 17: 106A-107A; doi:10.1016/j.amjhyper.2004.03.275
P-201: Treatment and control of hypertension in the veterans health administration
Elaine M. Furmaga, Francesca E. Cunningham, William C. Cushman, Peter A. Glassman, Jan Basile, Diane Dong, Lois A. Katz and Gale H. Rutan
Am J Hypertens 17: 107A-107A; doi:10.1016/j.amjhyper.2004.03.276
P-202: Efficacy and tolerability of HCTZ 25 mg in combination with valsartan 160 mg in hypertensive patients not adequately controlled with a combination of high doses of arbs and HCTZ 12,5 mg
Xavier Girerd, Thierry Denolle, Patrick Brunel, Caroline Yau, Beatrice Fiquet, Bruno Moulin and Daniel Herpin
Am J Hypertens 17: 107A-108A; doi:10.1016/j.amjhyper.2004.03.277
P-203: Effect of thiols on peroxynitrite: relationship to blood pressure changes
Harvey C. Gonick and Stanislav Shelkovnikov
Am J Hypertens 17: 108A-108A; doi:10.1016/j.amjhyper.2004.03.278
P-204: Aliskiren, a novel orally effective renin inhibitor, provides antihypertensive efficacy and placebo-like tolerability similar to an at1-receptor blocker in hypertensive patients
Alan H. Gradman, Roland E. Schmieder, Robert L. Lins, Yanntong Chiang and Martin P. Bedigian
Am J Hypertens 17: 108A-108A; doi:10.1016/j.amjhyper.2004.03.279
P-205: Administration time-dependent effects on ambulatory blood pressure of doxazosin gits as added therapy in uncontrolled hypertensive patients
Ramon C. Hermida, Carlos Calvo, Diana E. Ayala, Maria J. Dominguez, Manuel Covelo, Artemio Mojon, Jose R. Fernandez and Jose E. Lopez
Am J Hypertens 17: 108A-109A; doi:10.1016/j.amjhyper.2004.03.280
P-206: Effects of nebivolol monotherapy on ambulatory blood pressure in patients with essential hypertension
Carlos Calvo, Ramon C. Hermida, Diana E. Ayala, Jose E. Lopez, Maria J. Dominguez and Manuel Covelo
Am J Hypertens 17: 109A-109A; doi:10.1016/j.amjhyper.2004.03.281
P-207: Administration time-dependent effects of pharmacologic treatment on ambulatory blood pressure in patients with refractory hypertension
Carlos Calvo, Ramon C. Hermida, Diana E. Ayala, Jose E. Lopez, Maria J. Dominguez and Manuel Covelo
Am J Hypertens 17: 109A-109A; doi:10.1016/j.amjhyper.2004.03.282
P-208: Effects of morning versus evening administration of valsartan on ambulatory blood pressure in elderly hypertensive patients
Carlos Calvo, Ramon C. Hermida, Diana E. Ayala, Jose E. Lopez, Maria J. Dominguez and Manuel Covelo
Am J Hypertens 17: 109A-110A; doi:10.1016/j.amjhyper.2004.03.283
P-209: Effects of valsartan monotherapy on the circadian blood pressure profile of patients with grade 1–2 essential hypertension
Ramon C. Hermida, Carlos Calvo, Diana E. Ayala, Maria J. Dominguez, Manuel Covelo, Artemio Mojon, Jose R. Fernandez and Jose E. Lopez
Am J Hypertens 17: 110A-110A; doi:10.1016/j.amjhyper.2004.03.284
P-210: Administration time-dependent effects on ambulatory blood pressure of amlodipine as added therapy in uncontrolled hypertensive patients
Carlos Calvo, Ramon C. Hermida, Diana E. Ayala, Jose E. Lopez, Maria J. Dominguez and Manuel Covelo
Am J Hypertens 17: 110A-110A; doi:10.1016/j.amjhyper.2004.03.285
P-211: Administration time-dependent effects of valsartan on ambulatory blood pressure in nondipper patients with grade 1–2 essential hypertension
Ramon C. Hermida, Carlos Calvo, Diana E. Ayala, Maria J. Dominguez, Manuel Covelo, Artemio Mojon, Jose R. Fernandez and Jose E. Lopez
Am J Hypertens 17: 111A-111A; doi:10.1016/j.amjhyper.2004.03.286
P-212: The effect of losartan versus atenolol on carotid atherosclerosis in the common carotid arteries in hypertension. Icarus, a life substudy
Aud Hoieggen, Eigil Fossum, Michael H. Olsen, Kristian Wachtell, Elsa Hjerkinn, Richard B. Devereux, Hans Ibsen and Sverre E. Kjeldsen
Am J Hypertens 17: 111A-111A; doi:10.1016/j.amjhyper.2004.03.287
P-213: Comparison of blood pressure reduction of cilinidipine vs. amlodipine on ambulatory blood pressure
Satoshi Hoshide, Kazuomi Kario, Kazuo Eguchi and Kazuyuki Shimada
Am J Hypertens 17: 111A-111A; doi:10.1016/j.amjhyper.2004.03.288
P-214: Efficacy and safety of combination of valsartan with hydrochorothatizide in the management of patients with essential hypertension
Qi Hua and Dongbao Li
Am J Hypertens 17: 111A-112A; doi:10.1016/j.amjhyper.2004.03.289
P-215: Effect of amlodipine on left ventricular remodeling and function in patients with essential hypertension
Mei Li and Qi Hua
Am J Hypertens 17: 112A-112A; doi:10.1016/j.amjhyper.2004.03.290
P-216: Effect of bisoprolol on vascular endothelial function in patients with essential hypertension
Qi Hua, Dongbao Li and Hailing Chen
Am J Hypertens 17: 112A-112A; doi:10.1016/j.amjhyper.2004.03.291
P-217: Effectiveness and tolerability of enalapril plus nitrendipine on a fixed dose in hypertensive patients over 65 years
Alex Iniguez, Alex de la Sierra, Manuel Luque and Josep Combalia
Am J Hypertens 17: 112A-112A; doi:10.1016/j.amjhyper.2004.03.292
P-218: Comparison of the effects of valsartan HCT versus amlodipine on 24-hour abpm blood pressure in african americans with mild to moderate hypertension: The aadvance trial
Kenneth Jamerson, Matthew R. Weir, Elijah Saunders and Steven Zelenkofske the AADVANCE Investigators
Am J Hypertens 17: 112A-113A; doi:10.1016/j.amjhyper.2004.03.293
P-219: The effects of valsartan HCT versus amlodipine on inflammatory markers in hypertensive African Americans: The advance trial
Kenneth Jamerson, James Herron, Deanna G. Cheung and Steven Zelenkofske
Am J Hypertens 17: 113A-113A; doi:10.1016/j.amjhyper.2004.03.294
P-220: Lisinopril reduces left ventricular hypertrophy and cardiac polyamine concentrations without a reduction in left ventricular wall stress in transgenic hypertensive mice carrying both human renin and angiotensinogen genes
Tatsuya Kai and Ken Kanamasa
Am J Hypertens 17: 113A-113A; doi:10.1016/j.amjhyper.2004.03.295
P-221: Both atenolol and metoprolol have favourable effects on ECG parameters before, during and after exercise in healthy controls
Ilkka Kantola, Mika Kontro, Risto Vesalainen and Leo Tarssanen
Am J Hypertens 17: 113A-114A; doi:10.1016/j.amjhyper.2004.03.296
P-222: Greater efficacy of chlorthalidone over hydrochlorothiazide for achieving blood pressure goals
Nitin Khosla, Dave Chua, William J. Elliott and George L. Bakris
Am J Hypertens 17: 114A-114A; doi:10.1016/j.amjhyper.2004.03.297
P-223: The combination of olmesartan medoxomil plus hydrochlorothiazide in subjects with stage 2 hypertension: Results of a randomized, double-blind, factorial-design study
John B. Kostis and Tonous Silfani
Am J Hypertens 17: 114A-114A; doi:10.1016/j.amjhyper.2004.03.298
P-224: Persistence and adherence to antihypertensive agents
Jean Lachaine, Farzad Ali and Elizabeth Merikle
Am J Hypertens 17: 114A-115A; doi:10.1016/j.amjhyper.2004.03.299
P-225: Effective blood-pressure control with valsartan/HCTZ combination therapy in patients with moderate to severe systolic hypertension: The valor trial
Yves Lacoursiere, Daniel Hebert, Linda Assouline, Bonita Rehel and Yasser Khder
Am J Hypertens 17: 115A-115A; doi:10.1016/j.amjhyper.2004.03.300
P-226: Effects on blood pressure, nitric oxide urinary excretion and on enos protein expression by nevibolol and metoprolol in spontaneously-hypertensive rats
Bjoern Lemmer, Kirsten Meier and Stefan Gorbey
Am J Hypertens 17: 115A-115A; doi:10.1016/j.amjhyper.2004.03.301
P-227: Effects of irbesartan on platelet aggregation and markers of inflammation in hypertensive patients with and without atherosclerotic cardiovascular disease
Pavel J. Levy, Ronald D. Smith, Bridget Brosnihan, John Owen, Mark Espeland and Carlos M. Ferrario
Am J Hypertens 17: 115A-116A; doi:10.1016/j.amjhyper.2004.03.302
P-228: Equivalent blood pressure reduction with angiotensin ii receptor antagonist based therapy compared with a calcium channel blocker in mild-to-moderate hypertensive patients of african origin
Elena N. Libhaber, Carlos D. Libhaber, Geoffrey P. Candy, Karen Sliwa, Ntombi Hlatshwayo, Singh Kavier, Woodiwiss Angela, Norton R. Gavin, Essop R. Mohammed and Sareli Pinchas
Am J Hypertens 17: 116A-116A; doi:10.1016/j.amjhyper.2004.03.303
P-229: Association of BP control and frequency of mortality and CV morbidity in hypertensive patients with CAD: the international verapamil SR-trandolapril study
Giuseppe Mancia, Rhonda M. Cooper-DeHoff, Ann C. Hewkin, Stuart R. Kupfer and Carl J. Pepine
Am J Hypertens 17: 116A-116A; doi:10.1016/j.amjhyper.2004.03.304
P-230: Nsaid do not modified the antihypertensive effect of the dihydropiridine lercanidipine
Luque Otero Manuel and Navarro Angel
Am J Hypertens 17: 117A-117A; doi:10.1016/j.amjhyper.2004.03.305
P-231: Angiotensin receptors blockers and muscle strength in older hypertensive patients
Guilherme Augusto, Mariano Pego, Silvina Maria Neves and Luís Augusto Providência
Am J Hypertens 17: 117A-117A; doi:10.1016/j.amjhyper.2004.03.306
P-232: Amlodipine reduces platelet derived vegf and angiopoietin-1 in hypertension
Sunil Nadar and Gregory Y.H. Lip
Am J Hypertens 17: 117A-117A; doi:10.1016/j.amjhyper.2004.03.307
P-233: Effects of amlodipine-based therapy on platelet morphology, beta-thromboglobulin and soluble and platelet P-selectin in essential hypertension
Sunil Nadar and Gregory Y.H. Lip
Am J Hypertens 17: 118A-118A; doi:10.1016/j.amjhyper.2004.03.308
P-234: Telmisartan 40 or 80 mg/HCT 12.5 mg fixed dose combinations provide superior BP reductions compared to losartan 50 mg/HCT 12.5 mg fixed dose combination during the last 6 hours of the dosing interval: An ABPM comparison
Joel M. Neutel, Steven G. Chrysant and Thomas W. Littlejohn
Am J Hypertens 17: 118A-118A; doi:10.1016/j.amjhyper.2004.03.309
P-235: Blood pressure goal attainment: comparative efficacy of olmesartan medoxomil, losartan potassium, valsartan, and irbesartan
Suzanne Oparil and J.Findlay Walker
Am J Hypertens 17: 118A-119A; doi:10.1016/j.amjhyper.2004.03.310
P-236: Interaction between nitrates and tadalafil
Michael F. O'Rourke, Miok Kim and Audrey Adji
Am J Hypertens 17: 119A-119A; doi:10.1016/j.amjhyper.2004.03.311
P-237: The decrease in urinary albumin excretion after irbesartan treatment in normotensive diabetes type 1 patients with incipient nephropathy is related to blood pressure, and not to changes in soluble cytokines and growth factors
Branimir Draganov, Srdjan Djurovic and Ingrid Os
Am J Hypertens 17: 119A-119A; doi:10.1016/j.amjhyper.2004.03.312
P-238: Menopause as a clinical indicator for the treatment for hypertension with nifedipine gits as monotherapy. the star study
Jesus E. Esparragoza-Romano, Fernando Petersen-Aranguren and Carlos Garcia-Gutierrez
Am J Hypertens 17: 119A-120A; doi:10.1016/j.amjhyper.2004.03.313
P-239: Patient compliance and persistence with combination valsartan/ hydrochlorothiazide therapy versus hydrochlorothiazide therapy
Anh B. Nguyen, Craig A. Plauschinat, Feride F. Frech, Douglas Gause and Winnie Zhang
Am J Hypertens 17: 120A-120A; doi:10.1016/j.amjhyper.2004.03.314
P-240: Practice pattern implications for dihydropyridine calcium-channel blocker monotherapy in the hypertension population
Craig A. Plauschinat, Paul J. Godley and Donald J. DiPette
Am J Hypertens 17: 120A-120A; doi:10.1016/j.amjhyper.2004.03.315
P-241: Risk of cardiovascular events with amlodipine, lisinopril, or valsartan therapy in hypertension population
Craig A. Plauschinat, Feride H. Frech, Douglas Gause and Winnie Zhang
Am J Hypertens 17: 120A-121A; doi:10.1016/j.amjhyper.2004.03.316
P-242: The dose-dependent antihypertensive actions of olmesartan medoxomil, an angiotensin II (AT-II) receptor blocker
Michael K. Pugsley, David E. Mire, Tony N. Silfani and Sandeep Gupta
Am J Hypertens 17: 121A-121A; doi:10.1016/j.amjhyper.2004.03.317
P-243: A comparative analysis of the efficacy of olmesartan medoxomil (O)/hydrochlorothiazide (HCTZ), valsartan (V)/HCTZ, irbesartan (I)/HCTZ and telmisartan (T)/HCTZ combinations
C.Venkata S. Ram and Tonous Silfani
Am J Hypertens 17: 121A-121A; doi:10.1016/j.amjhyper.2004.03.318
P-244: Variations in blood pressure control throughout the dosing interval with morning versus evening dosing of once-daily antihypertensive medications
Rebecca R. Reed, Deborah S. King, Marion R. Wofford, Cathy M. Adair, Kimberly G. Harkins, Jimmy L. Stewart, Sharon B. Wyatt and Thomas K. Harrell
Am J Hypertens 17: 121A-122A; doi:10.1016/j.amjhyper.2004.03.319
P-245: Depressive symptoms among hypertensive patients treated with verapamil-SR-led versus atenolol-led treatment strategies
L.Douglas Ried, Michael J. Tueth, Eileen Handberg and Carl J. Pepine
Am J Hypertens 17: 122A-122A; doi:10.1016/j.amjhyper.2004.03.320
P-246: High response rate of mexican hypertensive patients to once daily nifedipine
Alberto Rubio-Guerra, Carlos Garcia-Gutierrez and Fernando Rodriguez-Rergis
Am J Hypertens 17: 122A-122A; doi:10.1016/j.amjhyper.2004.03.321
P-247: Antihypertensive therapy and blood pressure control in renal transplant recipients
Annie Saint-Remy, Fatima Ait Oile, Laurent Weekers, Bernard Dubois and Jean-Marie Krzesinski
Am J Hypertens 17: 122A-123A; doi:10.1016/j.amjhyper.2004.03.322
P-248: Is combined antihypertensive therapy enough to achieve adequate blood pressure control?
Julian Segura, Carlos Campo, Cecilia Roldan, Elena Ratto, Luisa Fernandez, Lucia Guerrero, Jose L. Rodicio and Luis M. Ruilope
Am J Hypertens 17: 123A-123A; doi:10.1016/j.amjhyper.2004.03.323
P-249: Comparison of intraindividual blood pressure responses to ace inhibition and angiotensin blockade
George S. Stergiou, Stamatis P. Efstathiou, Leonidas G. Roussias and Theodore D. Mountokalakis
Am J Hypertens 17: 123A-123A; doi:10.1016/j.amjhyper.2004.03.324
P-250: Amlodipine: pharmacokinetics of the maleate vs besylate salts
Sandy S. Suh, M.S. Mohan and Matthew W. Davis
Am J Hypertens 17: 123A-124A; doi:10.1016/j.amjhyper.2004.03.325
P-251: Calcium antagonist reduces oxidative stress by upregulating cu/zn superoxide dismutase in stroke-prone SHR
Seiji Umemoto, Masakazu Tanaka, Shinji Kawahara, Kyoko Umeji, Makoto Kubo, Ryo Hashimoto and Masunori Matsuzaki
Am J Hypertens 17: 124A-124A; doi:10.1016/j.amjhyper.2004.03.326
P-252: Effects of valsartan hct versus amlodipine on 24 hour blood pressure control in hypertensive african americans: the aadvance trial
Matthew R. Weir, Elijah Saunders and Steven Zelenkofske
Am J Hypertens 17: 124A-124A; doi:10.1016/j.amjhyper.2004.03.327
P-253: Spironolactone for the treatment of isolated systolic hypertension
Steven A. Yarows
Am J Hypertens 17: 125A-125A; doi:10.1016/j.amjhyper.2004.03.328
P-254: Sympathovagal balance in essential hypertensives treated with angiotensin receptor blockers for a long period of time
Ilias Zarkos, Irini Vrana, Eleftherios Thireos, Gerasimos Livieratos, Aikaterini Mitropoulou, Nearchos Nearchou and Vasilis Tolis
Am J Hypertens 17: 125A-125A; doi:10.1016/j.amjhyper.2004.03.329
P-255: Angiotensin receptors blockade improves blood pressure response, exercise capacity and heart rate recovery in normotensives with excessive blood pressure elevation during exercise
Ilias Zarkos, Irini Vrana, Eleftherios Thireos, Gerasimos Livieratos, Aikaterini Mitropoulou, Nearchos Nearchou, Vasiliki Golfinopoulou and Vasilis Tolis
Am J Hypertens 17: 125A-125A; doi:10.1016/j.amjhyper.2004.03.330
P-256: Impact of acute maximal exercise on left ventricular diastolic function and arterial compliance in older hypertensives
Kunihiko Aizawa, Pooja Sahasrabudhe and Robert Petrella
Am J Hypertens 17: 126A-126A; doi:10.1016/j.amjhyper.2004.03.331
P-257: Left ventricular diastolic function and arterial compliance in older hypertensives: 8 week aerobic exercise training study
Kunihiko Aizawa, Pooja Sahasrabudhe and Robert Petrella
Am J Hypertens 17: 126A-126A; doi:10.1016/j.amjhyper.2004.03.332
P-258: Effect of naproxen and celecoxib on left ventricular diastolic function and arterial compliance in older hypertensives with osteoarthritis
Pooja Sahasrabudhe, Kunihiko Aizawa and Robert Petrella
Am J Hypertens 17: 126A-126A; doi:10.1016/j.amjhyper.2004.03.333
P-259: Is there an association between blood pressure variability and target organ damage in diabetic and non-diabetic hypertensive patients?
Paula Amado, José P. Carmona, Nuno Vasconcelos, José Alves and José Nazaré
Am J Hypertens 17: 127A-127A; doi:10.1016/j.amjhyper.2004.03.334
P-260: Impact of abnormal nocturnal blood pressure fall on aortic root performance in diabetic hypertensives
Gregory P. Vyssoulis, Konstantinos A. Aznaouridis, Eva A. Karpanou, Christina A. Chrysohoou, Andreas G. Marinakis, Dennis V. Cokkinos and Christodoulos I. Stefanadis
Am J Hypertens 17: 127A-127A; doi:10.1016/j.amjhyper.2004.03.335
P-261: A clinical trial of an age cross-link breaker, alt-711, in systolic hypertension
G.L. Bakris, A. Bank, D.A. Kass, J. Neutel and R. Preston
Am J Hypertens 17: 127A-128A; doi:10.1016/j.amjhyper.2004.03.336
P-262: Continuous improvement of arterial compliance beyond blood pressure decrease after three years of antihypertensive treatment
Claudio A. Bellido, Oscar R. Iavícoli, Daniel J. Piñeiro, Eduardo J. Rusak, Alejandro P. Sanz, Sonia T. Vazquez, Enrique L. Pittaluga and Jorge Lerman
Am J Hypertens 17: 128A-128A; doi:10.1016/j.amjhyper.2004.03.337
P-263: Effect of inhibition of HMG-co-reductase on carotid intima-media thickness (C-IMT) and sistemic inflammation parameters in type 2 diabetic patients
Mario Campanella, Stefano Stuard, Roberto Summa, Maria Rita Nanni and Virgilio Di Luzio
Am J Hypertens 17: 128A-128A; doi:10.1016/j.amjhyper.2004.03.338
P-264: The association between fasting plasma glucose and subclinical vascular damage in essential hypertension do not improve with the presence of metabolic syndrome criteria
Carlos Campo, Julian Segura, Cecilia Roldan, Luis Vigil, Luisa Fernandez, Lucia Guerrero, Elena Ratto and Luis M. Ruilope
Am J Hypertens 17: 128A-129A; doi:10.1016/j.amjhyper.2004.03.339
P-265: Relationship between morning rise blood pressure and arterial distensibility in type II diabetic and non diabetic hypertensive patients
José P. Carmona, Paula Amado, Nuno Vasconcelos, Manuel C. Rodrigues and José Nazaré
Am J Hypertens 17: 129A-129A; doi:10.1016/j.amjhyper.2004.03.340
P-266: The effect of hormone replacement therapy on vascular compliance in postmenopausal women
Lilian Soares da Costa, Monica Amorim de Oliveira, Alexandre Rouge Felipe, Cantidio Drumond Neto, Mauricio Wajngarten, Otavio Celso and Eluf Gebara
Am J Hypertens 17: 129A-129A; doi:10.1016/j.amjhyper.2004.03.341
P-267: Reproducibility of small vessel compliance measures at two time points in stable chronic hemodialysis patients
Anuj Dalal, Tina Braun, Raymond R. Townsend and Debbie L. Cohen
Am J Hypertens 17: 129A-130A; doi:10.1016/j.amjhyper.2004.03.342
P-268: Comparison of arterial compliance in lung transplant & renal transplant patients using pulse wave analysis
Anuj Dalal, Greg Warren, Roy D. Bloom, Raymond R. Townsend and Debbie L. Cohen
Am J Hypertens 17: 130A-130A; doi:10.1016/j.amjhyper.2004.03.343
P-269: Are arterial stiffness and micro-albuminuria in pre-hypertensives different from normotensives and hypertensives?
Daniel A. Duprez, Porur E. Somasundaram, Nathalia Florea, Lynn Hoke and Jay N. Cohn
Am J Hypertens 17: 130A-130A; doi:10.1016/j.amjhyper.2004.03.344
P-270: Arterial compliance and isolated clinical hypertension
Laura Sperduti, Piera Marchetti, Filippo Lintas, Maddalena Ragazzo, Roberto Terlizzi, Domenico Fidente and Giuseppe Germanò
Am J Hypertens 17: 130A-131A; doi:10.1016/j.amjhyper.2004.03.345
P-271: Hypertension and aortic calcification in a retired worker cohort
Amanda R. Harmon, Dan T. Lackland, Brent Egan, David Hoel, James Thomas, Joyce Nicholas and Stuart Lipsitz
Am J Hypertens 17: 131A-131A; doi:10.1016/j.amjhyper.2004.03.346
P-272: A novel arterial stiffness index (ASI) as a marker of arteriosclerosis
Kunihide Hiramatsu, Ako Oiwa, Satoshi Shigematsu, Minoru Nagai, Masafumi Katakura, Toru Aizawa and Kiyoshi Hashizume
Am J Hypertens 17: 131A-131A; doi:10.1016/j.amjhyper.2004.03.347
P-273: Hemodynamic determinants of carotid artery structure in essential hypertension
Ben Ariff, Andrew Zambanini, Vamadeva Sarita, Dean Barratt, Yun Xu, Peter Sever, Nish Chaturvedi, Alice Stanton, Simon Thom and Alun Hughes
Am J Hypertens 17: 131A-132A; doi:10.1016/j.amjhyper.2004.03.348
P-274: Vascular damage in hypertensive subjects
Roberto A. Ingaramo
Am J Hypertens 17: 132A-132A; doi:10.1016/j.amjhyper.2004.03.349
P-275: The detrimental effect of steroid treatment on vascular elasticity of patients that suffer from systemic lupus erythematosus is attenuated by hydroxychloroquine co-administration
Eyal Leibovitz, Angela Frayman, Reuven Zimlichman, Amir Tanai, Itzhak Elly, Marina Shargorodsky and Dov Gavish
Am J Hypertens 17: 132A-132A; doi:10.1016/j.amjhyper.2004.03.350
P-276: Determinants of central pulse pressure in hypertensive and normotensive patients
Lisong Liu, Qi Hua, Jian Zhang, Beilei Pang, Yungao Wan and Wenwu Ren
Am J Hypertens 17: 132A-133A; doi:10.1016/j.amjhyper.2004.03.351
P-277: Comparison of nicotine effects on hemodynamics and arterial stiffness between smokers and non-smokers
Yasser Mir, Bong Hee Sung and Michael F. Wilson
Am J Hypertens 17: 133A-133A; doi:10.1016/j.amjhyper.2004.03.352
P-278: Relationship between aortic stiffness and albumin excretion rate in untreated essential hypertensive patients
Giuseppe Mule', Santina Cottone, Anna Vadala', Vito Volpe, Gianfranco Mezzatesta, Rosalia Mongiovi', Giuseppe Piazza, Emilio Nardi and Giovanni Cerasola
Am J Hypertens 17: 133A-133A; doi:10.1016/j.amjhyper.2004.03.353
P-279: Anomalies of wave reflection phenomena in clinical studies
Michael F. O'Rourke, Audrey Adji, Alberto P. Avolio, John R. Cockcroft and Ian B. Wilkinson
Am J Hypertens 17: 133A-134A; doi:10.1016/j.amjhyper.2004.03.354
P-280: Can a generalized transfer function describe the relationship between pressure waveforms in central and upper limb arteries?
Michael F. O'Rourke, David Gallagher and Audrey Adji
Am J Hypertens 17: 134A-134A; doi:10.1016/j.amjhyper.2004.03.355
P-281: The impact of sns activity to the function of ascending aorta of hypertensive patients
Maria V. Papavasiliou, Kostas G. Thomopoulos, Cosmas G. Daskalakis, Panagiotis Ch. Kelepouris, Athanasios V. Anadiotis and Maria I. Kokladi
Am J Hypertens 17: 134A-134A; doi:10.1016/j.amjhyper.2004.03.356
P-282: Blood pressure variability, collagen metabolism and large artery stiffness in diabetic and non-diabetic hypertensives
Marek Rajzer, Marek Jastrzebski, Marek Klocek and Kalina Kawecka-Jaszcz
Am J Hypertens 17: 135A-135A; doi:10.1016/j.amjhyper.2004.03.357
P-283: Arterial compliance decreases during the isometric exercise grip test in normal subjects: Disassociation between pulse wave velocity and heart rate
Ciaran F. Reid and Michael A. Conway
Am J Hypertens 17: 135A-135A; doi:10.1016/j.amjhyper.2004.03.358
P-284: Effect of isometric exercise on large and small arterial compliance in healthy, normotensive men and women
Wirasat Hasnain, Bong Hee Sung, Atika Faiz and Michael F. Wilson
Am J Hypertens 17: 135A-136A; doi:10.1016/j.amjhyper.2004.03.359
P-285: Aerobic exercise-induced change in blood pressure is associated with change in reflction component of blood pressure: Evaluation using radial augmentation index
Yasuharu Tabara, Katsuhiko Kohara, Akira Oshiumi, Yoshinori Miyawaki, Tatsuya Kobayashi and Tetsuro Miki
Am J Hypertens 17: 136A-136A; doi:10.1016/j.amjhyper.2004.03.360
P-286: Brachial artery compliance and ambulatory pulse pressure in hypertension accompanied by left ventricular hypertrophy. a life study
Christian Tuxen, Niels Wiinberg, Per R. Hildebrandt and Jesper Mehlsen
Am J Hypertens 17: 136A-136A; doi:10.1016/j.amjhyper.2004.03.361
P-287: Brachial artery compliance and neurohormones in hypertension accompanied by left ventricular hypertrophy. A life study
Christian Tuxen, Niels Wiinberg, Per R. Hildebrandt and Jesper Mehlsen
Am J Hypertens 17: 136A-137A; doi:10.1016/j.amjhyper.2004.03.362
P-288: Mental stress has an unfavorable effect on aortic stiffness and wave reflection
Charalambos Vlachopoulos, Foteini Kosmopoulou, Nikolaos Alexopoulos, Konstantinos Aznaouridis, Nikolaos Ioakeimidis, Ioanna Dima and Christodoulos Stefanadis
Am J Hypertens 17: 137A-137A; doi:10.1016/j.amjhyper.2004.03.363
P-289: Dark chocolate improves arterial stiffness and endothelial function
Konstantinos Aznaouridis, Charalambos Vlachopoulos, Nikolaos Alexopoulos, Nikolaos Ioakeimidis, Dorothea Tsekoura, Christos Pitsavos and Christodoulos Stefanadis
Am J Hypertens 17: 137A-137A; doi:10.1016/j.amjhyper.2004.03.364
P-290: Effects of fluvastatin on non-endothelium dependent vasodilatation function in hyperensives
Liangdi Xie, Yuerong Yang, Ming Sun and Xin Wu
Am J Hypertens 17: 137A-138A; doi:10.1016/j.amjhyper.2004.03.365
P-291: Nondipping and mental stress-induced hormonal and hemodynamic changes as the risk of development of hypertension and cardiovascular disease
Rubin Zhang, Erwin A. Aguilar, Grant Butterbaugh, Shaminder Gupta, Jie Liao, Roberto Ingaramo, Chawnda Blake, Betsy Roques, Marcy Rose, Richard Costa and Efrain Reisin
Am J Hypertens 17: 138A-138A; doi:10.1016/j.amjhyper.2004.03.366
P-292: Prolonged treatment of hypertensive patients with low dose HCTZ improves arterial elasticity but not if they have niddm or ifg. treatment with full dose HCTZ (25 mg/d) aggravates metabolic parameters and arterial stiffness
Reuven Zimlichman, Marina Shargorodsky and Julio Wainstein
Am J Hypertens 17: 138A-138A; doi:10.1016/j.amjhyper.2004.03.367
P-293: Arterial stiffness in health and in disease
Reuven Zimlichman
Am J Hypertens 17: 139A-139A; doi:10.1016/j.amjhyper.2004.03.368
P-294: Evidence that meprin plays a mechanistic role in salt-adaptation and is a novel therapeutic target for hypertension
Elaine Gorelik, Bryan P. Roxas, Kumar Kotlo and Robert S. Danziger
Am J Hypertens 17: 140A-140A; doi:10.1016/j.amjhyper.2004.03.369
P-295: Circadian variation of blood pressure and electrolytes
Medet Jumabay, Yukio Ozawa, Satoshi Saito, Yoichi Izumi, Yuji Kasamaki, Tomohiro Nakayama, Hiroshi Kawamura, Hiromi Mitsubayashi, Zuheng Cheng and Yitong Ma
Am J Hypertens 17: 140A-140A; doi:10.1016/j.amjhyper.2004.03.370
P-296: Urine 20-HETE in rat hypertension
Cheryl L. Laffer, Huawei Zhao, Michal L. Schwartzman, Alberto Nasjletti and Fernando Elijovich
Am J Hypertens 17: 140A-141A; doi:10.1016/j.amjhyper.2004.03.371
P-297: Dexamethasone treatment alters the 24-hour blood pressure profile, angiotensin ii levels and the expression of rat- and mouse-renin in adult tgr(mren2)27-rats
Bjoern Lemmer, Ulrike Wagner and Stefan Gorbey
Am J Hypertens 17: 141A-141A; doi:10.1016/j.amjhyper.2004.03.372
P-298: Chronic cyclosporine-induced hypertension is coupled to calcineurin-mediated inhibition of t cell activation in mice
Jia-Ling Li, Robert A. Augustyniak, Ronald G. Victor and Weiguo Zhang
Am J Hypertens 17: 141A-141A; doi:10.1016/j.amjhyper.2004.03.373
P-299: Angiotensin II (ang II)-induced stimulation of nadph causes a biphasic effect on ERK1/2 in-vivo and in-vitro
Laura I. Pelaez, Carolina Davenport, Mariana Cordon, Melissa Manriquez, Rodney Bolterman and Luis A. Juncos
Am J Hypertens 17: 141A-142A; doi:10.1016/j.amjhyper.2004.03.374
P-300: Lidocaine: an anesthetic agent used in cardiovascular research and hypertension research
Amparo Sosa, Mariselis Salazar-Rodriguez and Manuel Velasco
Am J Hypertens 17: 142A-142A; doi:10.1016/j.amjhyper.2004.03.375
P-301: Increased oxidative stress in a rat model of preeclampsia
Mona H. Sedeek, Yuping Wang and Joey P. Granger UMMC; LSU
Am J Hypertens 17: 142A-142A; doi:10.1016/j.amjhyper.2004.03.376
P-302: Dopaminergic modulation on the cardiovascular responses in hypertensive subjects
Freddy O. Contreras, Gloria A. Cabezas, Jorge Rocafull, María Carrucci, José Ceballos, Christian F. Fouillioux, Alejandra E. Bolívar, Glorifé Ibañez, Miriam González and Manuel Velasco
Am J Hypertens 17: 142A-142A; doi:10.1016/j.amjhyper.2004.03.377
P-303: Dopaminergic mediated cardiovascular responses during cold pressor test in diabetic subjects
Freddy O. Contreras, Gloria A. Cabezas, Jorge Rocafull, María Carrucci, José Ceballos, Christian F. Fouillioux, Alejandra E. Bolívar, Glorifé Ibañez, Miriam González and Manuel Velasco
Am J Hypertens 17: 142A-143A; doi:10.1016/j.amjhyper.2004.03.378
P-304: Early cardiac hypertrophy in male pulmonary hypertensive rats
Palaniswamy Vijay, Janet Wheeler, Thomas G. Sharp and John W. Brown
Am J Hypertens 17: 143A-143A; doi:10.1016/j.amjhyper.2004.03.379
P-305: Selection of explicit criteria for a JNC-7 guideline adherence tool
Jessica L. Milchak, Barry L. Carter, George L. Bakris, Henry R. Black, Daniel W. Jones and Alan J. Zillich
Am J Hypertens 17: 144A-144A; doi:10.1016/j.amjhyper.2004.03.380
P-306: Systolic hypertension remains difficult to control despite refferal to hypertension specialists
Marek Galazka, Michael C. Ruddy and Grace B. Bialy
Am J Hypertens 17: 144A-144A; doi:10.1016/j.amjhyper.2004.03.381
P-307: What prescription choices are primary care physicians making regarding treatment and control of hypertension?
Robert J. Petrella, Elizabeth Merikle and Farzad Ali
Am J Hypertens 17: 144A-145A; doi:10.1016/j.amjhyper.2004.03.382
P-308: Effect of percutaneous transluminal renal artery angioplasty with stenting on systemic hypertension in patients with atherosclerotic renal artery stenosis
Stamatis Dimitropoulos, Roy P. Venzon, David S. Bromet, Johan D. Aasbo, Martha Gulati, Dennis G. Caralis, Clifford J. Kavinsky, Gary L. Schaer and Jeffrey R. Snell
Am J Hypertens 17: 146A-146A; doi:10.1016/j.amjhyper.2004.03.383
P-309: Persistence of reduced left ventricular hypertrophy after a supervised exercise and weight loss program
Alan L. Hinderliter, Andrew Sherwood, Michael Babyak, Elizabeth C. Gullette, Anastasia Georgiades, Lana Watkins, Robert Waugh and James A. Blumenthal
Am J Hypertens 17: 146A-146A; doi:10.1016/j.amjhyper.2004.03.384
P-310: Uncontrolled hypertension and chronic kidney disease in the keep study
Michael J. Klag, Wendy W. Brown and Allan J. Collins
Am J Hypertens 17: 146A-147A; doi:10.1016/j.amjhyper.2004.03.385
P-311: The effect of home-based versus hospital-based cardiac rehabilitation on 24-hour ambulatory blood pressure and lipid profile in patients with coronary heart disease: The birmingham rehabilitation uptake maximisation study (BRUM)
Kaeng W. Lee, Kate Jolly and Gregory Y.H. Lip
Am J Hypertens 17: 147A-147A; doi:10.1016/j.amjhyper.2004.03.386
P-312: Anthropometric, hemodynamic and metabolic implications of the degree of physical exercise in patients with high cardiovascular risk
Rosa Fabregate, Olivia Sanchez, Enrique Bernal, Ana Bajo, Elena Sanchez-Largo, David Coca, Judith Marquez and Jose Saban-Ruiz
Am J Hypertens 17: 147A-147A; doi:10.1016/j.amjhyper.2004.03.387
P-313: Obesity in adults. effect of life style modification on weight, hemodynamic and autonomic nervous system
Rosa Maria Santos, Joao Pedro Freitas, Agostinho Coelho Monteiro, Maria Irene Rebelo and Mario Espiga Macedo
Am J Hypertens 17: 147A-148A; doi:10.1016/j.amjhyper.2004.03.388
P-314: The effect of carotid atherosclerosis screening on risk stratification during primary cardiovascular disease prevention
Robert L. Bard and Robert D. Brook
Am J Hypertens 17: 149A-149A; doi:10.1016/j.amjhyper.2004.03.389
P-315: C-reactive protein is related to an increased blood pressure response during exercise in a primary prevention population
Daniel A. Duprez, Kevin Straith, Lynn Hoke, Natalia Florea and Jay N. Cohn
Am J Hypertens 17: 149A-149A; doi:10.1016/j.amjhyper.2004.03.390
P-316: P-wave dispersion evaluated on ecg or 24h-ECG is a predictor of paroxysmal atrial fibrillation in essential hypertension
Amalia Hatziyianni, Kostas Tsioufis, John Kallikazaros and Christodoulos Stefanadis
Am J Hypertens 17: 149A-150A; doi:10.1016/j.amjhyper.2004.03.391
P-317: Association between P-wave dispersion and left atrial dimension in hypertensive patients at risk for paroxysmal atrial fibrillation
Amalia Hatziyianni, Kostas Tsioufis, Christodoulos Stefanadis and John Kallikazaros
Am J Hypertens 17: 150A-150A; doi:10.1016/j.amjhyper.2004.03.392
P-318: Reduction of blood pressure with calcium and potassium supplementation in children with sodium sensitivity—a two years randomized double blind placebo controlled trial
Jianjun Mu, Zhiquan Liu, Weimin Liu, Jun Yang and Xianglin Xu
Am J Hypertens 17: 150A-150A; doi:10.1016/j.amjhyper.2004.03.393
P-319: Reducing cardiovascular health disparities in the mississippi delta: The mercy delta express project
Sharon B. Wyatt, Peggy Hewlett, Dennis Frate, Kaye Wilson, Fazlay Faruque, Susan Lofton and Jennie Gunn
Am J Hypertens 17: 150A-151A; doi:10.1016/j.amjhyper.2004.03.394
P-320: The prehypertension progression to hypertension
Radmila R. Zivkovic, Mirjana B. Ugljesic, Vesna M. Mijajlovic and Maja V. Djokanovic
Am J Hypertens 17: 151A-151A; doi:10.1016/j.amjhyper.2004.03.395
P-321: Us spending on diuretics directly predicts esrd incidence changes in a time-lagged fashion
Ralph G. Hawkins and Mark C. Houston
Am J Hypertens 17: 152A-152A; doi:10.1016/j.amjhyper.2004.03.396
P-322: Public perception, awareness and understanding of hypertension risk in canada:results of a national survey of the canadian coalition for high blood pressure prevention and control
Robert J. Petrella
Am J Hypertens 17: 152A-152A; doi:10.1016/j.amjhyper.2004.03.397
P-323: Cholesterol levels, plasma renin activity and incidence of stable hypertension in young subjects with high-normal blood pressure
Claudio Borghi, Maddalena Veronesi, Ada Dormi, Maria Grazia Prandin and Ettore Ambrosioni
Am J Hypertens 17: 153A-153A; doi:10.1016/j.amjhyper.2004.03.398
P-324: Low prevalcne of white-coat hypertension in subjects with resistant hypertension and hyperaldosteronism
David A. Calhoun, Mari K. Nishizaka and Amin Zaman
Am J Hypertens 17: 153A-153A; doi:10.1016/j.amjhyper.2004.03.399
P-325: Aldosterone excretion correlated with body weight in men but not women with resistant hypertension
David A. Calhoun, Mari K. Nishizaka and Amin Zaman
Am J Hypertens 17: 153A-153A; doi:10.1016/j.amjhyper.2004.03.400
P-326: Regulator of G protein signaling–2 and control of vascular tone in bartter's/gitelman's sydrome
Lorenzo A. Calo, Elisa Pagnin, Paul A. Davis, Michelangelo Sartori, Achille C. Pessina and Andrea Semplicini
Am J Hypertens 17: 153A-154A; doi:10.1016/j.amjhyper.2004.03.401
P-327: Intracellular and extracellular angiotensin II stimulate the at1 receptor through both common and unique signaling pathways
Julia L. Cook, Sarah J. Mills, Michael H. Hart and Richard N. Re
Am J Hypertens 17: 154A-154A; doi:10.1016/j.amjhyper.2004.03.402
P-328: Two novel mutations found in a patient with 17 -hydroxylase enzyme deficiency
Berrin Ergun-Longmire, Maria I. New and Robert C. Wilson
Am J Hypertens 17: 154A-154A; doi:10.1016/j.amjhyper.2004.03.403
P-329: Inhibition of oxidative stress and improvement of nitric oxide production by ACE inhibitors and AT1 receptor blockers in uric acid stimulated vascular smooth muscle cells
Pirooz Eslami, Dalila B. Corry, Michael D. Nyby and Michael L. Tuck
Am J Hypertens 17: 155A-156A; doi:10.1016/j.amjhyper.2004.03.404
P-330: Malignant hypertension (MHT) : A systematic therapeutic approach through blockade of renin angiotensin system
Alexandre Herbland, Raphael Lasserre, Philippe Lemetayer, Jacques Clementy and Philippe Gosse
Am J Hypertens 17: 155A-155A; doi:10.1016/j.amjhyper.2004.03.405
P-331: Angiotensin II potentiates vegf-induced proliferation and network formation of endothelial progenitor cells
Toshio Imanishi, Takuzo Hano, Chizu Moriwaki and Ichiro Nishio
Am J Hypertens 17: 155A-155A; doi:10.1016/j.amjhyper.2004.03.406
P-332: Effect of angiotensin-receptor blockade on reduced cerebrovascular reserve and neuronal mass in diabetic hypertensives
Kazuomi Kario, Kazuo Eguchi, Joji Ishikawa, Masato Morinari, Shizukiyo Ishikawa, Satoshi Hoshide and Kazuyuki Shimada
Am J Hypertens 17: 155A-156A; doi:10.1016/j.amjhyper.2004.03.407
P-333: Arginine-aminopeptidase in rat cardiac fibroblasts participates in angiotensin turnover
Paul J. Lijnen, Victor V. Petrov and Robert H. Fagard
Am J Hypertens 17: 156A-156A; doi:10.1016/j.amjhyper.2004.03.408
P-334: Reversal of angiotensin ii-stimulated collagen gel contraction in cardiac fibroblasts by aminopeptidase-inhibition
Paul J. Lijnen, Victor V. Petrov and Robert H. Fagard
Am J Hypertens 17: 156A-156A; doi:10.1016/j.amjhyper.2004.03.409
P-335: Collagen production in cardiac fibroblasts during inhibition of angiotensin converting enzyme and aminopeptidases
Paul J. Lijnen, Victor V. Petrov and Robert H. Fagard
Am J Hypertens 17: 156A-157A; doi:10.1016/j.amjhyper.2004.03.410
P-336: Effect of lisinopril on angiotensin I- and transforming growth factor-beta1-stimulated collagen production in cardiac fibroblasts
Paul J. Lijnen, Victor V. Petrov and Robert H. Fagard
Am J Hypertens 17: 157A-157A; doi:10.1016/j.amjhyper.2004.03.411
P-337: Captopril test identifies severity of residual pressure gradient in recoartation
Antonio J. Marinho-da-Silva, Dina S. Rodrigues, Guilherme M. Pêgo, Antonio M. Sá-e-Melo and Luis A. Providência HUC
Am J Hypertens 17: 157A-157A; doi:10.1016/j.amjhyper.2004.03.412
P-338: Effects of adrenomedullin (AM) on renin-angiotensin-aldosterone (RAA) system and oxidative stress in rats with acute myocardial infarction (MI)
Ryosai Nakamura, Johji Kato, Kazuo Kitamura, Kenji Kangawa and Tanenao Eto
Am J Hypertens 17: 157A-158A; doi:10.1016/j.amjhyper.2004.03.413
P-339: Role of at2 receptor in the protective effect of telmisartan in cardiac tissue
Hector L. Nolly, Pablo A. Osso and Mariela B. Nolly
Am J Hypertens 17: 158A-158A; doi:10.1016/j.amjhyper.2004.03.414
P-340: Optimizing dose selection with computer modeling and simulation: application to the vasopeptidase inhibitor m100240
Marc Pfister, Nancy E. Martin and Lloyd P. Haskell
Am J Hypertens 17: 158A-158A; doi:10.1016/j.amjhyper.2004.03.415
P-341: Ionic aspects of acute angiotensin receptor blockade in normal subjects
Lawrence M. Resnick, Daniel Catanzarro, Jean E. Sealy and John H. Laragh
Am J Hypertens 17: 158A-158A; doi:10.1016/j.amjhyper.2004.03.416
P-342: Influence of plasma aldosterone levels on oxidative stress in patients with essential hypertension
Jose Saban-Ruiz, Enrique Bernal, Arturo Ugalde, Olivia Sanchez, Maria Calbacho, Ana Bajo, Rosa Fabregate and Juan J. Villafruela
Am J Hypertens 17: 158A-159A; doi:10.1016/j.amjhyper.2004.03.417
P-343: Aldosterone activates ERK1/2 and p38map kinase in vascular smooth muscle cells by nongenomic mechanisms in WKY and SHR – role of endothelin-1
R.M. Touyz, S. Malkinson, G. Yao, D. Endemann and E.L. Schiffrin
Am J Hypertens 17: 159A-159A; doi:10.1016/j.amjhyper.2004.03.418
P-344: Loss of normal dietary sodium blood pressure response to angiotensin ii infusion in human essential hypertension
Jonathan S. Williams, Gordon H. Williams, Naomi D. Fisher, Paul N. Hopkins, Xavier Jeunemaitre, Nancy J. Brown and Paul R. Conlin
Am J Hypertens 17: 159A-159A; doi:10.1016/j.amjhyper.2004.03.419
P-345: Study of 46 women 3 month and 20 years after pre eclampsia
Claudine Gueret, Jean-Claude Alphonse and Patrice Deteix
Am J Hypertens 17: 160A-160A; doi:10.1016/j.amjhyper.2004.03.420
P-346: Depression, stress, and bp control in urban african american women
Nancy T. Artinian, John M. Flack, Jillon S. VanderWal, K-L Catherine Jen and Olivia G. Washington
Am J Hypertens 17: 160A-160A; doi:10.1016/j.amjhyper.2004.03.421
P-347: Circadian pattern of ambulatory pulse pressure in normal pregnancy, gestational hypertension, and preeclampsia
Diana E. Ayala, Ramon C. Hermida, Artemio Mojon, Jose R. Fernandez, Ignacio Alonso, Maria F. Aguilar, Jose Codesido and Manuel Iglesias
Am J Hypertens 17: 161A-162A; doi:10.1016/j.amjhyper.2004.03.422
P-348: Differences in day/night blood pressure ratio between normal pregnancy, gestational hypertension, and preeclampsia
Diana E. Ayala, Ramon C. Hermida, Artemio Mojon, Jose R. Fernandez, Ignacio Alonso, Maria F. Aguilar, Jose Codesido and Manuel Iglesias
Am J Hypertens 17: 161A-161A; doi:10.1016/j.amjhyper.2004.03.423
P-349: Hair care and health care: cvd awareness, concerns, and issues among women
Deborah S. King, Sara L. Noble, Jimmy L. Stewart, Stephanie J. Barud, Stacye Sims, Mollie Cannon, Sandra E. Greene, Christi C. Capers, William H. Replogle and Shannon Pittman
Am J Hypertens 17: 161A-161A; doi:10.1016/j.amjhyper.2004.03.424
P-350: Plasma markers of angiogenesis in pregnancy induced hypertension
Sunil Nadar and Gregory Lip
Am J Hypertens 17: 161A-162A; doi:10.1016/j.amjhyper.2004.03.425
P-351: Effects of drospirenone/estradiol on blood pressure and serum potassium in hypertensive postmenopausal women at risk for hyperkalemia
Richard A. Preston, William B. White, Bertram Pitt, George L. Bakris, Paul M. Norris and Vladimir Hanes
Am J Hypertens 17: 162A-162A; doi:10.1016/j.amjhyper.2004.03.426
P-352: Circulating MMP-9, TIMP-1 and TIMP-2 in gestational hypertension
Muzahir H. Tayebjee, Ioannis Karalis, Sunil K. Nadar, D.Gareth Beevers, Robert J. MacFadyen and Gregory Y. Lip
Am J Hypertens 17: 162A-163A; doi:10.1016/j.amjhyper.2004.03.427
P-353: A novel hormonal therapy with antihypertensive activity for postmenopausal women: drospirenone with estradiol (angeliq)
William B. White, Bertram Pitt, Richard A. Preston and Vladimir Hanes
Am J Hypertens 17: 163A-163A; doi:10.1016/j.amjhyper.2004.03.428
P-354: Association of mitral annular calcification and aortic valve sclerosis with left ventricular geometry and function in hypertensive adults: the hypertension genetic epidemiology network (HyperGEN) study
Felizen S. Agno, Marcello Chinali, Jonathan N. Bella, Jennifer E. Liu, Donna K. Arnett, Dalane W. Kitzman, Albert Oberman, Paul N. Hopkins, D.C. Rao and Richard B. Devereux
Am J Hypertens 17: 164A-164A; doi:10.1016/j.amjhyper.2004.03.429
P-355: Left ventricular regional systolic and diastolic function of inappropriate left ventricular hypertrophy in patients with systemic hypertension
Bahattin Balci and Osman Yesildag
Am J Hypertens 17: 164A-164A; doi:10.1016/j.amjhyper.2004.03.430
P-356: The impact of mild and moderate aortic stenosis on left ventricular remodeling
Adam E. Berman, Khaldoon Alaswad, Yvonne Gilliland, Carl Lavie and Richard V. Milani
Am J Hypertens 17: 164A-165A; doi:10.1016/j.amjhyper.2004.03.431
P-357: Synergistic efficacy of irbesartan and benazepril on exercise performance and oxygen consumption at peak exercise in hypertensives with congestive heart failure
Maria Leonarda De Rosa, Orazio Viola, Michele Polimeno and Massimo Chiariello
Am J Hypertens 17: 165A-165A; doi:10.1016/j.amjhyper.2004.03.432
P-358: Valvular abnormalities in hypertensive outpatients: a general practitioner study
Virgilio Di Legge, Vittorio Taccini, Riccardo Busoni, Carlo Verardi and Cataldo Graci
Am J Hypertens 17: 165A-165A; doi:10.1016/j.amjhyper.2004.03.433
P-360: Hypercholesteremia induces cardiac concentric remodeling in the guinea pig
Michelle H. Barton, Stephen J. Lewis, John S. Munday and Jonathan E. Graves
Am J Hypertens 17: 165A-166A; doi:10.1016/j.amjhyper.2004.03.434
P-361: Irebesartan and atenolol improve diastolic function in patients with hypertensive left ventricular hypertrophy
Richard Müller-Brunotte, Magnus Edner, Karin Malmqvist and Thomas Kahan
Am J Hypertens 17: 166A-166A; doi:10.1016/j.amjhyper.2004.03.435
P-362: The arterial stiffness and cardiac remodeling in hypertensive patients
Natalya Khozyainova, Victor Milyagin and Irina Milyagina
Am J Hypertens 17: 166A-166A; doi:10.1016/j.amjhyper.2004.03.436
P-363: The association between isolated systolic hypertension and aortic regurgitation is not independent of age: The strong heart study
Marilyn B.Lawrence Wright, Richard B. Devereux, Mary J. Roman, Jennifer E. Liu, Lyle G. Best, James M. Galloway, Richard R. Fabsitz, Elisa T. Lee and Barbara V. Howard
Am J Hypertens 17: 166A-167A; doi:10.1016/j.amjhyper.2004.03.437
P-364: Left ventricular mass and diastolic function in patients with coronary artery disease with and without hypertension: Relationship to endothelial damage/dysfunction
Kaeng W. Lee and Gregory Y.H. Lip
Am J Hypertens 17: 167A-167A; doi:10.1016/j.amjhyper.2004.03.438
P-365: Raised arterial blood pressure exacerbates diastolic dysfunction in diabetes mellitus independent of atherosclerosis
Sern H. Lim, Sunil Nadar, Andrew D. Blann and Gregory Y.H. Lip
Am J Hypertens 17: 167A-167A; doi:10.1016/j.amjhyper.2004.03.439
P-366: Impaired atrial function after conversion of atrial fibrillation in hypertensive patients
Anna Vittoria Mattioli, Daniel Monopoli, Mauro Zennaro, Emma Tarabini Castellani and Giorgio Mattioli
Am J Hypertens 17: 167A-168A; doi:10.1016/j.amjhyper.2004.03.440
P-367: Hypercholesteremia-induced changes in left ventricular geometry in the guinea pig
John S. Munday, Michelle H. Barton, Stephen J. Lewis and Jonathan E. Graves
Am J Hypertens 17: 168A-168A; doi:10.1016/j.amjhyper.2004.03.441
P-368: Diastolic dysfunction and central obesity related hypertension: Role of trasforming growth factor beta-1
Gaspare Parrinello, Daniela Colomba, Christiano Argano, Tiziana Di Chiara, Rosario Scaglione and Giuseppe Licata
Am J Hypertens 17: 168A-168A; doi:10.1016/j.amjhyper.2004.03.442
P-369: Increased oxidative stress in hypertensive patients with borderline left ventricular mass evaluated by electrocardiography
Ana Bajo-Martinez, Arturo Ugalde, Enrique Bernal, Maria Calbacho, David Albillo, Jaime Herreros, Rosa Fabregate, Olivia Sanchez and J. Saban-Ruiz
Am J Hypertens 17: 168A-169A; doi:10.1016/j.amjhyper.2004.03.443
P-370: Left ventricular mass and mechanics in mild to moderate hypertension: effect of b-blocker versus angiotensin II receptor blocker
Aikaterini Fountoulaki, Christos Nicopoulos, John Giannakoulis, Vasilis Demopoulos, John Skoularigis and Filippos Triposkiadis
Am J Hypertens 17: 169A-169A; doi:10.1016/j.amjhyper.2004.03.444
P-371: Breaker of glycated collagen cross-links, alt-711, improves left ventricular function and aortic distensibility in elderly spontaneously hypertensive rats
Dinko Susic, Jasmina Varagic, Jwari Ahn, Louis C. Matavelli and Edward D. Frohlich
Am J Hypertens 17: 169A-169A; doi:10.1016/j.amjhyper.2004.03.445
P-372: Impact of renal replacement therapy on pulse pressure and left ventricular hypertrophy
Barbara M. Suwelack, Viola Kobelt, Ulf Gerhardt and Hege Hohage
Am J Hypertens 17: 170A-170A; doi:10.1016/j.amjhyper.2004.03.446
P-373: Changes in hemodynamic patterns with age in normotensive subjects
Sandra J. Taler, Nancy Driscoll, Mary Tibor, Genie Sprau, Jo Ellen Augustine, Timothy S. Larson, Mark D. Stegall and Stephen C. Textor
Am J Hypertens 17: 170A-170A; doi:10.1016/j.amjhyper.2004.03.447
P-374: Circulating tissue inhibitor of metalloproteinase-1 elevation correlates with impaired diastolic relaxation in patients with hypertension
Muzahir H. Tayebjee, Sunil K. Nadar, Robert J. MacFadyen and Gregory Y. Lip
Am J Hypertens 17: 170A-170A; doi:10.1016/j.amjhyper.2004.03.448
P-375: Exaggerated blood pressure response to exercise is not associated with changes in qtc intervals
Ilias Zarkos, Eleftherios Thireos, Irini Vrana, Gerasimos Livieratos, Aikaterini Mitropoulou, Irini Plakida, Christos Tolis, Nearchos Nearchou and Vasilis Tolis
Am J Hypertens 17: 171A-171A; doi:10.1016/j.amjhyper.2004.03.449
P-376: Exercise capacity and heart rate recovery in subjects with exaggerated blood pressure response during exercise
Ilias Zarkos, Eleftherios Thireos, Irini Vrana, Nearchos Nearchou, Gerasimos Livieratos, Aikaterini Mitropoulou, Eva Fakarou, Christos Tolis and Vasilis Tolis
Am J Hypertens 17: 171A-171A; doi:10.1016/j.amjhyper.2004.03.450
P-377: Effects of irbesartan on retinal damage in streptozotocin induced diabetic rats
Oscar Gómez, Esther Ruiz, Paula Vieitez, Natalia Camarasa, Olga González-Albarrán, Carlos Roa, José María Sancho and Rafael García-Robles
Am J Hypertens 17: 172A-172A; doi:10.1016/j.amjhyper.2004.03.451
P-378: Fibroblast growth factor upregulates periostin and osteopontin expression via distinct signaling pathways in rat pulmonary arterial smooth muscle cells
Peng Li, Suzanne Oparil and Yiu-Fai Chen
Am J Hypertens 17: 172A-172A; doi:10.1016/j.amjhyper.2004.03.452
P-379: Induction of various aminopeptidases in cardiac fibroblasts by transforming growth factor-beta1
Paul J. Lijnen, Victor V. Petrov and Robert H. Fagard
Am J Hypertens 17: 172A-172A; doi:10.1016/j.amjhyper.2004.03.453
P-380: Transforming growth factor-beta1-mediated collagen gel contraction by cardiac fibroblasts
Paul J. Lijnen, Victor V. Petrov and Robert H. Fagard
Am J Hypertens 17: 173A-173A; doi:10.1016/j.amjhyper.2004.03.454
P-381: Iron-catalyzed lipid peroxidation: relevance to hypertension?
Gene A. Morrill, Adele Kostellow, Lawrence M. Resnick and Raj K. Gupta
Am J Hypertens 17: 173A-173A; doi:10.1016/j.amjhyper.2004.03.455
P-382: Acute effect of at2 overstimulation on growth factors expression in uninephrectomized zucker rats
Paula Vieitez, Esther Ruiz, Oscar Gómez, Olga González-Albarrán, Pedro Pines, José María Sancho and Rafael García-Robles
Am J Hypertens 17: 173A-173A; doi:10.1016/j.amjhyper.2004.03.456
P-383: Effect of ferulate on migration induced by endothelin and platelet derived growth factor in cultured vascular smooth muscle cells from shr
Liangdi Xie, Ying Han, Huajun Wang and Changsheng Xu
Am J Hypertens 17: 173A-174A; doi:10.1016/j.amjhyper.2004.03.457
P-384: Effect of ferulate on attachment and migration induced by fibronectin and fibrinogen in cultured vascular smooth muscle cells from shr
Liangdi Xie, Ying Han and Huajun Wang
Am J Hypertens 17: 174A-174A; doi:10.1016/j.amjhyper.2004.03.458
P-385: Low red blood cell potassium is related to higher blood pressure, diabetes mellitus and to the gly allele of the alpha-adducin gene
Maria C. Delgado and Alan B. Weder
Am J Hypertens 17: 175A-175A; doi:10.1016/j.amjhyper.2004.03.459
P-386: Oxidative stress, intracellular ions and hypertension
Raj K. Gupta, Kirsten Brukamp and L.M. Resnick
Am J Hypertens 17: 175A-175A; doi:10.1016/j.amjhyper.2004.03.460
P-387: Ca2+ dependent k+ efflux in hypertension: an 39k-nmr spectroscopic study
Joseph C. Veniero, Raj K. Gupta and Lawrence M. Resnick
Am J Hypertens 17: 175A-175A; doi:10.1016/j.amjhyper.2004.03.461
P-388: Linkage between altered rbc free magnesium and plasma membrane and circulating lipids in hypertension: an 1H- and 31P-NMR spectroscopy study
Lawrence M. Resnick and Raj K. Gupta
Am J Hypertens 17: 175A-176A; doi:10.1016/j.amjhyper.2004.03.462
P-389: Presence of functionally active mg2+ uptake channels, TRPM6 and TRPM7, in vascular smooth muscle cells from WKY and SHR– differential regulation by aldosterone and angiotensin II
R.M. Touyz, Y. He and G. Yao
Am J Hypertens 17: 176A-176A; doi:10.1016/j.amjhyper.2004.03.463
P-390: Combination of losartan and hydrochlorothiazide in non-dippers hypertensive patients
Maria J. Armas-Hernandez, Rosalba Cammarata, Beatriz Sosa-Canache, Maria C. Armas-Padilla, Beatriz Pacheco, Jaime Guerrero and Rafael Hernandez-Hernandez
Am J Hypertens 17: 177A-177A; doi:10.1016/j.amjhyper.2004.03.464
P-391: Factors in the choice of beta-blocker vs. diuretic for initial treatment of hypertension in convince
Henry R. Black, William J. Elliott, Gregory Grandits, Patricia Grambsch, James D. Neaton, Peter Sleight, William B. White, Alberto Zanchetti and Robert J. Anders
Am J Hypertens 17: 177A-177A; doi:10.1016/j.amjhyper.2004.03.465
P-392: Circadian variation in cardiovascular events among diabetics in the convince trial
Henry R. Black, William J. Elliott, Gregory Grandits, Patricia Grambsch, James D. Neaton, William B. White and Robert J. Anders
Am J Hypertens 17: 177A-177A; doi:10.1016/j.amjhyper.2004.03.466
P-393: An efficacy and safety study of doxazosin gastrointestinal therapeutic system as combination therapy in hypertensive patients
Henry Black, Michael Keck, Peter Meredith, Kevin Bullen, Sheila Quinn and Andrew Koren
Am J Hypertens 17: 178A-178A; doi:10.1016/j.amjhyper.2004.03.467
P-394: Predictors of blood pressure control in the convince trial
Henry R. Black, William J. Elliott, Gregory Grandits, Patricia Grambsch, James D. Neaton, Peter Sleight, William B. White, Alberto Zanchetti and Robert J. Anders
Am J Hypertens 17: 178A-178A; doi:10.1016/j.amjhyper.2004.03.468
P-395: Outcomes with physician's choice of initial drug in convince
Henry R. Black, William J. Elliott, Gregory Grandits, Patricia Grambsch, James D. Neaton, Peter Sleight, William B. White, Alberto Zanchetti and Robert J. Anders
Am J Hypertens 17: 178A-179A; doi:10.1016/j.amjhyper.2004.03.469
P-396: Effects of perindopril (peri,,,) and hydrochlorthiazide (hydro,,,) on endotelial function in relation to baseline blood pressure and serum ace activity
Anatoly N. Britov, Olga N. Yakimenko, Tatiana V. Ektova, Maria M. Bystrova and Oleg A. Gomakzov
Am J Hypertens 17: 179A-179A; doi:10.1016/j.amjhyper.2004.03.470
P-397: Picxel: perindopril/indapamide has a greater benefit on left ventricular hypertrophy than enalapril
Björn Dahlöf, Philippe Gosse, Pascal Guéret, Olivier Dubourg, Youri Karpov, Giovanni de Simone and Roland Schmieder on Behalf of the PICXEL Co-ordinators and Investigators
Am J Hypertens 17: 179A-179A; doi:10.1016/j.amjhyper.2004.03.471
P-398: Efficacy of diltiazem er as add-on antihypertensive therapy in mild to moderate hypertension, and isolated systolic hypertension (the tiara study)
Indravadan M. Dattani, Alexander J. Lang and Jukka K. Karjalainen
Am J Hypertens 17: 179A-180A; doi:10.1016/j.amjhyper.2004.03.472
P-399: Blood pressure control in italian nephroly clinics. results of thin-study (treatment of hypertension in italian nephrology clinics)
Antonietta De Blasio, Michele Andreucci, Paolo Frattolillo, Giuseppe Palmiero and Domenico Russo
Am J Hypertens 17: 180A-180A; doi:10.1016/j.amjhyper.2004.03.473
P-400: Metabolic syndrome and insulin resistance in the trophy sub-study: contrasting views in high normal blood pressure
Brent M. Egan, Vasilios Papademitriou, Marion Wofford, David Calhoun, Jyotika Fernandes, Jessica E. Riehle, Shawna Nesbitt and Stevo Julius
Am J Hypertens 17: 180A-180A; doi:10.1016/j.amjhyper.2004.03.474
P-401: Safety and efficacy of combination ace inhibitor/calcium channel blocker therapy versus ace inhibitor monotherapy in african american patients with hypertension and type 2 diabetes
John M. Flack, George L. Bakris, Jennifer Mc Gregor, Das Purkayastha, Marjorie Gatlin and Oliseyenum M. Nwose
Am J Hypertens 17: 180A-181A; doi:10.1016/j.amjhyper.2004.03.475
P-402: Losartan prevents decline of cognitive function and decreases carotid intima-media thickness and pulse wave velocity along with reduction of blood pressure in elderly diabetic patients with hypertension
Shigeatsu Hashimoto, Minoru Yoneda, Ryo Muraoka, Sanae Midorikawa, Hironobu Sanada and Tsuyoshi Watanabe
Am J Hypertens 17: 181A-181A; doi:10.1016/j.amjhyper.2004.03.476
P-403: Effect of short-term supplementation of potassium chloride and potassium citrate on blood pressure in patients with untreated essential hypertension
Feng J. He, Nirmala D. Markandu, Rosemary Coltart and Graham A. Macgregor
Am J Hypertens 17: 181A-181A; doi:10.1016/j.amjhyper.2004.03.477
P-404: Plasma sodium - Ignored and underestimated
Feng J. He, Nirmala D. Markandu, Giuseppe A. Sagnella, Hugh E. de Wardener and Graham A. MacGregor
Am J Hypertens 17: 181A-182A; doi:10.1016/j.amjhyper.2004.03.478
P-405: In british asian hypertensive patients, doxazosin provides greater improvement in glycemic control and lipid profile than bendrofluazide
F.D. Richard Hobbs
Am J Hypertens 17: 182A-182A; doi:10.1016/j.amjhyper.2004.03.479
P-406: Association of left bundle branch block with cardiovascular morbidity and mortality in hypertensive patients with left ventricle hypertrophy: the life study
Zhibin Li, Richard B. Devereux, Sverre E. Kjeldsen, Stevo Julius, Kristian Wachtell, Hans Ibsen, Markku S. Nieminen, Sverker Jern, Peter M. Okin and Bjorn Dahlof
Am J Hypertens 17: 182A-182A; doi:10.1016/j.amjhyper.2004.03.480
P-407: Effect of quinapril and losartan on nitric oxide synthesis in patients with essential hypertension
Melvin D. Lobo, Ravic Nina, Andrew J. Webb, Pablo Forte, Annmarie Hedges, Eric Milne, Georgina Lewis and Nigel Benjamin
Am J Hypertens 17: 183A-183A; doi:10.1016/j.amjhyper.2004.03.481
P-408: Antihypertensive efficacy of indapamide SR vs candesartan and amlodipine in isolated systolic hypertensive patients
Gérard London, Roland Asmar, Carlos Calvo and Roland Schmieder
Am J Hypertens 17: 183A-183A; doi:10.1016/j.amjhyper.2004.03.482
P-409: Initial combination therapy in older patients with systolic hypertension: Results of the systolic evaluation of lotrel efficacy and comparative therapies (select) study
Joel M. Neutel, David H.G. Smith, Michael A. Weber, Oliseyenum M. Nwose, Lesley Schofield and Marjorie Gatlin
Am J Hypertens 17: 183A-184A; doi:10.1016/j.amjhyper.2004.03.483
P-410: Dual goal attainment with amlodipine/atorvastatin single pill in a broad range of patients: results from the gemini study
Joel Neutel, James La Salle, Lance Berman, Eric Gibson, David Gillen and Beth-Anne Piper
Am J Hypertens 17: 184A-184A; doi:10.1016/j.amjhyper.2004.03.484
P-411: Management of isolated vs. predominantly systolic hypertension: results of the systolic evaluation of lotrel efficacy and comparative therapies (select) study
Joel M. Neutel, David H.G. Smith, Michael A. Weber, Oliseyenum M. Nwose, Lesley Schofield and Marjorie Gatlin
Am J Hypertens 17: 184A-184A; doi:10.1016/j.amjhyper.2004.03.485
P-412: The use of combination therapy vs monotherapy in elderly systolic dipper vs systolic nondipper patients
Joel M. Neutel, David H.G. Smith, Michael A. Weber, Oliseyenum M. Nwose, Lesley Schofield and Marjorie Gatlin
Am J Hypertens 17: 184A-185A; doi:10.1016/j.amjhyper.2004.03.486
P-413: The efficacy and safety of fixed-dose combinations of amlodipine and atorvastatin in the treatment of patients with concomitant hypertension and dyslipidemia
Richard A. Preston, Peter Harvey, Ottmar Herfert and Gary Dykstra
Am J Hypertens 17: 185A-185A; doi:10.1016/j.amjhyper.2004.03.487
P-414: The effect of losartan versus candesartan on uric acid, renal function and hemostatic factors in patients with hypertension and diuretic-related hyperuricemia
Brian L. Rayner, Yvonne A. Trinder, Donette Baines and Lionel H. Opie UCT
Am J Hypertens 17: 185A-185A; doi:10.1016/j.amjhyper.2004.03.488
P-415: Losartan benefits over atenolol in non-smoking hypertensive patients with left ventricular hypertrophy: the life study
Henrik M. Reims, Sverre E. Kjeldsen, Richard B. Devereux, Suzanne Oparil, Stevo Julius, William E. Brady and Björn Dahlöf the LIFE Study Group
Am J Hypertens 17: 186A-186A; doi:10.1016/j.amjhyper.2004.03.489
P-416: The limits of antihypertensive therapy. what the first world can learn from the third world
Yackoob Kassim Seedat
Am J Hypertens 17: 186A-186A; doi:10.1016/j.amjhyper.2004.03.490
P-417: Effect of baseline cognitive function on outcomes in the study on cognition and prognosis in the elderly (scope)
Ingmar Skoog, Hans Lithell, Dag Elmfeldt, Albert Hofman, Bertil Olofsson, Peter Trenkwalder and Alberto Zanchetti
Am J Hypertens 17: 186A-187A; doi:10.1016/j.amjhyper.2004.03.491
P-173A: Results of the dream 3 study: blood pressure control in Saskatchewan first nations peoples with diabetes and hypertension
Sheldon Tobe, George Pylypchuk, Joan Wentworth, Susan Porter and Bev Bauer
Am J Hypertens 17: 96A-96A; doi:10.1016/j.amjhyper.2004.03.492
P-419: Preliminary data from hypertensive patients with albumiinuria & heart disease treated with irbesartan during a year. Design of koral-cardio study
Olga Velasco, Jose Ramon Gonzalez-Juanatey, Eduardo Alegria and Jesus Honorato KORAL CARDIO Investigators
Am J Hypertens 17: 187A-187A; doi:10.1016/j.amjhyper.2004.03.493
P-420: Effect of atenolol and losartan on 24-hour ambulatory blood pressure in patients with hypertension: A life substudy
Niels Wiinberg, Lia E. Bang, Kristian Wachtell, John Larsen, Christian Tuxen, Michael H. Olsen, Hans Ibsen and Per R. Hildebrandt
Am J Hypertens 17: 187A-187A; doi:10.1016/j.amjhyper.2004.03.494
P-421: Participant benefits throught hypertension clinical trials
Peter N. Johnson, Deborah S. King, Cathy M. Adair and Marion R. Wofford
Am J Hypertens 17: 188A-188A; doi:10.1016/j.amjhyper.2004.03.495
P-422: Outcomes in patients not receiving add-on therapy in the study on cognition and prognosis in the elderly (scope)
Alberto Zanchetti, Ingmar Skoog, Dag Elmfeldt, Albert Hofman, Bertil Olofsson, Peter Trenkwalder and Hans Lithell
Am J Hypertens 17: 188A-188A; doi:10.1016/j.amjhyper.2004.03.496
P-423: Incidence of MI is equivalent with verapamil SR-based and atenolol-based strategies in patients with hypertension and CAD: The international verapamil SR-trandolapril study
Jerome D. Cohen, Peter R. Kowey, Peter Sleight, Ann C. Hewkin, Eileen M. Handberg, Stuart R. Kupfer and Carl J. Pepine
Am J Hypertens 17: 189A-189A; doi:10.1016/j.amjhyper.2004.03.497
P-424: Reversion of ST-T alterations in hypertensives with LVH or coronary artery disease
Antonio R. Delgado-Almeida, Carlos L. Delgado-Leon and Antonio J. Delgado
Am J Hypertens 17: 189A-189A; doi:10.1016/j.amjhyper.2004.03.498
P-425: Relationship between leucocyte count changes and stress induced myocardial ischemia in hypertensive patients
Marina Z. Deljanin Ilic, Stevan N. Ilic, Predrag T. Milosavljevic, Ljubisa K. Nikolic and Dejan M. Petrovic
Am J Hypertens 17: 189A-190A; doi:10.1016/j.amjhyper.2004.03.499
P-426: Prevalence of chest pain or angina in hypertensive patients and their cardiovascular risk factor treatment and control
Brent M. Egan, Daniel T. Lackland and Susan Mayhan
Am J Hypertens 17: 190A-190A; doi:10.1016/j.amjhyper.2004.03.500
P-427: Hypertension and ischemic chest pain: strongly related-occurrences in olders
Aurelio Leone and Chiara Bellotto
Am J Hypertens 17: 190A-190A; doi:10.1016/j.amjhyper.2004.03.501
P-428: Lipid parameters and blood pressure in men with ischaemic heart disease and metabolic syndrome
S.A. Matveeva
Am J Hypertens 17: 190A-190A; doi:10.1016/j.amjhyper.2004.03.502
P-429: The association between body mass index and glucose in women with ischaemic heart disease and arterial hypertension and type 2 diabetes mellitus
S.A. Matveeva
Am J Hypertens 17: 190A-190A; doi:10.1016/j.amjhyper.2004.03.503
P-430: All-cause mortality and cardioprotection: equivalent efficacy of a verapamil-SR strategy compared with an atenolol strategy in hypertensive patients with CAD: the international verapamil SR-trandolapril study
Franz H. Messerli, Peter R. Kowey, Ann C. Hewkin, Stuart R. Kupfer and Carl J. Pepine
Am J Hypertens 17: 191A-191A; doi:10.1016/j.amjhyper.2004.03.504
P-431: Effects of body mass on blood pressure levels among whites and blacks in the evans county heart study
Jill E. Abell, Dan Lackland and Brent Egan
Am J Hypertens 17: 192A-192A; doi:10.1016/j.amjhyper.2004.03.505
P-432: Metabolic determinants of pulse pressure in hemodialysis patients
Serkan Kahraman, Mustafa Arici, Gultekin Genctoy, Rahmi Yilmaz, Bulent Altun, Alper Kirkpantur, Unal Yasavul and Sali Caglar
Am J Hypertens 17: 192A-192A; doi:10.1016/j.amjhyper.2004.03.506
P-433: An inflation of diagnostic tests in young hypertensive patients: a need for diagnostic guideline?
Alper Kirkpantur, Serkan Kahraman, Mustafa Arici, Gultekin Genctoy, Bulent Altun, Yunus Erdem, Unal Yasavul, Cetin Turgan and Sali Caglar
Am J Hypertens 17: 192A-192A; doi:10.1016/j.amjhyper.2004.03.507
P-434: Impact of abnormal nocturnal blood pressure fall on target organ damage in white coat hypertension
Gregory P. Vyssoulis, Eva A. Karpanou, Konstantinos A. Aznaouridis, Christina A. Chrysohoou, Andreas G. Marinakis, Dennis V. Cokkinos and Christodoulos I. Stefanadis
Am J Hypertens 17: 193A-193A; doi:10.1016/j.amjhyper.2004.03.508
P-435: Evaluation of hypertension prevalence and blood pressure goal attainment using data from the 1999–2000 national health and nutrition examination survey (nhanes)
Timothy J. Bell, Simon Tang and Michael J. Jamieson
Am J Hypertens 17: 193A-193A; doi:10.1016/j.amjhyper.2004.03.509
P-436: Hypertension prevalence and its control in the poland 2002–2003. polscreen project
Grazyna Broda, Andrzej Cieslinski, Stefan Rywik, Jerzy Adamus, Wiktor Szostak and Andrzej Rynkiewicz
Am J Hypertens 17: 193A-194A; doi:10.1016/j.amjhyper.2004.03.510
P-437: The impact of gender and age on left ventricular hypertrophy-related electrocardiographic abnormalities in patients with increased left ventricular mass
Navin Budhwani, Sanjeev Patel, Raghu Bejjanki, Allen Blaivas, Edward Dwyer and Muhamed Saric
Am J Hypertens 17: 194A-194A; doi:10.1016/j.amjhyper.2004.03.511
P-438: Prognostic impact of hypertensive urgencies on cardiovascular events
Andreas Bur, Harald Herkner, Marianne Vlcek, Christian Woisetschlaeger, Anton N. Laggner and Michael M. Hirschl
Am J Hypertens 17: 194A-194A; doi:10.1016/j.amjhyper.2004.03.512
P-439: Young patients with arterial hypertension and family history
Nanuli N. Burkadze, Marina M. Perashvili, Bella G. Bidzinashvili, Nino F. Sadradze and Dali D. Trapaidze
Am J Hypertens 17: 194A-194A; doi:10.1016/j.amjhyper.2004.03.513
P-440: Ethnic differences in central and augmentation index; do they account for differing susceptibility to left ventricular hypertrophy
Nishi Chaturvedi, Chakravarthi Rajkumar, William D. Strain, Petros Nihoyannopoulos, Angela C. Shore and Christopher J. Bulpitt
Am J Hypertens 17: 195A-195A; doi:10.1016/j.amjhyper.2004.03.514
P-440: Achievement of blood pressure goals for diabetic subpopulation in a hypertension clinic
Dave Y. Chua, Nitin Khosla, Peter Meyer, Gilberto S. Neri, George L. Bakris and William J. Elliott
Am J Hypertens 17: 195A-195A; doi:10.1016/j.amjhyper.2004.03.515
P-442: Ethnicity, left ventricular hypertrophy regression and cardiovascular events in the life echocardiography substudy
Richard B. Devereux, Kristian Wachtell, Eva Gerdts, Jackson Wright, Markku S. Nieminen, Vasilios Papademetriou, Jonathan M. Edelman, Kurt Boman, Bjorn Dahlof, Katherine E. Harris and Stevo Julius
Am J Hypertens 17: 195A-196A; doi:10.1016/j.amjhyper.2004.03.516
P-443: The t594m sodium channel polymorphism and stress-induced sodium excretion in black youth: A gene by environment interaction model of hypertension risk
Yanbin Dong, Gregory Harshfield, Haidong Zhu, Harold Snieder, David Ludwig and Frank Treiber
Am J Hypertens 17: 196A-196A; doi:10.1016/j.amjhyper.2004.03.517
P-444: Blood pressure and cardiovascular risk factors in hypertensive patients referred to a regional hospital in ghana
Seth Donkor, Seth Gordon, Per Omvik and Eva Gerdts
Am J Hypertens 17: 196A-196A; doi:10.1016/j.amjhyper.2004.03.518
P-445: Health care costs related to multi-drug treated hypertensives in the medicare population
John Flack, Roy C. Martin and Mary E. McGrory-Usset
Am J Hypertens 17: 196A-197A; doi:10.1016/j.amjhyper.2004.03.519
P-446: Higher anger-in scores are associated with increased left ventricular mass index
Lillian Gleiberman, Maria C. Delgado, Srijan Sen and Alan B. Weder
Am J Hypertens 17: 197A-197A; doi:10.1016/j.amjhyper.2004.03.520
P-447: Essential hypertensive patients predisposed to paroxysmal atrial fibrillation exhibit augmented plasma levels of brain natriuretic peptide
Amalia Hatziyianni, Kostas Tsioufis, Carmen Vasiliadi, John Kallikazaros and Christodoulos Stefanadis
Am J Hypertens 17: 197A-197A; doi:10.1016/j.amjhyper.2004.03.521
P-448: Renal failure incidence rates within countries are associated with hypertension treatment, not hypertension prevalence
Ralph G. Hawkins and Mark C. Houston
Am J Hypertens 17: 197A-198A; doi:10.1016/j.amjhyper.2004.03.522
P-449: Ethnicity and age related differences in treatment and control of dyslipidemia in hypertensive patients
Katharine H. Hendrix, Jessica Riehle and Brent M. Egan
Am J Hypertens 17: 198A-198A; doi:10.1016/j.amjhyper.2004.03.523
P-450: Differences in cardiovascular risk factor control rates by ethnicity: Using geocoding to identify and address health disparities
Katharine H. Hendrix, Daniel T. Lackland and Brent M. Egan
Am J Hypertens 17: 198A-198A; doi:10.1016/j.amjhyper.2004.03.524
P-451: Efficacy of a barbershop-based intervention to improve the treatment and control of hypertension in african american men
Paul L. Hess, Jason S. Reingold, Erica Ruger, Sharonda Clark, Gloria W. Griffin, David Leonard, Regina Waits, Keith Ferdinand, Robert Haley, Anne Freeman and Ronald G. Victor
Am J Hypertens 17: 198A-199A; doi:10.1016/j.amjhyper.2004.03.525
P-452: Impact of smoking and hypertension on plasma homocysteine level in a community-dwelling japanese population
Satoshi Hoshide, Kazuomi Kario, Kazuo Eguchi, Joji Ishikawa and Kazuyuki Shimada
Am J Hypertens 17: 199A-199A; doi:10.1016/j.amjhyper.2004.03.526
P-453: Investigation and analysis on psychological health status in patients with isolated sars and with sars and other diseases
Jian Zhang, Qi Hua and Xuewen Li
Am J Hypertens 17: 199A-199A; doi:10.1016/j.amjhyper.2004.03.527
P-454: Two decades of prevalence of hypertension and isolated systolic hypertension in japanese population
Shizukiyo Ishikawa, Yosikazu Nakamura, Kazuomi Kario, Joji Ishikawa, Kazuo Eguchi, Eiji Kajii and Kazuyuki Shimada
Am J Hypertens 17: 199A-200A; doi:10.1016/j.amjhyper.2004.03.528
P-455: Stress induced changes in pressure-natriuresis contribute to left ventricular filling in youth
Gaston K. Kapuku, Gregory A. Harshfield, Edmond Lesley, Lynne Mackey, Deloris Gillis, Corner Evans, Larry Hook, Sarita Vemulapalli and Martha Wilson
Am J Hypertens 17: 200A-200A; doi:10.1016/j.amjhyper.2004.03.529
P-456: Increased cardiovascular risk in white coat hypertensives with office isolated systolic hypertension
E.A. Karpanou, G.P. Vyssoulis, C.A. Chrysohoou, D.A. Papadogiannis, C.I. Stefanadis and D.V. Cokkinos
Am J Hypertens 17: 200A-200A; doi:10.1016/j.amjhyper.2004.03.530
P-457: Epidemiology of hypertension in the old old: data from the community in the 1990s
Donald M. Lloyd-Jones, Jane C. Evans and Daniel Levy
Am J Hypertens 17: 200A-200A; doi:10.1016/j.amjhyper.2004.03.531
P-458: Blood pressure in Portugal. distribution, awareness, treatment and control of hypertension. pap study
Mario A.E. Macedo, Maria J. Lima, Antonio O. Silva, Paula Alcantra and Jose Carmona
Am J Hypertens 17: 201A-201A; doi:10.1016/j.amjhyper.2004.03.532
P-459: May hypertension influence the seasonal variation of onset of myocardial infarction?
Roberto Manfredini, Massimo Gallerani, Benedetta Boari, Raffaella Salmi and Renato Fellin
Am J Hypertens 17: 201A-201A; doi:10.1016/j.amjhyper.2004.03.533
P-460: Which blood pressure value is the better marker of cardiovascular risk in the elderly?
Jesper Mehlsen
Am J Hypertens 17: 201A-201A; doi:10.1016/j.amjhyper.2004.03.534
P-461: Blood pressure and catecholamines in uygur centenarian in Xinjian, China
Hiromi Mitsubayashi, Hiroshi Kawamura, Yukio Ozawa, Yoichi Izumi, Medet Jumabay, Xiangyang Zhang and Mammet Yassen
Am J Hypertens 17: 202A-202A; doi:10.1016/j.amjhyper.2004.03.535
P-462: Endothelial progenitor cell senescence is related to telomerase activity in patients with hypertension
Chizu Moriwaki, Toshio Imanishi, Takuzo Hano and Ichiro Nishio
Am J Hypertens 17: 202A-202A; doi:10.1016/j.amjhyper.2004.03.536
P-463: Prevalence of hypertension in a large syncope population
Anne-Birgitte Pedersen and Jesper Mehlsen
Am J Hypertens 17: 202A-202A; doi:10.1016/j.amjhyper.2004.03.537
P-464: Relationship between mercury in blood and blood pressure in greenlanders and danes
Erling B. Pedersen, Marit E. Jørgensen, Michael B. Pedersen, Charlotte Siggaard, Tina B. Sørensen, Gert Mulvad, Jens C. Hansen, Gert Asmund and Henning Skjoldborg
Am J Hypertens 17: 202A-203A; doi:10.1016/j.amjhyper.2004.03.538
P-465: Current prevalence and control of hypertension in the primary care setting
Robert J. Petrella, Elizabeth Merikle and Farzad Ali
Am J Hypertens 17: 203A-203A; doi:10.1016/j.amjhyper.2004.03.539
P-466: Microalbuminuria detection and its association with cardiovascular risk markers in non_diabetic hypertensive patients evaluated by general practitioners
Jorge J. Polonia, Jose P. Carmona, Luis Pisco and Grant Support
Am J Hypertens 17: 203A-203A; doi:10.1016/j.amjhyper.2004.03.540
P-467: Racial differences in blood pressure control rates in the VA medical center
Shakaib U. Rehman, Brent M. Egan and Florence N. Hutchison
Am J Hypertens 17: 203A-204A; doi:10.1016/j.amjhyper.2004.03.541
P-468: Blood pressure control and anti-hypertensive medications in a population of diabetic hypertensives in the southeastern United States
Jessica E. Riehle, Daniel T. Lackland and Brent M. Egan
Am J Hypertens 17: 204A-204A; doi:10.1016/j.amjhyper.2004.03.542
P-469: The association of hypertension awareness, antihypertensive drug treatment, and lifestyle modification recommended by the physician with quality of life among older adults
Pilar Guallar-Castillon, Jose R. Banegas-Banegas, Esther Lopez-Garcia, Luz Leon, Ana Tabuenca and Fernando Rodriguez-Artalejo
Am J Hypertens 17: 204A-204A; doi:10.1016/j.amjhyper.2004.03.543
P-470: Cardiovascular risk factors in the elderly. accuracy of attention in primary care
Meritxell Sánchez-Amat, Alejandra Valero Suau, Mència Bené;tez-Camps, Antoni Dalfó Baqué, M.a Antònia, Vila Coll and Susana Pérez-Zamora
Am J Hypertens 17: 204A-205A; doi:10.1016/j.amjhyper.2004.03.544
P-471: To be non-dipper: a higher cardiovascular risk?
Carolina Galindo, Anna Soler, Meritxell Sanchez-Amat, Alejandra Valero, Mencia Benitez, Lluisa Fuentes, Antoni Dalfo, Maria Antonia Vila, Rosa Aragones and Oriol Rebagliato
Am J Hypertens 17: 205A-205A; doi:10.1016/j.amjhyper.2004.03.545
P-472: Coexistence of hypertension and hypercholesterolemia in employees of factories of northern greece
Panteleimon A. Sarafidis, Anastasios N. Lasaridis, Stavros Gousopoulos, Pantelis E. Zebekakis, Ioannis Tziolas and Fani Papoulidoy
Am J Hypertens 17: 205A-205A; doi:10.1016/j.amjhyper.2004.03.546
P-473: Hypertension in sub-Saharan Africa
Yackoob Kassim Seedat
Am J Hypertens 17: 205A-206A; doi:10.1016/j.amjhyper.2004.03.547
P-474: The risk of coronary heart disease, stroke or total cardiovascular events in hypertensive patients with hypercholesterolemia in Japanese population - sub-analysis of the J-LIT study, a large-scale observational cohort study
Kazuaki Shimamoto, Toru Kita, Hiroshi Mabuchi, Yuji Matsuzawa, Masunori Matsuzaki, Noriaki Nakaya, Shinichi Oikawa, Yasushi Saito, Jun Sasaki and Hiroshige Itakura
Am J Hypertens 17: 206A-206A; doi:10.1016/j.amjhyper.2004.03.548
P-475: Uncontrolled hypertension in Fabry disease
Gere Sunder-Plassmann, Francois Dehout, Andreas Schwarting, Abelardo Garcia de Lorenzo, Roberta Ricci, Christoph Kampmann, Michael Beck, Uma Ramaswami, Ales Linhart, Atul Mehta and Urs Widmer
Am J Hypertens 17: 206A-206A; doi:10.1016/j.amjhyper.2004.03.549
P-476: Hypertension and respiratory distress of the elderly with chief complaints of sleeping disturbance: a correlation analysis
Bing H. Tang
Am J Hypertens 17: 207A-207A; doi:10.1016/j.amjhyper.2004.03.550
P-477: A statewide plan for reducing cardiovascular disease and stroke
Sharon B. Wyatt, Evelyn R. Walker, Mary H. Connor, Samantha Heard, Deborah S. King, Tennille Howard, Jill Knight and Wanda Magers
Am J Hypertens 17: 207A-207A; doi:10.1016/j.amjhyper.2004.03.551
P-478: Effect of hypertension on sexual function in Japanese men
Minoru Yamakado, Yuko Ishizaka, Eiko Takahashi and Toshio Nakadate
Am J Hypertens 17: 207A-207A; doi:10.1016/j.amjhyper.2004.03.552
P-479: Hypertensive response to exercise in normotensives: special demographic and stress-test (related to cardiac autonomic nervous function) characteristics
Ilias Zarkos, Irini Vrana and Vasilis Tolis
Am J Hypertens 17: 208A-208A; doi:10.1016/j.amjhyper.2004.03.553
P-480: Autonomic nervous system function assessed by analysis of heart rate variability at rest and during exercise in hypertensive and normotensive subjects
Mario Biagini, Camillo Cammarota, Marco Prisco, Fabio Di Liberato, Veronica Fiori, Paolo Greziosi, Pietro Perelli, Romilda Romano and Mario Lanza
Am J Hypertens 17: 209A-209A; doi:10.1016/j.amjhyper.2004.03.554
P-481: Dopaminergic dilatation on cholinergic and electric induced contractions of rat isolated tracheal muscle
Gloria A. Cabezas, Ester Tabernero, Eduardo Romero and Manuel Velasco
Am J Hypertens 17: 209A-209A; doi:10.1016/j.amjhyper.2004.03.555
P-482: Divergent relationship of body mass index with plasma norepinephrine and epinephrine
Yehonatan Sharabi, David S. Goldstein, Courtney Holmes, Sandra Pechnik, Ehud Grossman and Graeme Eisenhofer
Am J Hypertens 17: 209A-209A; doi:10.1016/j.amjhyper.2004.03.556
P-483: Microalbuminuria in overweight and obese hypertensives
Emmanuel A. Andreadis, Georgios I. Tsourous, Charalambos V. Vassilopoulos, Evangelos P. Dimakakos, Monica G. Kakou, Maria P. Fotia, Georgia K. Yfanti and Emmanuel J. Diamantopoulos
Am J Hypertens 17: 210A-210A; doi:10.1016/j.amjhyper.2004.03.557
P-484: Blood pressure control is very difficult in patients with diabetic nephropathy and it is related to comorbidities
Jesus Arteaga, Maria Sorbet and Beatriz Espejo
Am J Hypertens 17: 210A-210A; doi:10.1016/j.amjhyper.2004.03.558
P-485: Insulin and chemoreceptors sensitivity
Agnieszka Ciarka, Sonia Velez-Roa, Miriam Cnop, Boutaina Najem, Robert Naeije, Jean-Paul Degaute, Fery Francoise and Philippe van de Borne
Am J Hypertens 17: 210A-210A; doi:10.1016/j.amjhyper.2004.03.559
P-486: Does increased waist-hip ratio predict augmented sympathetic contribution to vascular tone in humans?
Marcelo L.G. Correia, Alexei V. Agapitov, Christine A. Sinkey, John M. Dopp, Bradley G. Phillips and William G. Haynes
Am J Hypertens 17: 211A-211A; doi:10.1016/j.amjhyper.2004.03.560
P-487: Arterial hyperpension in the diabetic woman. Exist a difference in cardiovascular risk? demographic sub-analysis of diabetic patients of the Koral-HTA study
Fernando de Alvaro, Olga Velasco, Jesus Honorato, Carlos Calvo and Inma Parrondo
Am J Hypertens 17: 211A-211A; doi:10.1016/j.amjhyper.2004.03.561
P-488: Early endothelial activation in obese children
Giovambattista Desideri, Teresa Rosato, Gabriella Passacquale, Giuseppe Croce, Cristina Lippi, Letizia Valeri, Simona Broccoletti, Michele De Simone and Claudio Ferri
Am J Hypertens 17: 211A-211A; doi:10.1016/j.amjhyper.2004.03.562
P-489: Effect of valsartan on insulin sensitivity and leptin in hypertensive obese patients
Roberto Fogari, Giuseppe Derosa, Amedeo Mugellini, Paola Preti, Pierluigi Lazzari, Annalisa Zoppi and Carlo Pasotti
Am J Hypertens 17: 212A-212A; doi:10.1016/j.amjhyper.2004.03.563
P-490: PPAR-g2 Pro12Ala and the b3- adrenergic receptor Trp64Arg polymorphisms in Brazilian subjects: comparison between obese hypertensives and non obese individuals
Stenio F.P. Duarte, Sergio G. Barroso, Debora C.T. Valença, Virginia G. Abreu, Marcia M.G. Pimentel and Emilio A. Francischetti
Am J Hypertens 17: 212A-212A; doi:10.1016/j.amjhyper.2004.03.564
P-491: Intervention with rosiglitazone, a PPAR-
agonist in Brazilian obese subjects: effects on lipid profile and glucose tolerance
Sergio G. Barroso, Stenio F.P. Duarte, Maria L.G. Rodrigues, Antonio F. Sanjuliani, Virginia G. Abreu, Marcia M.G. Pimentel and Emilio A. Francischetti
Am J Hypertens 17: 212A-212A; doi:10.1016/j.amjhyper.2004.03.565
P-492: Insulin resistance in non-obese and overweight essential hypertensives from an urban population in Argentina
Delia Garrido, Maia Akopian, Aurora Renauld, Mauricio Soccol and Carlos A. Feldstein
Am J Hypertens 17: 213A-213A; doi:10.1016/j.amjhyper.2004.03.566
P-493: Metabolic changes during complete blockade of raa in diabetics hypertensive patients
Giovanni Gaudio, Alberto Schizzarotto, Ivano Cosini, Pietromario Bossi, Giuditta Riganti and Pietro Margaroli
Am J Hypertens 17: 213A-213A; doi:10.1016/j.amjhyper.2004.03.567
P-494: Detecting an risk factor of the metabolic syndrome in South Carolina State University freshmen: obesity
Theodosha S. Gilliard, Brent Egan, Daniel Lackland and Robert Woolson
Am J Hypertens 17: 213A-213A; doi:10.1016/j.amjhyper.2004.03.568
P-495: Relationships between endogenous insulin secretion and insulin resistance and blood pressure in obesity
Olga González-Albarrán, Carlos Roa, Pedro Pines, José Maré;a Sancho and Rafael Garcé;a-Robles
Am J Hypertens 17: 213A-214A; doi:10.1016/j.amjhyper.2004.03.569
P-496: Altered nocturnal decline of blood pressure in hypertensive patients with type 2 diabetes mellitus
Ramon C. Hermida, Carlos Calvo, Diana E. Ayala, Maria J. Dominguez, Manuel Covelo, Artemio Mojon, Jose R. Fernandez, Maria J. Fontao, Rita Soler and Jose E. Lopez
Am J Hypertens 17: 214A-214A; doi:10.1016/j.amjhyper.2004.03.570
P-497: Elevated ambulatory pulse pressure in hypertensive patients with type 2 diabetes mellitus
Ramon C. Hermida, Carlos Calvo, Diana E. Ayala, Maria J. Dominguez, Manuel Covelo, Artemio Mojon, Jose R. Fernandez and Jose E. Lopez
Am J Hypertens 17: 214A-214A; doi:10.1016/j.amjhyper.2004.03.571
P-498: Tempol reduces oxidative stress, improves insulin sensitivity and restores renal dopamine D1 receptor-G protein coupling and function in obese Zucker rats
Anees Ahmad Banday, Aditi Marwaha and Mustafa F. Lokhandwala
Am J Hypertens 17: 214A-215A; doi:10.1016/j.amjhyper.2004.03.572
P-499: Association between nocturnal hypoxia and diabetes mellitus in Japanese hypertensives with and without obesity
Masato Morinari, Kazuomi Kario, Satoshi Hoshide, Kazuo Eguchi, Joji Ishikawa and Kazuyuki Shimada
Am J Hypertens 17: 215A-215A; doi:10.1016/j.amjhyper.2004.03.573
P-500: Obesity but not nocturnal hypoxia is associated with increased ambulatory blood pressure level in Japanese hypertensives
Masato Morinari, Kazuomi Kario, Satoshi Hoshide, Kazuo Eguchi, Joji Ishikawa and Kazuyuki Shimada
Am J Hypertens 17: 215A-216A; doi:10.1016/j.amjhyper.2004.03.574
P-501: Dietary fish oil prevents hypertension, oxidative stress and suppression of endothelial nitric oxide synthase expression in fructose-fed rats
Michael D. Nyby, Karolin Abedi, Pirooz Eslami, Gustavo Hernandez, Victoria Smutko, Morris E. Berger and Michael L. Tuck
Am J Hypertens 17: 216A-216A; doi:10.1016/j.amjhyper.2004.03.575
P-502: Insulin resistance and insulin secretion under prolonged enalapril treatment
Mariya A. Orynchak, Evgen M. Neyko, Olga S. Chovganyuk and Vasyl E. Neyko
Am J Hypertens 17: 216A-216A; doi:10.1016/j.amjhyper.2004.03.576
P-503: High prevalence of the metabolic syndrome and its components in a veteran population
Deborah I. Panebianco, Karen A. Tisdel, Sonja K. Fredrickson, Brandi C. Bradley and Franklin J. Zieve
Am J Hypertens 17: 216A-217A; doi:10.1016/j.amjhyper.2004.03.577
P-504: The effect of a regular exercise program in the control of blood pressure and plasma glucose levels in tipe II sedentary diabetic patients
Albertino Damasceno, Paula Caupers, Antonio Prista, B. Fernhaall, B. Chemane, O. Pateguane and Jorge Polonia
Am J Hypertens 17: 217A-217A; doi:10.1016/j.amjhyper.2004.03.578
P-505: Regional variation in leptin-induced sympathoactivation in agouti obese mice
Kamal Rahmouni, William G. Haynes, Donald A. Morgan, Gina M. Morgan, Marcelo L.G. Correia and Allyn L. Mark
Am J Hypertens 17: 217A-217A; doi:10.1016/j.amjhyper.2004.03.579
P-506: Retinal changes in the cohen-rosenthal diabetic (non-insulin-dependent) hypertensive rat model
Aharon Greenbaum, Talma Rosenthal, Mordechai Rosner and Arie Solomon
Am J Hypertens 17: 218A-218A; doi:10.1016/j.amjhyper.2004.03.580
P-507: Endothelial impact of insulin resistance in hypertensive patients
Elena Sanchez-Largo, David Coca, Olivia Sanchez, Enrique Bernal, Ana Bajo, Rosa Fabregate, Judith Marquez and Jose Saban-Ruiz
Am J Hypertens 17: 218A-218A; doi:10.1016/j.amjhyper.2004.03.581
P-508: The effects of telmisartan and lercanidipine on blood pressure and insulin resistance in hypertensive patients
Panteleimon A. Sarafidis, Anastasios N. Lasaridis, Lina Hatzistavri, Pantelis E. Zebekakis, Ioannis Tziolas and Athanasios Diamantopoulos
Am J Hypertens 17: 218A-219A; doi:10.1016/j.amjhyper.2004.03.582
P-509: Antiphospholipid syndrome and metabolic syndrome - myth or pathogenetic reality?
Larysa P. Sydorchuk, Igor I. Sydorchuk, Ruslan I. Sydorchuk and Mykola M. Mozol
Am J Hypertens 17: 219A-219A; doi:10.1016/j.amjhyper.2004.03.583
P-510: Ace inhibition ameliorates cardiac steatosis in obese zucker rats
Jorge E. Toblli, Gabriel Cao, Graciela De Rosa, Pablo Piorno and Patricia Pagano
Am J Hypertens 17: 219A-219A; doi:10.1016/j.amjhyper.2004.03.584
P-511: Orlistat-induced weight loss contributes to more effective blood pressure control in treated obese essential hypertensive subjects
C. Tsioufis, V. Katsi, K. Dimitriadis, I. Kallikazaros and C. Stefanadis
Am J Hypertens 17: 219A-220A; doi:10.1016/j.amjhyper.2004.03.585
P-512: Heart rate control in hypertensive subjects with type 2 diabetes mellitus
Andris Vitols, Daina Voita, Mara Vitola and Vitolds Mackevics
Am J Hypertens 17: 220A-220A; doi:10.1016/j.amjhyper.2004.03.586
P-513: High fat plus high salt diet induced metabolic syndrome in wistar rat
Chengyi Shen, Zhiming Zhu, Zhencheng Yan and Yinxing Ni
Am J Hypertens 17: 220A-220A; doi:10.1016/j.amjhyper.2004.03.587
P-514: Polymorphism of peroxisome proliferator activated receptor delta in the patients with metabolic syndrome
Zhencheng Yan, Zhiming Zhu, Chengyi Shen, Yinxing Ni and Gang Zhang
Am J Hypertens 17: 220A-221A; doi:10.1016/j.amjhyper.2004.03.588
P-515: Effect of medication compliance with antihypertensive therapy on blood pressure control
Philip P. Gerbino, Brian S. Nightengale, Thomas J. Bramley and Feride Frech
Am J Hypertens 17: 222A-222A; doi:10.1016/j.amjhyper.2004.03.589
P-516: Improving medication adherence in a southeastern hypertension clinic using adhererx
Deborah S. King, Stephanie J. Barud, Marion R. Wofford, Sara L. Noble, Tibb M. Fontenot, Rebecca R. Reed, Kimberly G. Harkins, Jimmy L. Stewart, Sharon B. Wyatt and Angee McDaniel
Am J Hypertens 17: 222A-222A; doi:10.1016/j.amjhyper.2004.03.590
P-517: Correlates of hypertension control in a primary care setting
Thomas G. Majernick, Nancy A. Madden, Christopher Zacker, Daniel A. Belletti and Stephen Arcona
Am J Hypertens 17: 222A-223A; doi:10.1016/j.amjhyper.2004.03.591
P-518: Compliance patterns of patients treated with 2 separate antihypertensive agents versus fixed-dose combination therapy
Robert Wanovich, Patrick Kerrish, Philip P. Gerbino and Omar Shoheiber
Am J Hypertens 17: 223A-223A; doi:10.1016/j.amjhyper.2004.03.592
P-519: Telemonitoring of blood pressure self-measurement (BPSM) in a postmarketing surveillance study with an AT-1 receptor antagonist -the olmetel study
Sakir Uen, Silke Ewald, Stefanie Kaufmann, Johannes vor dem Esche and Thomas Mengden
Am J Hypertens 17: 223A-223A; doi:10.1016/j.amjhyper.2004.03.593
P-520: A low uric acid clearance after pre eclampsia is a risk factor for further high blood pressure
Claudine Guéret, Jean-Claude Alphonse and Patrice Deteix
Am J Hypertens 17: 224A-224A; doi:10.1016/j.amjhyper.2004.03.594
P-521: Microalbuminuria and fundoscopy. its relation with time of evolution of arterial hypertention and type II diabetes mellitus
Margarita Egaña Arucas, Isabel Otero Alba, Xiomara Gracial Baralt and Grisel Fernández Labadiño
Am J Hypertens 17: 224A-224A; doi:10.1016/j.amjhyper.2004.03.595
P-522: Screening for depression and anxiety in a hypertension specialty clinic
Stephanie J. Barud, Deborah S. King, Rebecca R. Reed, Kimberly G. Harkins, Marion R. Wofford and Sara L. Noble
Am J Hypertens 17: 224A-224A; doi:10.1016/j.amjhyper.2004.03.596
P-523: Quality of life assessments predict hospitalization in patients with heart failure
Becky Briesacher, Ileana Pina, Puneet Singhal and Feride Frech
Am J Hypertens 17: 225A-225A; doi:10.1016/j.amjhyper.2004.03.597
P-524: Blood pressure control, its impact on cardiovascular risk. differences between men and women (coronaria study)
Juan Cosé;n, Jose Luis Zamorano, Luis Rodriguez-Padial, Amparo Hernandiz, Amparo Aguilar, Rosa Aristegui and Beatriz Armada
Am J Hypertens 17: 225A-225A; doi:10.1016/j.amjhyper.2004.03.598
P-525: Blood pressure control its impact on cardiovascular risk in diabetic patients (coronaria study)
Luis Rodriguez-Padial, Juan Cosé;n, Jose Luis Zamorano, Amparo Hernandiz, Amparo Aguilar, Rosa Aristegui and Beatriz Armada
Am J Hypertens 17: 225A-225A; doi:10.1016/j.amjhyper.2004.03.599
P-526: Female smokers are at high risk for cardiac hypertrophy: gender-related difference in the impact of smoking on hypertensive target organ damage
Kazuo Eguchi, Kazuomi Kario, Satoshi Hoshide, Joji Ishikawa and Kazuyuki Shimada
Am J Hypertens 17: 226A-226A; doi:10.1016/j.amjhyper.2004.03.600
P-527: Asymptomatic nocturnal hypoxia is a major predictor of silent cerebrovascular disease in a high-risk but apparently healthy japanese community-dwelling population
Kazuo Eguchi, Kazuomi Kario, Satoshi Hoshide and Kazuyuki Shimada
Am J Hypertens 17: 226A-226A; doi:10.1016/j.amjhyper.2004.03.601
P-528: Uric acid: is it a determinant of left ventricular mass progression in men?
Pierre Fesler, Guilhem du Cailar, Jean Ribstein and Albert Mimran
Am J Hypertens 17: 226A-226A; doi:10.1016/j.amjhyper.2004.03.602
P-529: The relationship between stress-induced neurophysiologic responces and common carotid artery ultrasonographic imaging in normotensive and pre-hypertensive adults
William Gabbard, Grant Butterbaugh, Erwin A. Aguilar, Jie Liao, Betsy Roques, Marcy Rose, Richard Costa, Kenneth Tourgemann and Efrain Reisin
Am J Hypertens 17: 226A-227A; doi:10.1016/j.amjhyper.2004.03.603
P-530: Relationship between waist circumference and other risk factors for cardiovascular and cerebrovascular diseases in diabetic hypertensive patients
Giovanni Gaudio, Alberto Schizzarotto, Ivano Cosini, Adriano Daverio, Pietromario Bossi, Marco Scaltritti, Pietro Margaroli and Luigina Guasti
Am J Hypertens 17: 227A-227A; doi:10.1016/j.amjhyper.2004.03.604
P-531: Follow-up assessment of cardiovascular risk factor awareness in rural Mississippi high school students
T.Kristopher Harrell, Deborah S. King, Marion R. Wofford, Sara L. Noble and Daniel W. Jones
Am J Hypertens 17: 227A-227A; doi:10.1016/j.amjhyper.2004.03.605
P-532: High plasma levels of brain natriuretic peptide and prolonged P-Wave dispersion as predictive factors of paroxysmal atrial fibrillation in essential hypertension
Amalia Hatziyianni, Kostas Tsioufis, Marina Toutouza, John Kallikazaros and Christodoulos Stefanadis
Am J Hypertens 17: 227A-228A; doi:10.1016/j.amjhyper.2004.03.606
P-533: BNP plasma levels or left atrial dimension for the prediction of paroxysmal atrial fibrillation in subjects with essential hypertension?
Amalia Hatziyianni, Kostas Tsioufis, Marina Toutouza, John Kallikazaros and Chris Stefanadis
Am J Hypertens 17: 228A-228A; doi:10.1016/j.amjhyper.2004.03.607
P-534: Cardiovascular disease education and community awareness: training high school students as health promoters
Deborah S. King, Thomas K. Harrell, Robert L. Hester, Peter N. Johnson, Marion R. Wofford and Sara L. Noble
Am J Hypertens 17: 228A-228A; doi:10.1016/j.amjhyper.2004.03.608
P-535: Cardiovascular health awareness among rural Mississippi high school students: school-wide versus high achievers
Deborah S. King, Thomas K. Harrell, Peter N. Jo